Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),0.8544141381800128,2.363782740974261,0.0,0.0,0.0,8/22,2.65%,PTGDS;ALDH1A2;ADH7;ADH4;RBP1;ABCA4;CYP26B1;CRABP2
prerank,cadherin binding (GO:0045296),-0.47210110397009847,-2.213399240778803,0.0,0.0010201686720595828,0.001,117/315,16.13%,PTPRM;DOCK9;SPTBN1;COBLL1;PTPRB;FMNL2;STXBP6;CDH11;ABI1;AHNAK;PDLIM5;MRTFB;DAB2IP;BMPR2;CALD1;ESYT2;MYO1B;BSG;TJP1;ITGA6;VCL;LRRFIP1;FXYD5;CLINT1;NOTCH3;ACVR1;PROM1;WASF2;YWHAE;CDH13;MYH9;IQGAP1;EGFR;CDH1;MACF1;TMPO;PTPRJ;KDR;TAGLN2;CAST;F11R;CTNNA1;YWHAB;EIF3E;SERBP1;FLNA;PHLDB2;CHMP2B;TJP2;ITGB1;MB21D2;PAK2;NUMB;RACK1;EEF2;PPFIBP1;SNX1;TRIM25;SPTAN1;CLIC1;NCK1;ANXA1;APC;EPN2;ALDOA;CHMP4B;TRPC4;SCYL1;RPL29;SWAP70;KTN1;RPL7A;CNN2;RPS26;STK24;TMOD3;LDHA;VASN;SRC;RPL6;GAPVD1;PPP1CA;PTPN1;EPS8L2;CTNNA3;CD2AP;S100A11;PSMB6;YWHAZ;LRRC59;PRDX6;RPL24;FASN;TES;PARVA;CAPG;FNBP1L;EHD4;LIMA1;ARHGAP1;PFN1;RPL34;SHTN1;STK38;IST1;TBC1D10A;CIP2A;RAB11B;CDH2;VAPB;RPL14;SNX2;GOLGA3;CD46;CBL;CEMIP2;RTN4
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.8431906401374543,-2.1092443912182293,0.0,0.004080674688238331,0.006,6/12,6.15%,PDE4D;PDE3A;PDE7B;PDE8A;PDE8B;PDE2A
prerank,amino acid:sodium symporter activity (GO:0005283),0.8246986498310622,1.9896910627844488,0.001953125,0.05846760624049321,0.097,4/11,4.11%,SLC6A13;SLC6A1;SLC6A12;SLC38A1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.875421482441644,1.9782841519712906,0.0,0.04651204530056043,0.112,3/10,0.49%,SLC6A13;SLC6A1;SLC6A12
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.7522736994994572,1.931258796253833,0.001876172607879925,0.06976806795084065,0.218,7/15,10.86%,ALDH1A2;ADH4;ALDH1L1;ALDH7A1;ALDH1A1;ALDH3B1;ALDH2
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.5893657586958485,-1.923506883223215,0.0,0.051688546051018865,0.131,11/34,11.99%,CYTH3;MYO10;MYO1B;ARAP2;PARD3;IQGAP1;ARAP3;ARAP1;ZFYVE16;JPH2;HIP1R
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.7108726160940221,-1.9089183954170523,0.0,0.04565254807466633,0.151,7/17,7.48%,ATP10A;PITPNC1;ATP8B1;ABCA1;PLTP;ABCA3;MTTP
prerank,histone demethylase activity (GO:0032452),0.6497952332659376,1.9003473988195005,0.0019157088122605363,0.08352515177213315,0.309,10/27,12.21%,KDM7A;FBXL19;PHF8;JARID2;PHF2;KDM5B;KDM6B;KDM2A;KDM5C;KDM4A
prerank,cAMP binding (GO:0030552),-0.7582745933872159,-1.8378245871583343,0.003937007874015748,0.10242493467478211,0.365,5/11,7.78%,PDE4D;RAPGEF2;PDE10A;PDE2A;RAPGEF4
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7684769226338283,1.8360010942296843,0.0,0.16295593335935782,0.537,4/11,2.78%,SLC5A3;SLC5A10;SLC23A2;SLC23A1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.6108822131923459,-1.7830557059669438,0.00663716814159292,0.16968805578591062,0.597,8/21,6.15%,PDE4D;PDE3A;PDE7B;PDE8A;PDE8B;PDE10A;PDE9A;PDE2A
prerank,retinoic acid binding (GO:0001972),0.7392880511776367,1.777137223038659,0.011976047904191617,0.26503443116939057,0.768,4/12,16.56%,CYP26B1;NR2F2;RXRA;RARA
prerank,AMP binding (GO:0016208),0.7566397530433585,1.7725879959047304,0.002004008016032064,0.24210010903363888,0.785,5/11,11.40%,PRKAG2;PRKAG3;ACSS2;MPPED2;PYGL
prerank,vinculin binding (GO:0017166),-0.7172559948695402,-1.771917091394917,0.004016064257028112,0.16293551076608767,0.64,4/11,6.66%,UTRN;CTNNA1;ACTN1;PXN
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.7070953972095674,1.7697482714850004,0.007874015748031496,0.22153272280478192,0.793,11/15,16.31%,HS3ST3A1;HS3ST3B1;HS6ST1;HS6ST3;NDST1;NDST4;HS3ST5;HS3ST6;HS6ST2;HS2ST1;NDST2
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.7131708519339599,1.763466472196866,0.018,0.2139226534210987,0.819,6/12,19.06%,KDM7A;PHF8;PHF2;KDM4A;KDM1A;KDM3B
prerank,acid-thiol ligase activity (GO:0016878),0.7093738842363942,1.7534907127391421,0.007827788649706457,0.21528942863191539,0.84,5/13,9.95%,ACSL1;ACSM2A;ACSM2B;AASDH;ACSS2
prerank,sulfotransferase activity (GO:0008146),0.5666650329498677,1.7301087850891075,0.005597014925373134,0.24664485993888738,0.901,6/33,4.32%,HS3ST3A1;UST;CHST4;CHST15;HS6ST1;CHST10
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.508375928029454,-1.7292681211810632,0.002173913043478261,0.22277933376101142,0.787,15/42,13.02%,STXBP6;PDLIM5;BSG;ESAM;CD200;PALLD;NPTN;ROBO4;ANXA1;TMOD3;PPP1CA;S100A11;DSCAML1;JAM3;EMB
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.635073749733721,-1.7243963430061275,0.008350730688935281,0.18730296819013942,0.805,4/16,3.78%,PTPRM;PTPRB;PTPRG;PTPRK
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.635073749733721,-1.7243963430061275,0.008350730688935281,0.18730296819013942,0.805,4/16,3.78%,PTPRM;PTPRB;PTPRG;PTPRK
prerank,ligand-gated ion channel activity (GO:0015276),0.5709434761933835,1.7092731902850293,0.016728624535315983,0.27604873689758397,0.936,8/30,8.95%,ANXA6;TRPV1;GRIN3A;GRID2;GRIN2D;GRIK5;GRIK2;CHRNB2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5019174991588884,1.7047897534149976,0.005454545454545455,0.2668593504518069,0.944,10/55,4.11%,SLC16A6;SLC6A13;SLC13A3;SLC6A12;SLC16A11;SLC38A3;SLC23A2;SLC23A1;SLC16A12;SLC38A1
prerank,actin binding (GO:0003779),-0.39182145086891795,-1.6984351160518898,0.0,0.22276774093519255,0.885,47/170,17.80%,UTRN;SYNE1;ACTN4;PDLIM5;MYRIP;CALD1;ABLIM1;VCL;MICAL2;NOS3;TMSB4X;FXYD5;GSN;PARVB;SMTN;MYH9;MACF1;MTSS1;SSH2;ITGB1;CAP2;EPS8;MSRB2;KLHL2;ALDOA;TPM2;CEACAM1;SYNPO2;CAP1;EPS8L2;MYO19;MYO1F;TMSB10;PARVA;LDB3;LIMA1;PFN1;TRPV4;AVIL;FERMT2;TLNRD1;MAP1B;KLHL1;MYL4;DMD;PHACTR2;NOD2
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.572311741518491,1.6969046361474351,0.00945179584120983,0.26675640628715785,0.957,7/26,4.62%,SLC16A6;SLC6A13;SLC6A1;SLC6A12;SLC16A11;SLC16A12;MPC2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.5675171416770578,-1.6962893607199596,0.006696428571428571,0.2093046058842244,0.889,8/23,6.15%,PDE4D;PDE3A;PDE7B;PDE8A;PDE8B;PDE10A;PDE9A;PDE2A
prerank,phospholipid transfer activity (GO:0120014),-0.5800540179156713,-1.679295800525261,0.006382978723404255,0.22851778254134658,0.923,16/21,28.78%,PITPNC1;CERT1;PLEKHA8;PLTP;TNFAIP8L3;ABCA3;MTTP;PRELID3B;PITPNB;GLTP;TRIAP1;C2CD2L;PRELID2;PITPNM1;PLEKHA3;CPTP
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.41377680105728715,-1.6621836713696256,0.0026595744680851063,0.2497227170820136,0.955,23/100,10.71%,HIP1;CYTH3;MYO10;PLA2G4A;DAB2IP;MYO1B;ARAP2;PARD3;CERT1;IQGAP1;ARAP3;WIPI1;SNX13;ANKFY1;PLEKHA8;ARAP1;OSBP;PLEKHA4;SH3PXD2B;ZFYVE16;GOLPH3;PLEKHA5;JPH2
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.6652943340774264,1.6589454347207295,0.013232514177693762,0.34269878447684043,0.982,2/15,0.79%,CCR9;ACKR2
prerank,calcium:sodium antiporter activity (GO:0005432),0.7239128055258416,1.6527749187174499,0.01006036217303823,0.33959188004240987,0.983,2/10,0.71%,SLC8A3;SLC24A3
prerank,alkali metal ion binding (GO:0031420),0.6782244563954885,1.6435124190370822,0.03067484662576687,0.3460561680284654,0.99,4/13,9.77%,ATP1A2;CAPN3;ACAT1;DRG1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.5314383839596641,-1.6427322926812113,0.006396588486140725,0.2771458225761867,0.978,11/28,20.45%,DAB2IP;TRAF5;TRIM37;FEM1B;CASP8AP2;BABAM2;MADD;TMBIM1;RIPK1;TRAF4;MYD88
prerank,Tat protein binding (GO:0030957),-0.6984364493646565,-1.6398686286948632,0.013944223107569721,0.2667741077435809,0.981,3/10,4.30%,ACTB;MDFIC;DNAJA1
prerank,CoA-ligase activity (GO:0016405),0.6451212627886318,1.6369644975700377,0.0273972602739726,0.3468233237052167,0.991,4/14,9.95%,ACSL1;ACSM2A;ACSM2B;ACSS2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.7180537032185328,1.6270383147749699,0.027726432532347505,0.35763504691138664,0.993,1/10,0.04%,PRKAG2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.6538431267456375,1.6239771385173076,0.028142589118198873,0.3485127901394105,0.993,5/13,10.86%,ALDH1A2;ALDH1L1;ALDH7A1;ALDH1A1;ALDH2
prerank,glycerophospholipid flippase activity (GO:0140333),-0.6656171740544486,-1.617920641058805,0.018329938900203666,0.30641066114919,0.99,5/11,7.43%,ATP10A;ATP8B1;ATP8A1;ABCA3;ATP11C
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.43739480980627465,-1.617671953558532,0.016241299303944315,0.2900679590889414,0.99,13/60,5.92%,NRP1;TEK;ROR1;NTRK3;NRP2;TIE1;INSR;MERTK;CRIM1;EGFR;KDR;FLT1;MET
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.6990700431110041,1.615004395786529,0.027139874739039668,0.3569695256486033,0.995,4/10,12.21%,KDM7A;PHF8;KDM2A;KDM4A
prerank,cyclic nucleotide binding (GO:0030551),-0.554394620763633,-1.6066712032686796,0.021367521367521368,0.30121822369759266,0.991,5/21,7.78%,PDE4D;RAPGEF2;PDE10A;PDE2A;RAPGEF4
prerank,lipase activity (GO:0016298),0.49408218723698555,1.6046556977463589,0.014336917562724014,0.3686642120929601,0.998,11/43,12.23%,LIPA;CEL;PLA1A;DDHD2;ABHD5;SMPD3;PNPLA8;SEC23IP;SMPD2;PLA2G15;ABHD3
prerank,phospholipase C activity (GO:0004629),-0.5323930654223644,-1.5946076111270635,0.017543859649122806,0.3149770774983962,0.994,6/25,4.35%,PLCB4;PLCE1;EDNRA;PLCL1;PLCG1;PLCG2
prerank,triglyceride lipase activity (GO:0004806),0.5749475362218377,1.5911786069490295,0.02895752895752896,0.39002970381438257,0.999,4/20,11.61%,CEL;DDHD2;ABHD5;PLA2G15
prerank,store-operated calcium channel activity (GO:0015279),-0.678341848983057,-1.5885201505445399,0.01953125,0.3145034277577971,0.994,5/10,9.58%,STIM2;TRPC3;TRPC6;TRPC4;TRPC1
prerank,fatty acid synthase activity (GO:0004312),-0.6899730028184223,-1.5831443818097568,0.018255578093306288,0.3137946092648726,0.995,6/10,18.22%,ELOVL7;ELOVL5;ELOVL6;ELOVL1;ELOVL4;MCAT
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.5071580337670514,-1.582702168548948,0.022935779816513763,0.3010384685768865,0.995,11/30,14.68%,GAS6;CAST;RPS6KA3;CARD16;CST3;XIAP;TNFAIP8;SERPINB9;BIRC3;PTTG1;MT3
prerank,semaphorin receptor binding (GO:0030215),-0.5442160530998196,-1.5768029513064725,0.02107728337236534,0.3029050815456911,0.998,13/23,28.58%,SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;SEMA6D;SEMA5A;SEMA3F;SEMA4C;SEMA4D;SEMA4F;SEMA6B
prerank,death receptor binding (GO:0005123),-0.6031485999862307,-1.5724959803473604,0.030303030303030304,0.3009089515106945,0.998,11/15,31.04%,DAB2IP;NGF;FEM1B;CASP8AP2;MADD;TMBIM1;RIPK1;MYD88;FADD;EDA;PIDD1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.6657890017308947,1.5685788457967504,0.03696498054474708,0.4394012572520831,1.0,1/11,0.05%,PPP1R1A
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.6456836765897087,-1.5668211274782078,0.03512396694214876,0.3027546720619901,1.0,5/11,21.29%,MAP3K5;EGFR;MAP3K20;MAP3K6;MAP3K4
prerank,SUMO binding (GO:0032183),-0.6256469990809552,-1.5639992024372482,0.03512396694214876,0.2982670924903092,1.0,6/13,17.34%,RNF111;HERC2;SERBP1;CASP8AP2;USPL1;TDG
prerank,outward rectifier potassium channel activity (GO:0015271),0.6594749726018638,1.561822279141757,0.03495145631067961,0.44052903577193847,1.0,4/11,7.48%,KCNK2;KCND3;KCNT1;KCND2
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.3522644004724218,-1.5481351567649746,0.0,0.3257617177458832,1.0,58/173,21.38%,KLF12;FOXP1;ZBTB16;ELK3;ZFHX3;TRPS1;ZEB1;LRRFIP1;FOXP2;PLAGL1;PPARD;TBX3;FOXO3;CTCF;PRDM16;TBX18;DACH1;ZNF25;JUN;BHLHE40;KLF8;CREB3L1;HES1;JDP2;ZNF3;TGIF1;ZNF436;NACC2;HEYL;ZBTB1;PRDM5;HEY2;MAFK;ETS2;SREBF2;HHEX;ETV6;NACC1;TBX2;NFIL3;SP2;SKIL;ZBTB5;ZBTB33;ZFP57;BCL6B;HEY1;ZBTB37;NR2F1;NFATC3;PRDM1;ZNF177;ATF3;ZBTB45;ZBTB25;THAP1;SKI;SOX13
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.6289180377501321,-1.5473204035497765,0.03275529865125241,0.31621711010839965,1.0,3/12,2.71%,DAB2IP;VEGFC;ITGA5
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.610585230770909,1.5448636241657994,0.05846774193548387,0.47702142234307154,1.0,5/16,13.22%,IDO1;ETHE1;ADI1;HAAO;CDO1
prerank,MAP kinase activity (GO:0004707),0.606712615376272,1.5447424542098425,0.045275590551181105,0.46044117279428026,1.0,5/14,11.92%,MAPK4;MAPK6;MAPK10;MAPK14;MAPK9
prerank,cGMP binding (GO:0030553),-0.6244539560683358,-1.543457310706393,0.045081967213114756,0.3146880297079793,1.0,3/11,6.15%,RAPGEF2;PDE10A;PDE2A
prerank,ligand-gated channel activity (GO:0022834),0.5206105900072882,1.5385512391894995,0.0375234521575985,0.4623871079442308,1.0,7/29,8.95%,ANXA6;GRIN3A;GRID2;GRIN2D;GRIK5;GRIK2;CHRNB2
prerank,CARD domain binding (GO:0050700),-0.5899525013131006,-1.5374524604332536,0.042826552462526764,0.3177331783462991,1.0,9/14,28.72%,CARD14;NOD1;CARD16;NOD2;CARD19;RIPK2;BCL10;CASP1;CASP4
prerank,ion channel activity (GO:0005216),0.4324863552779778,1.534733242675032,0.00922509225092251,0.4588642553630641,1.0,13/80,8.95%,TRPM3;ANXA6;TRPM6;TRPV1;TMEM120B;GRIN3A;GRID2;GRIN2D;NALCN;GRIK5;GRIK2;UNC80;CHRNB2
prerank,phosphoric ester hydrolase activity (GO:0042578),0.4552841923802383,1.530863272857793,0.023636363636363636,0.4547762248481193,1.0,11/49,14.08%,ATP1A2;DUSP11;PXYLP1;PRUNE1;ARMT1;ACP6;MPPED2;PPP1CB;DUSP28;EPHX2;PTPRO
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.41860855445104755,-1.5296170605810218,0.021479713603818614,0.3269002988530926,1.0,13/60,5.92%,TEK;ROR1;NTRK3;ACVR1;TIE1;ACVRL1;INSR;MERTK;EGFR;KDR;TGFBR2;FLT1;MET
prerank,N-acetyltransferase activity (GO:0008080),0.5706678171589842,1.5195791011447857,0.053604436229205174,0.47203993861809956,1.0,4/19,6.77%,GNPNAT1;SAT1;ATAT1;NAT2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5429398714845474,-1.5165439681240058,0.05010438413361169,0.34843397281162297,1.0,7/18,3.58%,LTBP4;BMPR2;LTBP1;ACVR1;ACVRL1;ENG;TGFBR2
prerank,BMP binding (GO:0036122),-0.6217219936400262,-1.511570243849224,0.06237816764132553,0.349467780102293,1.0,3/11,2.10%,BMPR2;ENG;GREM2
prerank,LRR domain binding (GO:0030275),0.6041042624796111,1.5097563676413177,0.06289308176100629,0.4856369697867093,1.0,2/14,2.35%,ROBO1;PAWR
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.5655542719665303,1.5083997849254303,0.056925996204933584,0.47516851912997965,1.0,6/18,10.86%,ALDH1A2;ALDH8A1;ADH4;ALDH1A1;ALDH3B1;ALDH2
prerank,high voltage-gated calcium channel activity (GO:0008331),0.6430724351517992,1.5066823630605084,0.06707317073170732,0.4662528388167447,1.0,3/10,1.81%,CACNA1D;CACNB1;CACNB3
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5473314809398548,1.5034208987373596,0.04873294346978557,0.4615719988453503,1.0,7/20,12.95%,LPGAT1;AGPAT4;ABHD5;MOGAT1;PLA2G15;LCLAT1;DGAT2
prerank,leak channel activity (GO:0022840),0.5583790941892306,1.501581933908753,0.06593406593406594,0.454249346871404,1.0,3/18,5.41%,KCNK2;TMEM175;NALCN
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.39340332808197453,-1.5004956116088723,0.019184652278177457,0.3674064603231726,1.0,23/72,16.36%,HIP1;STXBP6;MYO1B;PARD3;MARK1;SVIL;GSN;KCNJ2;SNX18;FCHO2;PLEKHA4;KCNQ1;AMER1;JPH2;EXOC1;CAPG;HIP1R;PFN1;AVIL;VILL;AMER2;SYTL2;LDLRAP1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.5129337182933875,-1.5002793946602475,0.0407725321888412,0.35790917578090364,1.0,5/23,4.35%,PLCB4;PLCE1;EDNRA;PLCG1;PLCG2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.5451793127240684,-1.4989714244413277,0.05263157894736842,0.3511034559461278,1.0,6/18,9.82%,STXBP6;PDLIM5;ANXA1;TMOD3;PPP1CA;S100A11
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.599843364562309,-1.4982853362690147,0.05894308943089431,0.3433672977800543,1.0,7/12,3.58%,LTBP4;BMPR2;LTBP1;ACVR1;ACVRL1;ENG;TGFBR2
prerank,voltage-gated potassium channel activity (GO:0005249),0.4112797438275615,1.4867734692920418,0.018456375838926176,0.4857905576443633,1.0,14/80,11.42%,KCNK2;KCND3;KCNA3;KCNT1;KCNJ13;LRRC38;KCNJ5;KCNJ10;KCNC3;KCND2;KCNH2;KCNC2;KCNJ16;KCNH7
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.627189984210982,-1.4841233190324188,0.06591337099811675,0.368490155982137,1.0,2/10,3.22%,MECOM;PRDM16
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.5304446224748622,1.4838847916253604,0.053784860557768925,0.4823797980927569,1.0,4/21,8.95%,P2RX6;TRPV1;GRIK2;CHRNB2
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.4382285755659728,-1.4790541242556756,0.036036036036036036,0.3721065231337329,1.0,22/42,27.94%,BCAR3;YWHAE;PIK3R1;SHE;YWHAB;PLCG2;VAV2;YES1;PFN1;FBXW7;IRS1;LDLRAP1;SH3BP2;PTPN6;HCK;NEDD4;SYK;RASA1;PTPN11;SHD;SAMSN1;GRB2
prerank,chemorepellent activity (GO:0045499),-0.4893252858587367,-1.4760126995298746,0.04328018223234624,0.3710179285141571,1.0,13/25,28.58%,SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;SEMA6D;SEMA5A;SEMA3F;SEMA4C;SEMA4D;SEMA4F;SEMA6B
prerank,transforming growth factor beta binding (GO:0050431),-0.49785204865738814,-1.4735662032580144,0.04693877551020408,0.3684509187255193,1.0,10/23,9.79%,LTBP4;LTBP1;ACVR1;ACVRL1;ENG;THBS1;TGFBR2;CD109;VASN;TGFB3
prerank,mechanosensitive ion channel activity (GO:0008381),-0.5931542166520367,-1.4672926222581948,0.062381852551984876,0.37577794411050547,1.0,2/12,2.87%,PIEZO2;PIEZO1
prerank,acylglycerol lipase activity (GO:0047372),-0.5900361014223225,-1.452882515626909,0.07554671968190854,0.4020391993980265,1.0,3/11,11.84%,ABHD2;MGLL;ABHD6
prerank,actin monomer binding (GO:0003785),-0.4994365681832197,-1.4509318887215796,0.05194805194805195,0.3978431116883026,1.0,7/22,16.75%,NOS3;TMSB4X;MTSS1;TMSB10;LIMA1;PFN1;MYL4
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.34086590962697777,-1.4492272239691233,0.010025062656641603,0.3941621262720645,1.0,33/147,10.44%,DOCK9;CYTH3;PREX2;FGD5;FARP1;ARHGEF28;PLCE1;DOCK1;RAPGEF2;DOCK10;FGD6;RAP1A;BCR;SPATA13;RASGRF2;DENND6A;HERC2;MON1A;ARHGEF2;ARHGEF15;RAPGEF6;RAPGEF4;DOCK2;EIF2B2;ABR;TIAM1;GAPVD1;DENND5B;EPS8L2;DENND2C;DOCK8;RABIF;VAV2
prerank,voltage-gated cation channel activity (GO:0022843),0.39119338244472907,1.4462377749646205,0.03409090909090909,0.5869852871892206,1.0,14/97,8.26%,CACNA1D;CACNA2D3;KCND3;CACNG7;KCNA3;CACNB1;CACNB3;LRRC38;CACNA2D2;GRIN3A;GRIN2D;KCNC3;KCND2;KCNH2
prerank,fibroblast growth factor receptor binding (GO:0005104),0.5089272962273484,1.4457932181215956,0.08458646616541353,0.5739627932967131,1.0,3/21,3.34%,FGF1;FGF4;FGF9
prerank,death domain binding (GO:0070513),-0.5993851867250104,-1.4454255368297957,0.06903353057199212,0.39552156472914296,1.0,7/11,19.91%,BCL2L1;DAPL1;CRADD;RACK1;DAP;MCL1;RIPK1
prerank,C-C chemokine receptor activity (GO:0016493),0.5365328326677201,1.4431019572016883,0.07575757575757576,0.5689770772959402,1.0,2/21,0.79%,CCR9;ACKR2
prerank,cell adhesion mediator activity (GO:0098631),-0.4818253523623708,-1.441022239314669,0.03696098562628337,0.39801455670124597,1.0,9/24,13.02%,BSG;ESAM;PALLD;NPTN;ROBO4;DSCAML1;BCAM;JAM3;EMB
prerank,SH3 domain binding (GO:0017124),-0.394701170751213,-1.43231036290612,0.03058823529411765,0.41223142258734163,1.0,14/62,9.66%,AFAP1L1;ABI1;SHANK3;DAB2IP;PTPN12;CBLB;WASF2;AFAP1L2;PLSCR1;SGIP1;WIPF1;ABI3;CD2AP;GPX1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3992861737086815,1.4301702186936371,0.039182282793867124,0.5989130444990605,1.0,12/73,11.17%,LGR4;GCGR;PTH2R;NPR3;BDKRB1;OPRD1;CRHR1;BDKRB2;LTB4R2;NMUR1;GPR37;GRPR
prerank,amyloid-beta binding (GO:0001540),-0.37405177620391394,-1.4291009477885257,0.022167487684729065,0.41206653001830673,1.0,22/79,18.81%,APBB2;COL25A1;FZD6;TGFB2;INSR;ITM2A;BCHE;CST3;GRIN2B;IAPP;APOE;EPHB2;CACNA1B;FZD4;CD74;ITM2B;GSAP;APBB3;LDLRAP1;LRP1;GRIN1;PFDN6
prerank,GTPase activator activity (GO:0005096),-0.30493007883624607,-1.4271275175192624,0.003003003003003003,0.40916765072507383,1.0,67/313,10.44%,ARHGAP31;DOCK9;NRP1;CYTH3;ARHGAP10;PREX2;TBC1D4;CHN2;FGD5;FARP1;RABGAP1L;ARHGEF28;PLCE1;DOCK1;RAPGEF2;DOCK10;ARHGAP42;RGS3;FGD6;RGS5;RASGRP3;SIPA1L2;RAP1A;STARD8;TBC1D8;CHN1;IQGAP1;ASAP2;BCR;SPATA13;RASGRF2;ARAP3;DENND6A;STARD13;TBC1D12;JUN;HERC2;TBC1D5;USP6NL;TBCD;ARAP1;MON1A;ARHGEF2;TBC1D2B;ARHGEF15;SIPA1L3;TBC1D1;ARHGAP32;RAPGEF6;RGS6;ARHGAP35;RAPGEF4;DOCK2;EIF2B2;EVI5L;ABR;TIAM1;GAPVD1;DENND5B;EPS8L2;SEC23A;DENND2C;TBC1D13;DOCK8;RP2;RABIF;VAV2
prerank,voltage-gated calcium channel activity (GO:0005245),0.45717863411506643,1.4244805732166825,0.06319702602230483,0.6048873624995258,1.0,6/37,3.66%,CACNA1D;CACNA2D3;CACNG7;CACNB1;CACNB3;CACNA2D2
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5508957526686553,-1.4211855825830337,0.08531746031746032,0.4158953015190596,1.0,7/13,13.96%,IL1R1;ITGA5;PTPRJ;ERN1;PDGFC;PDGFD;VEGFA
prerank,ADP binding (GO:0043531),0.4987419573634104,1.419289748348371,0.08366533864541832,0.6087182041307148,1.0,7/25,10.42%,PRKAG2;MYO9B;PGK1;MYO3A;MSH6;ABCD1;MYO18A
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.5018318480206312,-1.418759992682573,0.09554140127388536,0.41453495323538064,1.0,7/18,14.68%,GAS6;RPS6KA3;XIAP;TNFAIP8;SERPINB9;BIRC3;MT3
prerank,protein tyrosine kinase activity (GO:0004713),-0.34847644423207014,-1.4158406788316624,0.02544529262086514,0.41394288469439855,1.0,38/108,22.81%,TEK;ROR1;NTRK3;HIPK1;TIE1;INSR;MERTK;EGFR;PEAK1;KDR;BMX;FLT1;MET;LYN;TEC;SCYL1;FLT4;SRC;YES1;EPHB2;JAK1;DYRK1A;RET;PTK2B;ALK;CSF1R;FGFR3;BTK;JAK3;HCK;DYRK2;SYK;EPHB6;IGF1R;ROR2;FYN;CAMKK2;RYK
prerank,C-C chemokine binding (GO:0019957),0.5164576782011299,1.415768453241024,0.09416195856873823,0.6075760528652202,1.0,2/22,0.79%,CCR9;ACKR2
prerank,potassium ion leak channel activity (GO:0022841),0.5534012303803426,1.4149401833625028,0.10227272727272728,0.5971996083151968,1.0,2/15,5.15%,KCNK2;TMEM175
prerank,hydro-lyase activity (GO:0016836),0.44006305336140167,1.414215019444313,0.07155963302752294,0.5868870223047827,1.0,11/41,10.83%,HACD3;ENO1;ACO1;NAXD;ENO4;HACD4;HACD1;FAHD2A;ECHDC3;ECHS1;ECHDC2
prerank,gated channel activity (GO:0022836),-0.5488740975525268,-1.4138720035758925,0.08761904761904762,0.41151749378752556,1.0,2/14,2.87%,PIEZO2;PIEZO1
prerank,methyl-CpG binding (GO:0008327),0.5095115885079865,1.4129435510306732,0.09784735812133072,0.5791411423835374,1.0,5/22,10.63%,CXXC5;ZBTB38;CXXC4;TET1;MBD1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.5558375083538272,-1.4124676152195796,0.09902912621359224,0.407848861251249,1.0,5/13,10.31%,PIP5K1B;PIP4K2A;PIK3C2A;PIK3CA;PIK3CD
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.42742053806209723,-1.412416387883981,0.07322654462242563,0.4008189019434098,1.0,10/38,10.71%,HIP1;PLA2G4A;DAB2IP;PARD3;WIPI1;SNX13;PLEKHA4;SH3PXD2B;PLEKHA5;JPH2
prerank,death receptor activity (GO:0005035),-0.586742386662918,-1.4118450776703673,0.09859154929577464,0.3952977713080529,1.0,5/11,12.62%,TNFRSF1B;FAS;TNFRSF11A;EDA2R;TNFRSF19
prerank,anion channel activity (GO:0005253),-0.3839823089188549,-1.4070637116888074,0.03935185185185185,0.3996467545307311,1.0,16/61,15.91%,SLC26A7;LRRC8D;CLIC4;ANO1;LRRC8C;CLIC1;LRRC8A;GABRA3;GLRB;CLCC1;LRRC8B;ANO4;GABRE;GLRA2;ANO2;CFTR
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.5755885884711136,-1.4063820304813943,0.10204081632653061,0.39480527608705857,1.0,5/12,8.36%,APAF1;NOD1;RACK1;CASP8AP2;ATP2A3
prerank,syntaxin binding (GO:0019905),0.4138514182950412,1.4062789178326869,0.05670103092783505,0.5871719904696523,1.0,18/61,12.97%,UNC13C;SYT12;SYT9;NAPB;SYT1;STX16;SNAP29;SNAP47;LRRK2;STXBP5L;NAPA;GOLGA2;SNAP25;NSF;SYT10;STXBP4;TMED9;CPLX1
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.3992348088312915,-1.4052039100348144,0.0481651376146789,0.3908751180881405,1.0,20/46,29.21%,GCNT2;EXT1;B3GNT2;MGAT5;MGAT4A;HEXA;MFNG;GCNT1;MGAT4B;LFNG;B3GNT3;PIGQ;B3GALT5;B3GNT8;MGAT3;EXT2;GCNT4;RFNG;B3GALT1;B3GNT6
prerank,frizzled binding (GO:0005109),0.4501314284839277,1.3995222289803193,0.07792207792207792,0.5966990600302634,1.0,6/34,9.47%,RNF43;WNT4;WNT5B;WNT7A;WNT6;FZD7
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.5059936644716568,-1.398025113661505,0.10887096774193548,0.4017160961235912,1.0,6/19,13.96%,ABI1;GAS6;AFAP1L2;PAK2;EFNA5;CD24
prerank,GDP binding (GO:0019003),-0.3720129294782595,-1.3962351635243446,0.04,0.399744187912109,1.0,28/63,26.41%,RAB14;RAP1A;RAB31;RALB;RAP2A;RASL12;RAB22A;KRAS;NRAS;GNAI3;RAB27A;NME2;RERG;RAB11B;RAB5C;RAP2B;MRAS;ARL8B;RRAGD;MIEF1;RAB27B;RAB35;RAB3B;TRIM23;RAB9B;RAB5B;RASEF;RHEBL1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.5795055520552831,1.3955298463980343,0.11244979919678715,0.597034761332302,1.0,4/13,5.35%,BMP7;BMP6;BMP3;BMP8A
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.5459111405521265,-1.390608113650254,0.0995850622406639,0.4063618743252335,1.0,5/14,8.36%,APAF1;NOD1;RACK1;CASP8AP2;ATP2A3
prerank,potassium channel activity (GO:0005267),0.3775642388244423,1.3877270792561764,0.03508771929824561,0.6111890406589056,1.0,20/89,17.56%,KCNK2;KCND3;KCNA3;KCNT1;LRRC38;TMEM175;KCNC3;GRIK5;GRIK2;KCND2;KCNH2;KCNN4;KCNC2;KCNH7;KCNK4;KCNS3;TMEM38A;KCNA4;KCNQ3;KCNK10
prerank,sialyltransferase activity (GO:0008373),-0.4938037184617633,-1.3870877223843225,0.08488612836438923,0.4084127566820687,1.0,7/20,7.88%,ST3GAL4;ST6GALNAC3;ST8SIA4;ST3GAL6;ST3GAL1;ST6GALNAC5;ST8SIA6
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.5835260755265403,1.385168993720454,0.11198428290766209,0.607768310247816,1.0,5/12,10.29%,SLC25A42;SLC25A5;SLC19A1;SLC25A25;SLC25A23
prerank,muscle alpha-actinin binding (GO:0051371),-0.5099228536425411,-1.383080419552446,0.09795918367346938,0.4117926301869598,1.0,4/15,11.60%,PDLIM5;PALLD;SYNPO2;LDB3
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.34953380191730504,-1.3830725220997189,0.028795811518324606,0.4056464715274529,1.0,26/91,16.36%,HIP1;STXBP6;MYO1B;PARD3;MARK1;SVIL;GSN;KCNJ2;WIPI1;SNX18;FCHO2;PLEKHA4;KCNQ1;SH3PXD2B;AMER1;PLEKHA5;JPH2;EXOC1;CAPG;HIP1R;PFN1;AVIL;VILL;AMER2;SYTL2;LDLRAP1
prerank,nucleosomal DNA binding (GO:0031492),-0.46283701292870366,-1.3768397553037865,0.07724425887265135,0.4143385056609053,1.0,5/21,8.67%,ACTB;H3-3A;SMARCC1;GATAD2B;RBBP4
prerank,monocarboxylic acid binding (GO:0033293),0.516408934480933,1.375553338177677,0.12213740458015267,0.6268406310000625,1.0,5/18,16.56%,CYP26B1;NR2F2;RXRA;PYGL;RARA
prerank,BMP receptor binding (GO:0070700),0.5795088978816719,1.371721488460103,0.11850311850311851,0.6283337467765848,1.0,4/12,5.35%,BMP7;BMP6;BMP3;BMP8A
prerank,insulin-like growth factor I binding (GO:0031994),-0.5408120013602459,-1.370133254154285,0.09766454352441614,0.42348827933047295,1.0,4/13,5.00%,ITGA6;INSR;ITGB4;IGFBP6
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.4597841037361924,-1.3680227550193194,0.0880503144654088,0.4226558808342851,1.0,11/26,31.34%,CSGALNACT1;B3GNT2;CHSY3;B3GNT3;B4GALNT3;B3GALT5;B3GNT8;B3GALT1;CSGALNACT2;B3GNT6;B4GALNT1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.5343308869614396,-1.3658966334563987,0.11801242236024845,0.42166013873606367,1.0,6/13,28.05%,SREBF2;ECI1;ECH1;IDI1;DDT;MIF
prerank,protein tyrosine kinase binding (GO:1990782),-0.3614267469873773,-1.3646888905137453,0.053738317757009345,0.418623380777783,1.0,20/71,16.16%,BMPR2;CBLB;ACVR1;GAS6;GRB14;CPNE3;TJP2;ITGB1;ANGPT2;RACK1;NCK1;CEACAM1;NEDD9;PTPN1;SOCS5;DUSP3;SQSTM1;DOCK4;CBL;SHC4
prerank,neurexin family protein binding (GO:0042043),0.59527048038895,1.3587517086458285,0.14717741935483872,0.6587712331617182,1.0,4/10,6.98%,CEL;NLGN2;SYTL3;NLGN3
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.4609527498452938,-1.3580782721732911,0.09207708779443255,0.4284848171783407,1.0,7/23,11.99%,HIP1;WIPI1;PLEKHA4;SH3PXD2B;PLEKHA5;JPH2;HIP1R
prerank,myosin binding (GO:0017022),-0.3707156778728186,-1.3573623203590421,0.07272727272727272,0.4243488093873787,1.0,10/55,7.35%,MYRIP;CALD1;SHROOM4;SPATA6;RHOA;GSN;RAB14;RAB6A;NKD2;MYOC
prerank,guanyl ribonucleotide binding (GO:0032561),-0.30176932762060615,-1.3483585599921697,0.0136986301369863,0.44007356062858244,1.0,65/196,23.50%,RHOJ;RAPGEF2;RHOBTB1;RHOA;INSR;RAB14;RAP1A;ATL3;EEF1A1;MFHAS1;RAB6A;GTPBP10;RAB31;RALB;PDE10A;GBP4;GNL3;GCH1;RAP2A;GBP5;PDE2A;TUBA1A;TGM2;RASL12;EIF2B2;BMS1;RAB22A;KRAS;NRAS;GNAI3;RAB27A;RRAGA;ARL5A;NME2;RERG;RAB11B;GLUD1;RAB5C;RND3;RAB1B;ARF5;RAP2B;ADSS1;MRAS;GNL1;NUDT16;ARHGEF5;ARL8B;RHOBTB3;RHOB;RRAGD;AGAP2;MIEF1;RAC3;RAB27B;ARL4D;RAB35;CDC42;TUBA4A;TUBE1;RND2;RAB3B;RHOT2;TRIM23;RAB9B
prerank,lysine-acetylated histone binding (GO:0070577),0.4882114482353816,1.3480022923497952,0.122,0.6731144583989553,1.0,7/20,13.40%,ZMYND8;KMT2A;PHIP;BRD7;TAF1;BRD2;YEATS4
prerank,acetylation-dependent protein binding (GO:0140033),0.4882114482353816,1.3480022923497952,0.122,0.6731144583989553,1.0,7/20,13.40%,ZMYND8;KMT2A;PHIP;BRD7;TAF1;BRD2;YEATS4
prerank,calcium-dependent phospholipid binding (GO:0005544),0.40810641381967633,1.3461915312885044,0.0986159169550173,0.667857287081533,1.0,11/49,9.43%,SYT11;SYT12;ANXA6;CPNE1;ANXA5;SYT9;CPNE4;PLA2G4C;SYT1;SYT13;SYT10
prerank,chemokine receptor activity (GO:0004950),0.47872694306696284,1.3429294606151834,0.13211009174311927,0.6676696172612541,1.0,2/24,0.79%,CCR9;ACKR2
prerank,lysine N-methyltransferase activity (GO:0016278),0.49048857435936877,1.324738037326108,0.1367837338262477,0.7178408299930654,1.0,6/20,13.46%,KMT5A;EEF2KMT;ANTKMT;SETD4;SETD7;SMYD2
prerank,sterol binding (GO:0032934),0.39910025718326614,1.3241648968211388,0.07321428571428572,0.7086457928036088,1.0,12/56,9.21%,RORA;OSBPL8;ANXA6;SOAT2;SIDT1;INSIG2;GRAMD1B;STARD5;APOF;SOAT1;OSBPL5;NR1H3
prerank,kinase binding (GO:0019900),-0.27280468088477644,-1.3225794676234663,0.0038314176245210726,0.49910409953315016,1.0,77/434,11.19%,UTRN;TTC28;ACTB;FRMD5;LIMS1;GHR;CAV1;SLC12A7;SLC12A2;PDE8A;DAB2IP;RHOBTB1;PTN;RHOA;BCAR3;GSN;ACVRL1;PKD1;IQGAP1;BCL2L1;FOXO3;EGFR;PLCG1;EEF1A1;BTG1;STAT3;PTPRJ;CSPG4;PPP1R12A;PTPRK;IRAK3;STX1A;ESR1;PLCG2;FAS;CACUL1;FLNA;CAB39;TFRC;CARD16;SPRED2;SMAD1;PIK3IP1;PAK2;CIT;ADAM10;EEF2;TRIM14;MIDN;PRKCD;RPS7;ANKRA2;CALM3;APC;RELB;RB1CC1;HDAC7;ACTA2;CEACAM1;RPS3;EMP2;SPRY2;TIAM1;SRC;PTPN1;PFKL;CIR1;BCAR1;DUSP3;CAV2;PER1;YWHAZ;RPTOR;ACSL3;BAG5;HSPB1;FBXO5
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.4502967702166183,1.3213534844251849,0.14185639229422067,0.7076453529459275,1.0,2/29,2.01%,PRKAG2;CDKN2A
prerank,transcription coactivator binding (GO:0001223),0.4768910017288476,1.3211529311644177,0.12449799196787148,0.6974085613668863,1.0,7/20,12.67%,RORA;SMAD3;THRB;CCNT2;MED25;ZBTB49;TERT
prerank,receptor antagonist activity (GO:0048019),0.49091482166634215,1.317917559967379,0.1346153846153846,0.6980380063609075,1.0,3/17,11.23%,ADH7;DKK3;FST
prerank,calcium channel activity (GO:0005262),0.3600441267310812,1.317264095133436,0.07460035523978685,0.6898488215547067,1.0,9/84,3.66%,CACNA1D;CACNA2D3;ANXA6;SLC24A3;CACNG7;TRPV1;CACNB1;CACNB3;CACNA2D2
prerank,epidermal growth factor receptor binding (GO:0005154),-0.4360239203349128,-1.3140899553693497,0.12447257383966245,0.515476656153535,1.0,9/25,28.85%,HIP1;PLSCR1;SNX1;SNX2;EFEMP1;FAM83B;EGF;GRB2;BTC
prerank,cation channel activity (GO:0005261),0.3547491523265192,1.3128086382611166,0.06506849315068493,0.6943859157360799,1.0,6/94,1.13%,TRPM3;CACNA1D;ANXA6;SLC24A3;TRPM6;TRPV1
prerank,protein phosphatase 1 binding (GO:0008157),0.4715066826284464,1.3123316582565132,0.14534883720930233,0.6860455475394664,1.0,4/21,7.62%,SH3RF2;PPP1R3F;PPP1R16A;PHACTR4
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.47173429893734303,1.30966106975801,0.14311926605504588,0.6850045094159296,1.0,10/22,25.89%,CPEB2;ELAVL4;EXOSC8;ELAVL1;ILF3;CPEB3;ELAVL3;CPEB1;ZFP36;ZFP36L1
prerank,receptor tyrosine kinase binding (GO:0030971),-0.37180085493893866,-1.3093900478867049,0.08545034642032333,0.5221040156403396,1.0,17/56,16.16%,CBLB;GAS6;PIK3R1;GRB14;CPNE3;ANGPT2;RACK1;NCK1;PTPN1;SOCS5;DUSP3;SQSTM1;SH2B2;DOCK4;IRS1;CBL;SHC4
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5184780907337164,1.3093581475762825,0.16188524590163936,0.676131605554933,1.0,6/15,24.38%,P2RX6;GPR87;P2RX4;PTAFR;P2RY12;GPR34
prerank,glutamate receptor binding (GO:0035254),-0.48583086939054937,-1.3092861492292795,0.15257731958762888,0.515688806962372,1.0,2/17,0.55%,HIP1;SHANK3
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.516624095711512,-1.308438878351559,0.1488933601609658,0.511359546869866,1.0,7/12,31.93%,BRD4;MAPK1;CDK6;CDK8;CDK19;CDK13;CDK1
prerank,cardiolipin binding (GO:1901612),0.5607644826186154,1.3084020572307942,0.17567567567567569,0.6694022294313051,1.0,3/10,17.98%,GSDME;GSDMD;UQCC3
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.37332334156071817,1.3079012741899885,0.0957983193277311,0.6616995786724817,1.0,17/69,12.95%,LPGAT1;SPHK1;ASPG;SOAT2;PLAAT5;ZDHHC12;DBT;PLA2G4C;GLYAT;SOAT1;MOGAT1;ZDHHC1;ZDHHC16;PLA2G15;ZDHHC6;ZDHHC3;DGAT2
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5465915980738429,1.3076282573743399,0.16024340770791076,0.6534349234345197,1.0,3/11,8.26%,KCND3;KCNJ5;KCNH2
prerank,histone methyltransferase binding (GO:1990226),0.555685410185683,1.3068435615878349,0.16634429400386846,0.6469235912001329,1.0,3/11,10.36%,CBX1;PHF1;LCOR
prerank,insulin-like growth factor binding (GO:0005520),-0.4919472566395676,-1.30544317894303,0.15384615384615385,0.512691433747277,1.0,4/15,5.00%,ITGA6;INSR;ITGB4;IGFBP6
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.4496615700965856,-1.3032793457853655,0.13305613305613306,0.506396979383793,1.0,11/21,31.93%,CDK14;CDKL2;CDK5;CDK6;CDKL4;CDK11B;CDK2;CDK8;CDK19;CDK13;CDK1
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.4496615700965856,-1.3032793457853655,0.13305613305613306,0.506396979383793,1.0,11/21,31.93%,CDK14;CDKL2;CDK5;CDK6;CDKL4;CDK11B;CDK2;CDK8;CDK19;CDK13;CDK1
prerank,neuropeptide binding (GO:0042923),0.4852430288216789,1.3020692485735124,0.168,0.653254608070473,1.0,7/18,24.55%,OPRD1;NMUR1;GPR37;OPRM1;GPR149;OPRL1;NMUR2
prerank,kinase activator activity (GO:0019209),0.4466193089496718,1.3004419323938319,0.13419117647058823,0.6497733579266511,1.0,4/30,4.00%,PRKAG2;GPRC5A;GPRC5C;GPRC5B
prerank,sodium:proton antiporter activity (GO:0015385),-0.5263821170380928,-1.299792265290236,0.15560165975103735,0.5091370365485932,1.0,2/11,3.52%,SLC9A2;SLC9B2
prerank,Hsp90 protein binding (GO:0051879),-0.3959922624779693,-1.298478051603357,0.11812627291242363,0.5063997268259998,1.0,9/33,13.57%,SLC12A2;KDR;ERN1;PTGES3;RPS3;AHR;UNC45B;HDAC6;CSNK2A1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.5550148779799985,1.2968132914392476,0.17611336032388664,0.6516725566921423,1.0,4/11,11.37%,TRPV1;ITPR1;RYR2;TRPM2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.4217910676529191,1.2914684663254812,0.15063520871143377,0.6600290585978708,1.0,10/34,14.33%,KMT5A;EEF2KMT;DOT1L;ANTKMT;N6AMT1;SETD4;SETD7;SMYD3;SMYD2;MEN1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.436849904985743,1.290786391086888,0.13837638376383765,0.6541861850341236,1.0,5/27,6.12%,SLC22A6;SLC22A8;SLC5A5;SLC26A1;SLC25A11
prerank,pre-mRNA binding (GO:0036002),0.4456562747003786,1.284448337896323,0.17693836978131214,0.6664057570293127,1.0,6/28,11.03%,CELF2;DDX5;HNRNPU;HNRNPL;PTBP1;SLBP
prerank,translation initiation factor activity (GO:0003743),-0.3946937033746031,-1.283503892823878,0.11359026369168357,0.5391710056099088,1.0,12/36,17.24%,EIF3E;EIF3M;EIF3H;EIF2B2;MTIF3;EIF4E;EIF3F;AGO2;EIF1B;EIF3K;EIF4G3;EIF2B1
prerank,retinoid X receptor binding (GO:0046965),-0.5247693215964475,-1.2819494244923446,0.17738791423001948,0.5372536557213092,1.0,6/11,15.72%,TACC1;NRIP1;RARG;NCOA6;NR4A2;ARID5A
prerank,intracellular chloride channel activity (GO:0061778),-0.4704302012961535,-1.2816785115839824,0.17078189300411523,0.5258224437459467,1.0,7/16,27.25%,ANO1;TTYH2;ANO4;ANO2;ANO6;ANO10;TTYH3
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.4704302012961535,-1.2816785115839824,0.17078189300411523,0.5258224437459467,1.0,7/16,27.25%,ANO1;TTYH2;ANO4;ANO2;ANO6;ANO10;TTYH3
prerank,phosphotyrosine residue binding (GO:0001784),-0.3908025293166403,-1.2798112596036932,0.13707865168539327,0.5251601619613385,1.0,20/37,31.25%,BCAR3;PIK3R1;SHE;PLCG2;VAV2;YES1;PFN1;IRS1;LDLRAP1;SH3BP2;PTPN6;HCK;SYK;RASA1;PTPN11;SHD;SAMSN1;GRB2;PIK3R2;PTPN3
prerank,protein kinase C activity (GO:0004697),-0.4852667512268185,-1.2783989872530894,0.17184643510054845,0.5229429455556414,1.0,5/14,7.74%,PRKCH;PRKD3;PRKD1;PRKCD;PRKCG
prerank,GTPase regulator activity (GO:0030695),-0.2900316232899177,-1.2769767135316923,0.03519061583577713,0.5208182846662445,1.0,51/212,12.75%,ARHGAP31;NRP1;ARHGAP10;PREX2;TBC1D4;CHN2;RABGAP1L;DOCK1;RAPGEF2;ARHGAP42;SLIT2;RGS3;RGS12;RGS5;RASGRP3;SIPA1L2;STARD8;TBC1D8;SH3BP4;CHN1;IQGAP1;ASAP2;BCR;ARAP3;STARD13;TBC1D12;JUN;TBC1D5;USP6NL;TBCD;ARAP1;TBC1D2B;SIPA1L3;TBC1D1;ARHGAP32;RGS6;ARHGAP35;EVI5L;IPO7;ABR;PDE6D;SEC23A;TBC1D13;RP2;CDC42EP2;RGS10;IPO5;RALGAPA1;ARL2BP;ARHGAP1;SIPA1
prerank,amino acid binding (GO:0016597),-0.40443769354348647,-1.2744616705037444,0.13863636363636364,0.5214378260898093,1.0,21/31,31.88%,NOS3;GRM7;SRR;GRIN2B;GLRB;GCLC;DDAH1;GLRA2;THNSL2;CAD;GRIN1;ASS1;DDAH2;AARS2;SHMT2;CASTOR1;SHMT1;AGXT;GNMT;NOS2;NOS1
prerank,carboxylic acid binding (GO:0031406),-0.37809818165243664,-1.2719037889205471,0.13948497854077252,0.5221635672213054,1.0,15/38,18.49%,NOS3;GRM7;SRR;GRIN2B;GLRB;EPDR1;GCLC;PSAP;SESN3;GLRA2;GLUD1;THNSL2;CAD;GRIN1;UBR1
prerank,hormone receptor binding (GO:0051427),-0.4991004834487212,-1.269816436259548,0.18655097613882862,0.5218323836848776,1.0,6/14,21.16%,SOCS2;JAK1;NCOA6;NPPC;PTHLH;CCK
prerank,histone acetyltransferase binding (GO:0035035),0.4610706292338161,1.2692484767736836,0.1744421906693712,0.7050385623187493,1.0,4/21,9.76%,EPAS1;PAX6;KANSL1L;STAT1
prerank,calcium channel regulator activity (GO:0005246),-0.38126396288774506,-1.2691605380026483,0.14224137931034483,0.5178099883692425,1.0,5/37,4.57%,PRKG1;STIM2;YWHAE;SLC30A1;STIMATE
prerank,GTP binding (GO:0005525),-0.2905732079745129,-1.268744386002258,0.02997275204359673,0.5135234613469408,1.0,56/172,23.47%,RHOJ;RHOBTB1;RHOA;INSR;RAB14;RAP1A;ATL3;EEF1A1;MFHAS1;RAB6A;GTPBP10;RAB31;RALB;GBP4;GNL3;GCH1;RAP2A;GBP5;TUBA1A;TGM2;RASL12;EIF2B2;BMS1;RAB22A;KRAS;NRAS;RAB27A;RRAGA;ARL5A;RERG;RAB11B;GLUD1;RND3;RAB1B;ARF5;RAP2B;ADSS1;MRAS;GNL1;NUDT16;ARHGEF5;ARL8B;RHOBTB3;RHOB;RRAGD;AGAP2;RAC3;RAB27B;ARL4D;RAB35;CDC42;TUBA4A;TUBE1;RND2;RHOT2;TRIM23
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.45937884744993573,1.2665224593250117,0.18962432915921287,0.6891142937003579,1.0,7/22,16.30%,CHRM2;HRH2;HTR7;HTR1F;CHRM1;HRH1;HTR1A
prerank,G protein-coupled amine receptor activity (GO:0008227),0.45937884744993573,1.2665224593250117,0.18962432915921287,0.6891142937003579,1.0,7/22,16.30%,CHRM2;HRH2;HTR7;HTR1F;CHRM1;HRH1;HTR1A
prerank,serotonin receptor activity (GO:0099589),0.45937884744993573,1.2665224593250117,0.18962432915921287,0.6891142937003579,1.0,7/22,16.30%,CHRM2;HRH2;HTR7;HTR1F;CHRM1;HRH1;HTR1A
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.3566818259334726,1.2663828737417038,0.1320754716981132,0.6814669735761688,1.0,14/74,11.76%,NADK2;SPHK1;GK;FAM20A;TKFC;PANK1;PIK3CB;NT5C3A;PANK2;TRPT1;DGKI;CHKB;PI4KA;SPHK2
prerank,G protein-coupled receptor activity (GO:0004930),0.30125341082620094,1.262025251478265,0.050974512743628186,0.6869957851775832,1.0,35/239,11.17%,TAS1R2;LGR4;GCGR;PTH2R;GPR135;GPR62;GPR143;NPR3;C5AR2;BDKRB1;OPRD1;ADGRG4;GPR87;LPAR2;CRHR1;ADRA2A;ADGRB2;BDKRB2;ADGRB3;GPR45;GPR12;DRD3;LPAR1;ADGRV1;NTSR2;GPR26;LTB4R2;NMUR1;GABBR1;C3AR1;ADGRL1;GPR37;ADGRG3;GABBR2;GRPR
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5138345424094986,-1.2610026081918877,0.18653846153846154,0.5271149069225411,1.0,3/11,8.59%,LEF1;ZXDC;GATA2
prerank,glucuronosyltransferase activity (GO:0015020),-0.441572201052917,-1.260634166449572,0.1615720524017467,0.5227797683931995,1.0,2/19,1.51%,CSGALNACT1;EXT1
prerank,rRNA binding (GO:0019843),-0.36656215910514056,-1.2600315114354521,0.1299559471365639,0.5191128287775187,1.0,12/42,16.62%,RPL5;RPLP0;RPS5;RPS3;RPL23;NGRN;RPS9;CAVIN1;RPL12;RPS13;PTCD3;GTF3A
prerank,platelet-derived growth factor binding (GO:0048407),0.5307434429276033,1.2589822219668354,0.20809248554913296,0.6891271679766612,1.0,3/11,4.42%,COL5A1;PDGFRA;COL1A2
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.4306701419235493,-1.2584193800454877,0.15866388308977036,0.5175386378117713,1.0,5/20,9.65%,MAGI3;TJP2;CASK;MPP1;DTYMK
prerank,filamin binding (GO:0031005),0.5382572036833642,1.257588761702563,0.21653543307086615,0.6852153924825322,1.0,4/11,11.21%,NEBL;RFLNA;CRMP1;TMEM67
prerank,amino acid transmembrane transporter activity (GO:0015171),0.37511804267392485,1.2527163240407517,0.14337568058076225,0.6929748833758849,1.0,8/47,6.42%,SLC6A13;SLC6A1;SLC38A3;SLC7A11;SLC25A44;SLC38A1;SLC7A13;PDPN
prerank,Wnt-activated receptor activity (GO:0042813),-0.46761544864031324,-1.2511967804185815,0.19096509240246407,0.5308977772705364,1.0,7/15,14.27%,ROR1;FZD6;LRP5;PKD1;FZD4;TSPAN12;FZD1
prerank,hexosyltransferase activity (GO:0016758),-0.3091956242789028,-1.2504128923164972,0.0960591133004926,0.5275955808084452,1.0,38/101,29.30%,TMTC2;GCNT2;CSGALNACT1;EXT1;B3GNT2;B4GALT4;TMTC1;MTAP;GBE1;MGAT4A;HEXA;MFNG;GCNT1;B4GALT5;POGLUT3;CHSY3;MGAT4B;HAS1;LFNG;B3GAT3;ALG6;POMT2;TMTC3;HAS2;B3GNT3;B4GALNT3;B3GALT5;B3GNT8;DPY19L3;ALG5;EXT2;POGLUT1;GCNT4;RFNG;B3GALT1;CSGALNACT2;B3GNT6;B4GALT6
prerank,acetyltransferase activity (GO:0016407),0.4222111698402352,1.2488511002197766,0.17870036101083034,0.697302737645184,1.0,5/31,4.95%,SPHK1;GNPNAT1;SAT1;DBT;ACAT1
prerank,ligand-gated cation channel activity (GO:0099094),0.3470328152834056,1.2469685290796857,0.12966252220248667,0.6952133764317614,1.0,17/75,17.64%,P2RX6;KCNJ13;KCNJ5;GRIN3A;KCNJ10;GRIN2D;GRIK5;GRIK2;KCNH2;CHRNB2;KCNJ16;TRPM2;SHROOM2;TRPM8;GRIA2;SCNN1A;KCNJ9
prerank,metallocarboxypeptidase activity (GO:0004181),0.43691857994169697,1.246643744252695,0.18604651162790697,0.6884881580609988,1.0,4/26,9.13%,AEBP1;CPN1;AGBL4;CPA2
prerank,metal ion:proton antiporter activity (GO:0051139),-0.48305694230864393,-1.245318605244173,0.21084337349397592,0.5348038076989275,1.0,2/13,3.52%,SLC9A2;SLC9B2
prerank,antiporter activity (GO:0015297),0.4588715949362616,1.2441315124283172,0.19649805447470817,0.6888263861978936,1.0,6/20,13.89%,SLC35E2B;SLC35E2A;TMEM241;SLC25A11;CLCN4;CLCN3
prerank,"DNA binding, bending (GO:0008301)",-0.4784347432852168,-1.242492601487742,0.20618556701030927,0.5363172447398951,1.0,4/14,20.13%,LEF1;HHEX;TOP2A;HMGB1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.540728673151342,-1.23790866325772,0.20793950850661624,0.5425949942771241,1.0,4/10,3.09%,SLCO3A1;SLCO1C1;SLCO2A1;SLCO2B1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.2824474741292973,-1.2346204922661732,0.06779661016949153,0.5462097481646864,1.0,41/188,16.00%,MEF2C;PBX1;BNC2;ETS1;FLI1;TCF12;FOXO3;CTCF;PRDM16;STAT3;SIX1;TBX18;RUNX1;JUN;TFEB;SOX17;VSX1;NFYA;PSPC1;CREB3L1;XRCC5;AR;KLF11;ETV5;PRDM5;KLF4;ELK1;TAL1;AHR;MAFK;PER1;SOX7;HHEX;SOX18;LIN54;SOX12;SUV39H1;MTERF3;ATF6B;ARID5A;ATF4
prerank,growth factor receptor binding (GO:0070851),-0.31245592055354793,-1.2343237554942672,0.10741687979539642,0.541898484988094,1.0,18/95,11.59%,HIP1;IL6ST;IL1R1;VEGFC;ITGA5;PTPRJ;PLSCR1;ERN1;SNX1;IL6R;IL1RAP;PDGFC;SRC;FGF2;ESM1;FGF7;PDGFD;PIBF1
prerank,calcium-release channel activity (GO:0015278),0.4768656485010744,1.2317203611270005,0.20622568093385213,0.7197540756547509,1.0,5/17,11.37%,TRPV1;ITPR1;ITPR2;RYR2;TRPM2
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.4322863207769774,-1.2280919557153178,0.1991869918699187,0.5524634529755326,1.0,5/20,12.68%,SLC39A10;SLC30A1;SLC39A8;SLC39A7;SLC30A5
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3101085070828834,1.226651990342131,0.10815307820299501,0.7281939733114369,1.0,21/134,10.29%,SLC6A13;SLC6A1;SLC22A6;SLC13A3;SLC16A11;SLC38A3;SLC6A9;SLC23A2;SLC23A1;SLC16A12;SLC25A42;SLC38A1;SLC26A1;MPC2;SFXN2;PDPN;SLC19A1;SLC25A25;SLC38A9;SLC25A12;SLC25A23
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.26843149843340575,-1.2266033444903721,0.04105571847507331,0.5510580196039663,1.0,41/254,12.08%,MECOM;LEF1;MEF2C;ERG;ZBTB16;ELK3;PLAGL1;MEOX2;ETS1;TCF12;FOXO1;FOXO3;NFATC1;PRDM16;STAT3;PLSCR1;SIX1;NFIA;RUNX1;REL;JUN;ESR1;KLF7;SOX17;SMAD1;CREB3L1;ETV1;NRF1;AR;TFCP2L1;ELF4;ETV5;NFAT5;IRF2;KLF4;ELK1;RFXAP;HHEX;SOX18;FOXF2;FOSL2
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.5115780311031457,-1.2210798133884642,0.2408906882591093,0.5599715031643808,1.0,7/10,30.91%,ANKRD13A;DNAJC2;ANKRD13B;USP15;ANKRD13D;FAAP20;LAPTM5
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.4872671152049516,-1.2204395664148573,0.22964509394572025,0.5565384452039331,1.0,2/12,3.52%,SLC9A2;SLC9B2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.37056985988933067,1.2198715378600926,0.1721014492753623,0.741879616704503,1.0,3/48,0.81%,TRPM3;SLC41A1;TRPM6
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.48537614076443514,1.217319822350284,0.21146245059288538,0.7422207424341946,1.0,2/14,1.22%,ADH7;ADH4
prerank,FAD binding (GO:0071949),0.4384658980427992,1.217175014726187,0.21235521235521235,0.7352099247669251,1.0,9/24,15.26%,DDO;AIFM1;QSOX1;MICAL3;KMO;NDOR1;MTHFR;SQLE;CYB5R1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.3916546347989676,-1.216758193545086,0.18550106609808104,0.5606233114827963,1.0,7/30,12.68%,SLC39A10;SLC40A1;SLC30A1;SLC39A8;SLC31A1;SLC39A7;SLC30A5
prerank,transmitter-gated ion channel activity (GO:0022824),0.41579961550178024,1.2162192381538923,0.1875,0.7309335164021591,1.0,9/29,18.33%,GABRG1;GRID2;GRIN2D;GRIK5;GRIK2;GABRG3;GABRB2;GRIA2;GABRB3
prerank,protein serine/threonine kinase activity (GO:0004674),-0.25856187550261334,-1.2158333349660304,0.03761755485893417,0.5582291382726033,1.0,111/334,24.12%,PRKCH;SNRK;BMPR2;MARK1;NEK7;HIPK1;ACVR1;ACVRL1;MAP3K5;RPS6KA5;STK38L;STK3;EGFR;LIMK2;BCR;AKT3;TGFBR2;ALPK1;IRAK3;CDK14;RPS6KA3;TNIK;PRKD3;CPNE3;BRD4;CSNK1E;MAP3K20;NUAK1;CASK;PRKD1;CSNK1G1;PAK2;CIT;ERN1;CAMK2D;MAST4;CDC42BPA;PRKCD;CDKL2;PLK2;CSNK1G3;MAPK1;CSNK1A1;RPS6KA2;PRKCG;STK24;CDK5;STK33;MAPKAPK2;EIF2AK3;BCKDK;NEK3;MAP4K4;GRK5;VRK3;STK10;DYRK1A;SQSTM1;PTK2B;STK16;STK32A;STK38;AKT2;CSNK2A1;LIMK1;PKN3;ACVR1C;PIK3R4;IRAK2;MKNK2;PRKACA;TAOK3;MAP3K8;LATS1;MASTL;MAST2;MAPK12;STK35;HUNK;MAPK3;MARK3;CDK16;STK17B;CAMK1G;RIPK1;CDK6;ULK2;DYRK2;CHEK1;SYK;CDKL4;RIPK2;MAP3K6;MAP3K4;ROCK1;TRIO;TOP1;TAOK1;CSNK1D;SLK;MYLK;MAP4K3;SIK3;STK32C;GAK;CDK11B;MAPK11;CSNK2B;PLK3;RIOK1;PRKCE
prerank,phosphatase activity (GO:0016791),0.33832282958795296,1.2151350061774215,0.17421602787456447,0.7268488105524199,1.0,14/73,14.08%,ATP1A2;PON1;LPIN1;DUSP11;PXYLP1;PRUNE1;ARMT1;PLPPR3;CILP2;ACP6;PPP1CB;DUSP28;EPHX2;PTPRO
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.49577701467975976,-1.2150366038415237,0.24293785310734464,0.555335469909582,1.0,6/12,29.21%,B3GNT2;B3GNT3;B3GALT5;B3GNT8;B3GALT1;B3GNT6
prerank,cholesterol binding (GO:0015485),0.37271599009669026,1.214937921250658,0.19304347826086957,0.7202430676803021,1.0,10/47,9.21%,OSBPL8;ANXA6;SOAT2;SIDT1;GRAMD1B;STARD5;APOF;SOAT1;OSBPL5;NR1H3
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5114302414273909,-1.2141353974882008,0.23917525773195877,0.5528610637961519,1.0,3/11,9.48%,SGMS1;SGMS2;SAMD8
prerank,myosin V binding (GO:0031489),-0.4529467669323002,-1.2135111526852669,0.21308016877637131,0.549705245823285,1.0,8/15,23.00%,RAB14;RAB6A;RAB3A;RAB11B;RAB3D;RAB11A;RAB27B;RAB3B
prerank,glutamate receptor activity (GO:0008066),0.45473305859307184,1.213463834961988,0.22285714285714286,0.7180014759989424,1.0,6/19,17.45%,GRID2;GRIN2D;GRIK5;GRIK2;GRIA2;GRM8
prerank,carboxypeptidase activity (GO:0004180),0.3969078364742913,1.2131827067525214,0.2,0.7119290877518879,1.0,5/35,9.13%,AEBP1;CTSA;CPN1;AGBL4;CPA2
prerank,phosphatidic acid binding (GO:0070300),-0.42440744066471436,-1.212106041765301,0.21382289416846653,0.5484789891875592,1.0,6/19,10.71%,PITPNC1;RAPGEF2;MARK1;PLTP;RAPGEF6;JPH2
prerank,N-methyltransferase activity (GO:0008170),0.4413597178360411,1.2100367328365411,0.2263056092843327,0.7146196738733992,1.0,7/20,17.96%,FDXACB1;N6AMT1;RNMT;TRMT11;METTL5;METTL18;TRMT1L
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.5254275823453839,1.2066051527018045,0.250996015936255,0.7177786294575723,1.0,4/11,10.29%,SLC25A42;SLC19A1;SLC25A25;SLC25A23
prerank,sterol transfer activity (GO:0120015),-0.44358127625568755,-1.2021128176109943,0.2268041237113402,0.5685082814086658,1.0,7/17,12.35%,ABCA1;PLTP;NPC2;OSBP;MTTP;STARD4;GRAMD1A
prerank,chemokine receptor binding (GO:0042379),-0.36593043851683005,-1.2015471437062084,0.2086021505376344,0.5651309372930065,1.0,24/35,50.43%,CXCL12;CCL13;CCL25;CXCL16;CCL28;CCRL2;CCL5;CCL4;PF4;PPBP;CCL8;CCL19;CXCL5;CCL14;CXCL1;CCL7;CX3CR1;CCL1;CCL3;CCL11;CXCL13;CXCL2;CKLF;XCL1
prerank,mRNA 3'-UTR binding (GO:0003730),0.3371916072137545,1.1984422971267288,0.18771929824561404,0.7357835772217192,1.0,26/79,21.64%,CPEB2;CELF2;DDX5;ANGEL2;ELAVL4;HNRNPA2B1;PABPC4L;HNRNPU;EXOSC8;CPEB4;UTP23;ELAVL1;RNF20;BOLL;FXR2;CSDC2;PCBP4;RNPS1;CCT5;ELAVL2;ILF3;LARP4B;CPEB3;ELAVL3;LARP1;CELF1
prerank,clathrin adaptor activity (GO:0035615),-0.45427558924413153,-1.1981185916003307,0.24123711340206186,0.5685796273252409,1.0,6/15,16.36%,HIP1;STON2;AP2B1;HIP1R;AP2A1;LDLRAP1
prerank,ligand-gated calcium channel activity (GO:0099604),0.44249083926054816,1.1976942954338363,0.24758220502901354,0.7310816416168486,1.0,6/19,14.08%,TRPV1;ITPR1;GRIN2D;RYR2;TRPM2;TRPM8
prerank,phosphatase inhibitor activity (GO:0019212),-0.41725070864869884,-1.1949598783604054,0.22745901639344263,0.5716707480766671,1.0,9/20,30.90%,PTN;MGAT5;PPP1R2;BOD1L1;SET;TESC;PPP1R1B;LMTK2;ANP32E
prerank,metalloexopeptidase activity (GO:0008235),0.358935494523687,1.1942993194923421,0.19964349376114082,0.7351295171189235,1.0,4/51,2.67%,AEBP1;METAP2;CPQ;CPN1
prerank,channel activity (GO:0015267),0.3764868447084988,1.1926934254747874,0.23191094619666047,0.7332257681609538,1.0,6/41,9.72%,P2RX6;TRPV1;TMEM120B;PDPN;BCL2;MPV17
prerank,steroid hydroxylase activity (GO:0008395),-0.437527505845486,-1.1917952840352182,0.2478448275862069,0.5748940758954303,1.0,3/16,5.08%,CYP7B1;CYP1B1;CYP39A1
prerank,protein kinase binding (GO:0019901),-0.2427849738051973,-1.1912272263018857,0.012195121951219513,0.5716646788553235,1.0,139/479,22.98%,UTRN;ACTB;FRMD5;LIMS1;GHR;CAV1;PDLIM5;SLC12A7;SLC12A2;DAB2IP;BMPR2;RHOBTB1;PTN;RHOA;ACVR1;ACVRL1;PKD1;IQGAP1;BCL2L1;FOXO3;CAVIN2;PLCG1;EEF1A1;STAT3;PTPRJ;CSPG4;PPP1R12A;PTPRK;IRAK3;ESR1;PLCG2;CACUL1;ADCY4;TFRC;GCH1;TJP2;ITGB1;SPRED2;SMAD1;PAK2;CIT;ADAM10;RACK1;EEF2;TRIM14;PRKCD;KCNQ1;RPS7;ANKRA2;CALM3;APC;RELB;RB1CC1;HDAC7;HDAC9;ACTA2;CEACAM1;RPS3;NBR1;EMP2;SPRY2;NEDD9;PTPN1;MAPKAPK2;CIR1;BCAR1;DUSP3;CAV2;YWHAZ;RPTOR;ACSL3;BAG5;GRK5;HSPB1;FBXO5;SQSTM1;TPR;TRPV4;STK38;PEBP1;GSKIP;AP2A1;PTPRC;CD24;PGAM1;CNTLN;PPP1CC;RND3;FERMT2;IRS1;PRKAR2B;MAD2L2;PRKACA;ATF4;SHC4;UNC5C;TOP2A;LATS1;NOD2;DUSP6;HINT1;CCND1;PTPN6;DSP;IRF5;PRC1;RHOBTB3;RHOB;POLA1;AGAP2;NELL2;TRIB2;FBXW5;CCND2;KIZ;TICAM1;FAM83B;DCTN1;RAC3;MAP2K7;FAF1;SKI;ROR2;CDC42;DUSP1;CAVIN3;TUBA4A;MSN;CYLD;IBTK;PRKRIP1;RPS19;RND2;RAB11FIP2;TPX2;CDKN1B;BCL10;HCLS1;CDK5RAP2
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.41062196811392826,1.1895015177715396,0.24955436720142601,0.7364731771306094,1.0,3/27,2.78%,SLC8A3;SLC41A1;SLC23A1
prerank,ionotropic glutamate receptor activity (GO:0004970),0.4535298745751608,1.1886282174592344,0.248046875,0.7325647134838266,1.0,4/17,7.26%,GRIN3A;GRIN2D;GRIK5;GRIK2
prerank,protein heterodimerization activity (GO:0046982),0.2927599725790536,1.1873508947773033,0.1461187214611872,0.729908083201017,1.0,38/178,15.52%,ATP1A2;EPAS1;BMP6;NPAS3;ABCG5;TOP2B;RRAGC;MIGA2;ARNT2;TENM1;PGLYRP3;SIM1;CHUK;ATP1B2;ZHX1;ADD2;ADRA2A;BDKRB2;FZD9;ADCY8;IKBKG;LSM5;USF1;BCL2;PAFAH1B2;GABBR2;TAF1;BHLHE41;ARNT;QTRT2;MICU1;CYBA;FXR2;QTRT1;SMC3;DGKD;GADD45A;TCF4
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.47084106443094365,-1.1873499841079174,0.2544731610337972,0.5764361064605467,1.0,3/12,11.16%,TRAF5;TRIM37;BABAM2
prerank,copper ion binding (GO:0005507),0.36714684623756383,1.18654618196984,0.20260223048327136,0.725996481734563,1.0,14/42,22.57%,MOXD1;LOXL3;SUMF1;LACC1;CUTC;RNF7;ATP7A;IL1A;PAM;PRNP;P2RX4;AOC2;ATP13A2;COA6
prerank,peptidase inhibitor activity (GO:0030414),0.40168934373894255,1.186400635219752,0.224105461393597,0.7202303342937424,1.0,6/33,11.41%,TFPI;ITIH2;RENBP;SERPIND1;HRG;SPINT2
prerank,signal sequence binding (GO:0005048),-0.359699095876505,-1.1836058766305644,0.185589519650655,0.581083217659081,1.0,10/35,15.63%,NFKBIA;AP2B1;TIMM22;CAT;BABAM2;IPO5;SEC61A1;KDELR3;KPNA2;CEMIP
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.36249038926469773,-1.1831388207146585,0.1965065502183406,0.5776725187597861,1.0,4/35,1.87%,PLCB4;PLCE1;GPCPD1;PLCL1
prerank,ATPase binding (GO:0051117),-0.30942975691490204,-1.1824932391502843,0.17464114832535885,0.5747454956893179,1.0,17/71,9.58%,PDE4D;CAV1;SLC2A13;EGFR;ATP6V0A4;ABCA1;ESR1;RALB;GABARAPL2;NKD2;AR;PPP3CA;CHMP4A;UBXN1;ATP6V0A1;SRC;TRPC1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.38673807369632424,-1.181809909759935,0.22602739726027396,0.5719982936542447,1.0,3/25,6.59%,HIP1;ARAP3;PLEKHA4
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.5192527888502059,1.1814023377733176,0.26774847870182555,0.7290915580855939,1.0,2/10,4.06%,TRPV1;GABRG1
prerank,retinoic acid receptor binding (GO:0042974),-0.42732174881856044,-1.1810022560338236,0.22540983606557377,0.5695837119648358,1.0,7/17,15.72%,ACTN4;TACC1;NRIP1;RARG;NCOA6;NR4A2;ARID5A
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.3728050474825213,-1.1807173321866056,0.24887892376681614,0.5659833492209646,1.0,10/32,14.15%,SLC6A6;SLC1A5;SLC7A5;SFXN1;SLC38A5;SLC43A2;SLC43A1;SLC1A1;SLC38A6;SLC36A4
prerank,protein phosphatase binding (GO:0019903),-0.29126453336567343,-1.1785042898868088,0.1272264631043257,0.5669896536992969,1.0,25/117,11.42%,DAB2IP;MAP3K5;FOXO1;CDC27;PIK3R1;IQGAP1;EGFR;STAT3;ITGA1;MFHAS1;ANAPC5;STRN3;MET;RACK1;PPP1R16B;PXN;KCNQ1;SHOC2;CEACAM1;SOD1;FLT4;EIF2AK3;GTF2F1;JAK1;VRK3
prerank,DNA replication origin binding (GO:0003688),-0.39219989541505207,-1.1764784282272471,0.2276595744680851,0.5676970194571563,1.0,12/23,33.06%,KAT7;ORC1;ORC2;CDC45;ORC5;POLA1;MCM3;MCM5;MCM6;ORC3;CDC6;GRWD1
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.4635932761148406,-1.1755235302223566,0.274703557312253,0.5656911418560839,1.0,8/13,31.88%,SH3BP4;ARHGDIB;ARHGDIA;RANBP1;GPSM2;GDI1;ITGB1BP1;GDI2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.3847088321817561,-1.1749235068858552,0.2301255230125523,0.5630575389271075,1.0,4/25,2.67%,FMO1;MICAL2;NOS3;FMO2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.44015341307046857,-1.1745795696257153,0.24158415841584158,0.5596375290270386,1.0,5/15,15.91%,SLC26A7;SLC26A2;SLC39A8;SLC26A6;CFTR
prerank,GTPase activity (GO:0003924),-0.26347204295109083,-1.174372788359889,0.09523809523809523,0.5560366051924168,1.0,63/192,23.00%,RHOJ;DNM3;RHOBTB1;RHOA;RAB14;RAP1A;ATL3;EEF1A1;RAB6A;GTPBP10;RAB31;RALB;GNA11;GBP4;GCH1;RAP2A;GBP5;ARHGDIB;GNB1;EEF2;RASL12;NKIRAS1;BMS1;GFM1;RAB22A;DNAJC27;GNG5;KRAS;NRAS;RAB3A;GNAI3;GNB2;RAB27A;RRAGA;RERG;RAB11B;SAR1A;RAB5C;GNA12;RND3;RAB1B;GFM2;RAP1GAP;RAP2B;MRAS;GNL1;SRPRA;GNA14;RAB11A;ARL8B;RHOBTB3;RHOB;RRAGD;AGAP2;MTG1;RAC3;RAB27B;RAB35;CDC42;AGAP3;RND2;RAB3B;RHOT2
prerank,RNA polymerase binding (GO:0070063),0.4372045299841169,1.1730529270575876,0.2698412698412698,0.7476781886586837,1.0,5/18,13.34%,PABPN1;CCNT2;TAF10;TCERG1L;YTHDC2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.49078944794460194,1.1727386871191097,0.2729044834307992,0.7423329091995508,1.0,2/12,1.76%,ADH4;NQO1
prerank,chemokine activity (GO:0008009),-0.36494625132168146,-1.1716291214483912,0.24481327800829875,0.5579953009835462,1.0,22/31,50.43%,CXCL12;CCL13;CCL25;CXCL16;CCL28;CCL5;CCL4;PF4;PPBP;CCL8;CCL19;CXCL5;CCL14;CXCL1;CCL7;CCL1;CCL3;CCL11;CXCL13;CXCL2;CKLF;XCL1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.3981296244160478,1.1716208844187068,0.26264591439688717,0.7391831424650788,1.0,5/28,8.95%,GABRG1;GRID2;GRIK5;GRIK2;CHRNB2
prerank,N-acyltransferase activity (GO:0016410),0.39724863530092447,1.169667784523289,0.2382608695652174,0.7385998151363818,1.0,5/32,7.02%,NMT2;GNPNAT1;PLAAT5;SAT1;GLYAT
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.35694379212073074,-1.1654336085543011,0.22939866369710468,0.569041278063278,1.0,12/35,21.77%,PEAK1;BMX;LYN;TEC;SRC;YES1;DYRK1A;PTK2B;BTK;HCK;SYK;FYN
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.38530377747146893,-1.1631419018829496,0.24678111587982832,0.5703107222767375,1.0,8/24,10.71%,PLA2G4A;DAB2IP;CERT1;PLEKHA8;OSBP;GOLPH3;PLEKHA5;JPH2
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3898912661725302,-1.1615581910978805,0.2668112798264642,0.5701947000544085,1.0,8/24,19.41%,RPL41;RPL5;GNL3;RPS7;SYNCRIP;RPS13;FMR1;NCL
prerank,histone deacetylase binding (GO:0042826),-0.294049041381394,-1.160184596904673,0.16791979949874686,0.5693403304463227,1.0,27/88,20.08%,LEF1;MEF2C;YWHAE;MIER1;YWHAB;GLI3;NIPBL;HES1;ANKRA2;NACC2;HDAC9;HEY2;RBBP4;CIR1;TAL1;MTA1;HDAC6;NACC1;SP2;KPNA2;HDAC2;TOP2A;CCND1;MTA3;MIER2;PRDM1;SPI1
prerank,ubiquitin protein ligase binding (GO:0031625),-0.251871345652844,-1.1591741070603792,0.0856269113149847,0.5676560925579092,1.0,95/254,26.50%,VCL;FZD6;TRAF5;YWHAE;FOXO1;ACTG1;PRR5L;EGFR;NFKBIA;RPL5;TNFRSF1B;UBC;FAF2;SPOPL;MID1;MFHAS1;JUN;HERC2;DNAJA1;RALB;GABARAPL2;TRIM37;NKD2;RPS27A;UBB;SMAD5;XRCC5;AXIN2;UBE2J1;ANKRA2;APC;MAP1LC3B;UBXN1;USP7;TXNIP;SLC22A18;ARIH1;PER1;YWHAZ;PRDX6;RPL23;BAG5;FZD4;JAK1;ISG15;SQSTM1;RRAGA;HDAC6;GABARAP;UBE2L3;FBXW7;CCT2;CD40;UBE2J2;HM13;PRKAR2B;PA2G4;AUP1;PRKACA;BAG1;UBE2A;RTN4;PCBP2;UBE2G1;RPA2;SLF2;UCHL1;ARRB2;RIPK1;TRIB2;TRAF4;GLMN;FHIT;DIO2;FAF1;SKI;ATXN3;BCL10;SMAD6;TMBIM6;RNF40;TSG101;TRIB3;SUMO2;CUL3;MUL1;CUL4A;CXCR4;WFS1;UQCRC1;CASP8;OTUB1;PRKAR2A;FANCL;ASB4
prerank,ion channel inhibitor activity (GO:0008200),-0.35091745146750963,-1.1586595991207342,0.2205240174672489,0.5648900641343257,1.0,10/35,15.91%,NEDD4L;STX1A;SLC30A1;RACK1;CAMK2D;KCNMB2;MCUB;STX7;STX8;CFTR
prerank,carboxylic ester hydrolase activity (GO:0052689),0.31985310319512683,1.1572793220775137,0.2119205298013245,0.770510388899995,1.0,14/85,12.76%,LIPA;CEL;ASPG;PON1;PLAAT5;PLA2G4C;DDHD2;ABHD5;TARS2;MRPL58;PAFAH1B2;PLA2G15;ABHD3;GDE1
prerank,phosphatidylinositol binding (GO:0035091),-0.2906305134364645,-1.1559449512082722,0.18615751789976134,0.567178603435057,1.0,22/91,17.04%,HIP1;PITPNC1;ESYT2;PARD3;SCARB1;MCF2L;SNX13;ANKFY1;FCHO2;TNFAIP8L3;SNX1;ESYT3;ZFYVE16;AIDA;HIP1R;SNX10;ITPR3;SNX2;EPB41;PITPNB;PIGK;DENND1B
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.302962791880711,-1.1548865761786435,0.2171837708830549,0.5658023154202237,1.0,26/70,29.21%,GCNT2;CSGALNACT1;EXT1;B3GNT2;MGAT4A;HEXA;MFNG;GCNT1;POGLUT3;CHSY3;MGAT4B;HAS1;LFNG;B3GAT3;HAS2;B3GNT3;B4GALNT3;B3GALT5;B3GNT8;EXT2;POGLUT1;GCNT4;RFNG;B3GALT1;CSGALNACT2;B3GNT6
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3443546597840187,1.1542396154187335,0.24077328646748683,0.7736023844846964,1.0,7/51,6.12%,SLC22A6;SLC22A8;SLC5A5;SLC35E2B;SLC35E2A;TMEM241;SLC25A11
prerank,ATP hydrolysis activity (GO:0140603),0.3624092548820745,1.1521012636918686,0.23507462686567165,0.7741355530100146,1.0,11/41,11.36%,HSPA1A;ABCA4;RUVBL2;TDRD9;ABCB10;ATAD1;CHD3;TOR1B;ABCD1;MYO18A;CLU
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.48531142331032096,-1.1509853862329231,0.29549902152641877,0.5709058206687723,1.0,5/11,12.80%,TRPC3;TRPC6;TRPC4;TRPC1;ITPR3
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4445205461852086,1.1495876991817924,0.2840909090909091,0.7758012626364603,1.0,8/16,25.32%,SLC13A3;SLC25A11;SLC25A12;SLC38A7;SLC13A5;SLC25A13;SLC25A18;SLC1A4
prerank,dynactin binding (GO:0034452),0.47542392664090427,1.1465685481920351,0.2885375494071146,0.7788474740540323,1.0,3/12,10.65%,SNX6;HTT;BICD1
prerank,cytokine activity (GO:0005125),0.2944969928646564,1.1460576476937605,0.21354166666666666,0.7743584845713021,1.0,12/131,7.53%,BMP7;WNT4;BMP6;IL18;WNT5B;WNT7A;IL17D;BMP3;BMP8A;WNT6;NRG1;INHA
prerank,R-SMAD binding (GO:0070412),0.4260770318661172,1.1408945933184287,0.28810408921933084,0.7843085256631819,1.0,8/18,21.67%,DDX5;SMAD3;PAX6;PMEPA1;MEN1;SMAD2;SMAD4;TRIM33
prerank,protein kinase regulator activity (GO:0019887),0.3090553453134348,1.1406913643157564,0.23934426229508196,0.7787952708341747,1.0,8/95,4.05%,PRKAG2;SH3BP5L;PRKAG3;GPRC5A;GPRC5C;GPRC5B;CCNT2;SH3BP5
prerank,syntaxin-1 binding (GO:0017075),0.4146610572449067,1.1385511821903898,0.3014705882352941,0.7789739234402081,1.0,11/22,24.57%,UNC13C;SYT1;LRRK2;SNAP25;NSF;CPLX1;CPLX2;STXBP3;SYNPR;SNPH;STXBP2
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.3654727427733034,-1.1381114258190768,0.26824034334763946,0.5976465160377163,1.0,10/29,24.51%,NFATC1;PTPRJ;GCH1;NBR1;MAPKAPK2;TPR;DUSP6;DUSP1;PRMT1;DUSP7
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.4610349654454101,1.1373687829837007,0.2892057026476578,0.7763832931058227,1.0,7/14,25.96%,AIFM1;NOX1;KMO;CYBA;NCF1;MICAL1;CYBB
prerank,double-stranded DNA binding (GO:0003690),-0.231702876589769,-1.136396720851159,0.07575757575757576,0.5977983015180821,1.0,123/531,20.71%,KLF12;LEF1;FOXP1;MEF2C;ERG;PBX1;ELK3;TBX15;RARB;MEOX2;PPARD;FLI1;TCF12;TBX3;RAD51B;FOXO3;EGFR;POLR3F;RUNX2;NFATC1;SIX1;CRY1;TBX18;JUN;ESR1;TBX1;GLI3;NFIX;TFEB;BHLHE40;PRRX2;NR3C2;VSX1;IRF9;SMAD5;CREB3L1;AIM2;LHX6;HES1;JDP2;ETV1;XRCC5;REXO4;SP3;KLF11;TGIF1;TFCP2L1;RFX7;ELF4;ETV5;FOXQ1;NFAT5;MBNL2;RPS3;HEY2;GATA2;BACH2;HMBOX1;IRF2;KLF4;ELK1;NR2C1;HOXA6;AHR;ETS2;CPSF4;SREBF2;NFATC2;SOX7;CEBPD;SOX18;DMC1;TEAD1;RARG;KIN;KLF2;TBX2;SOX12;MAFF;HSF5;NR4A2;SP2;TFCP2;ATF6B;FOXO4;ZNF445;ZFP1;SIX4;ATF4;ZBTB33;FOXD2;BCL6B;ZNF250;HEY1;NFKB2;TDG;NEIL3;ZBTB37;ZCCHC3;JUNB;FOXN2;ZBTB48;IRF5;NR2F1;HIVEP1;SOX8;PAX3;RAD51AP2;HOXA4;FOXE1;FOXL2;NFATC3;LMX1B;PRDM1;ZNF177;ATF3;HMGB1;MAU2;XPA;CENPX;JUND;ZBTB45;HSF4
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.43961646518984354,-1.135579858532903,0.3047034764826176,0.5960573505864927,1.0,6/14,23.11%,OTUD7B;MINDY1;USP7;MINDY2;ATXN3;USP15
prerank,protein homodimerization activity (GO:0042803),-0.23097034001164096,-1.135500883076179,0.07692307692307693,0.5923261455992039,1.0,150/589,19.72%,HIP1;ABCG2;SYNE1;GHR;ACTN4;PECAM1;ZBTB16;ECE1;DAB2IP;SLIT2;LRRFIP1;EXT1;LRP6;FOXP2;ANO1;B2M;ACVR1;TGFB2;MAP3K5;FAP;PIP4K2A;RBPMS;MYH9;BCL2L1;ZHX3;STAT3;RASIP1;IRAK3;TBX18;F11R;MID1;MKLN1;MFF;TBX1;DEFA6;NOD1;MID2;ACTN1;SCARB2;FLNA;GBP4;PANK3;TFRC;GCH1;MGLL;CISD2;BHLHE40;TRIM37;TPD52;GSS;ACOX1;GBP5;ERN1;XDH;ADAM10;NECTIN3;RACK1;HES1;S100A13;CAMK2D;PDE2A;SNX1;TRIM14;TPM4;NRF1;TRPC6;IL6R;SRR;DPY30;CHMP4B;CHMP4A;NACC2;ZBTB1;TPM2;CEACAM1;SPPL3;CUBN;PDGFC;ABCD2;PEX7;AOX1;FLT4;CAT;FBXO4;DROSHA;S100A11;S100A6;AHR;CAV2;APOE;DSCAML1;MFSD1;PSAP;HSPB1;S100A16;YARS2;FZD4;STK10;PHB2;HHEX;TPST2;HIP1R;BLM;SMCHD1;TPR;ASMT;RRAGA;RPE;NFS1;HOGA1;CIP2A;VEGFA;ZNF318;S100A10;HM13;VAPB;SNX2;BAK1;IRAK2;CSF1R;NQO2;RAP1GAP;ZDHHC2;CDA;FMR1;FXR1;RAB11FIP3;MTMR1;PLN;TOP2A;PDXK;TDG;NUDT16;ALDH1A3;STK26;BARD1;ST3GAL2;ENPP1;KIF20B;MCL1;MYOM1;PTH1R;GREM1;CADM1;KYNU;AIMP1;MTHFD1L;CYP2R1;ABCG4;IMPA2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.4171049935780502,1.1331331936642992,0.2988505747126437,0.7828560812481972,1.0,4/19,7.26%,GABRG1;GRID2;GRIK5;GRIK2
prerank,kinase activity (GO:0016301),0.2996654663518546,1.131066566013296,0.22696245733788395,0.7835284558217966,1.0,28/109,18.18%,NADK2;SPHK1;GK;TKFC;PANK1;STK39;PSTK;PIK3CB;COQ8B;PGK1;PANK2;LRRK2;DGKI;CHKB;TAF1;PI4KA;SPHK2;EPHA4;DGKE;ABL1;DGKD;IPPK;CERK;CDKL5;IP6K2;CDK5R1;PKMYT1;AKT1
prerank,tRNA methyltransferase activity (GO:0008175),-0.4226426722244744,-1.1263607022416489,0.292,0.6107588760356714,1.0,7/16,19.12%,METTL2A;METTL2B;THUMPD2;FTSJ1;TRMT44;TYW3;LCMT2
prerank,potassium channel regulator activity (GO:0015459),0.3404730562708992,1.1226667777882877,0.2877442273534636,0.8033856194822152,1.0,10/49,14.01%,KCNIP3;LRRC38;SLC5A3;WNK3;DLG1;WNK4;DPP10;KCNIP4;KCNS3;ENSA
prerank,chloride channel activity (GO:0005254),-0.3084084970640498,-1.1218780434928604,0.2628992628992629,0.6172953953634256,1.0,13/59,15.91%,SLC26A7;CLIC4;ANO1;TTYH2;CLIC1;GABRA3;GLRB;CLCC1;ANO4;GABRE;GLRA2;ANO2;CFTR
prerank,E-box binding (GO:0070888),-0.34960508303630494,-1.121010839621033,0.28761061946902655,0.6154001902402022,1.0,8/34,11.80%,ZEB1;BHLHE40;HES1;TAL1;AHR;PER1;SREBF2;TWIST1
prerank,diacylglycerol kinase activity (GO:0004143),-0.4667332241070151,-1.1209947031901866,0.3378640776699029,0.6114561933656734,1.0,3/11,3.92%,DGKH;DGKZ;AGK
prerank,G protein-coupled receptor binding (GO:0001664),0.2859192726000838,1.1187612920123016,0.246875,0.8098933109761133,1.0,22/132,14.65%,RNF43;WNT4;HSPA1A;WNT5B;TULP3;WNT7A;GPRC5B;ARR3;NTS;GPRASP2;WNT6;ARRB1;ARHGEF11;FZD7;RSPO1;C1QBP;BICD1;USP20;GRK3;PSMC5;GNAO1;HSPA1B
prerank,MAP kinase kinase activity (GO:0004708),0.43778348535934286,1.118211336456055,0.3187250996015936,0.8055391282194713,1.0,4/15,11.12%,MAP2K6;LRRK2;MAPK10;MAPK14
prerank,lipoprotein particle binding (GO:0071813),-0.39080138506874507,-1.1174932070982497,0.3153692614770459,0.616096863867983,1.0,5/20,4.91%,SCARB1;THBS1;CDH13;SCARF1;PLTP
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.33021206615784127,1.1169267817755906,0.2833935018050541,0.8035755432084395,1.0,9/55,11.37%,CACNA1D;ANXA6;SLC24A3;TRPV1;ITPR1;PKD2L2;ITPR2;RYR2;TRPM2
prerank,transcription coregulator binding (GO:0001221),0.33220967710543575,1.1144602271092043,0.2787193973634652,0.8052412785616403,1.0,16/50,18.39%,RORA;SMAD3;THRB;CCNT2;USP11;PHF1;MED25;LCOR;ZBTB49;TERT;CTBP2;PER2;CHD6;RELA;MTF2;HDGF
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.22291176246056446,-1.1130291783195019,0.09389671361502347,0.623479007979548,1.0,144/731,16.94%,KLF12;MECOM;LEF1;FOXP1;MEF2C;ERG;ZBTB7C;ZBTB16;PBX1;ELK3;ZFHX3;EBF1;ZEB1;LRRFIP1;TBX15;RARB;FOXP2;PLAGL1;MEOX2;ETS1;PPARD;TCF12;FOXO1;TBX3;TEAD4;PBX3;FOXO3;CTCF;RUNX2;DACH2;EBF2;NFATC1;PRDM16;H3-3A;STAT3;SIX1;NFIA;TBX18;DACH1;RUNX1;REL;JUN;ESR1;TBX1;KLF7;BPTF;GLI3;NFIX;TFEB;SOX17;BHLHE40;PRRX2;NR3C2;NFYA;KLF8;SMAD1;IRF9;SMAD5;CREB3L1;HES1;JDP2;ETV1;NLRC5;NRF1;AR;SP3;KLF11;TGIF1;TFCP2L1;RFX7;ZBTB11;ELF4;RELB;NACC2;HEYL;ZBTB1;FOXQ1;NFAT5;ZNF83;PRDM5;HEY2;ZKSCAN1;GATA2;NRIP1;BACH2;IRF2;KLF4;ELK1;TAL1;NR2C1;NFE2L1;HOXA6;AHR;MAFK;ETS2;ZSCAN18;PER1;SREBF2;NFATC2;SOX7;ZBTB41;CEBPD;ZKSCAN8;MTA1;TWIST1;HHEX;SOX18;FOXF2;FOSL2;ZBTB24;TEAD1;RARG;HDAC6;NACC1;KLF2;TBX2;NFIL3;SOX12;POU2F1;MAFF;HSF5;NR4A2;SP2;TFCP2;E2F5;SKIL;ATF6B;FOXO4;ZBTB5;ZNF445;ZFP1;SIX4;ATF4;SP4;ZNF691;ZBTB33;RREB1;FOXD2;MKX;BCL6B;ZNF250;ZSCAN25;HEY1;ZFHX4
prerank,protein phosphatase inhibitor activity (GO:0004864),0.38768568643184886,1.111936463829892,0.31203007518796994,0.8070822508491612,1.0,1/26,0.05%,PPP1R1A
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.29054191543190727,-1.1095682975871113,0.23902439024390243,0.627842793251454,1.0,14/71,12.04%,PTPRM;PTPRB;PTPRG;PTPN12;PTP4A2;PTPRJ;PTPRK;PALD1;UBASH3B;PTPN1;DUSP3;PTP4A3;DUSP23;PTPRZ1
prerank,GABA receptor binding (GO:0050811),0.4842771014846651,1.1094521372033181,0.34235976789168276,0.8088967343267898,1.0,3/11,8.70%,TRAK1;SHISA7;JAKMIP1
prerank,ATP binding (GO:0005524),0.2634730522567542,1.1090866773552785,0.22334293948126802,0.8043331737250083,1.0,39/266,12.93%,ATP1A2;PRKAG2;HSPA1A;P2RX6;OXSR1;TRPV1;SPHK1;ABCG5;GCK;DMPK;OAS2;WNK3;BMPR1A;NVL;ABCF3;PLK1;MYO9B;NIM1K;SYN2;PGK1;HNRNPU;PNPLA8;WNK4;PDK2;PRKCI;KSR1;MSH6;ABCD1;OAS3;TGFBR1;PEX1;MYO18A;ABCA2;PYGL;MTHFS;DARS2;RTEL1;TARS1;SYN3
prerank,histone acetyltransferase activity (GO:0004402),0.3708319177777612,1.1088356702482984,0.31346153846153846,0.7993952886126435,1.0,12/30,21.96%,MCM3AP;ARRB1;KAT5;TAF10;CLOCK;KAT14;TAF1;BAZ1A;TADA3;KAT6B;KAT8;ATF2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.43002939763861925,-1.1070934032060051,0.35260115606936415,0.6302396739018656,1.0,4/13,10.12%,THUMPD2;TRMT10A;FTSJ1;TRMT10B
prerank,low-density lipoprotein particle binding (GO:0030169),-0.4145777795114992,-1.1061786983355137,0.3193612774451098,0.6285833033437123,1.0,5/16,4.91%,SCARB1;THBS1;CDH13;SCARF1;PLTP
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.2220050466316789,-1.1046750219716237,0.11764705882352941,0.6283858832804275,1.0,173/732,20.91%,KLF12;MECOM;LEF1;FOXP1;MEF2C;ERG;ZBTB7C;ZBTB16;PBX1;ELK3;ZFHX3;EBF1;ZEB1;LRRFIP1;TBX15;RARB;FOXP2;PLAGL1;MEOX2;ETS1;PPARD;TCF12;FOXO1;TBX3;TEAD4;PBX3;FOXO3;CTCF;RUNX2;DACH2;EBF2;NFATC1;PRDM16;H3-3A;STAT3;SIX1;NFIA;TBX18;DACH1;RUNX1;REL;JUN;ESR1;TBX1;KLF7;BPTF;GLI3;NFIX;TFEB;SOX17;BHLHE40;PRRX2;NR3C2;NFYA;KLF8;SMAD1;IRF9;SMAD5;HES1;JDP2;ETV1;NLRC5;NRF1;AR;SP3;KLF11;TGIF1;TFCP2L1;RFX7;ZBTB11;ELF4;RELB;FOXN3;NACC2;HEYL;ZBTB1;FOXQ1;NFAT5;ZNF83;PRDM5;HEY2;ZKSCAN1;GATA2;NRIP1;BACH2;IRF2;KLF4;ELK1;TAL1;NR2C1;NFE2L1;HOXA6;AHR;MAFK;ETS2;ZSCAN18;PER1;SREBF2;NFATC2;SOX7;ZBTB41;CEBPD;ZKSCAN8;MTA1;HHEX;SOX18;FOXF2;FOSL2;ZBTB24;TEAD1;RARG;HDAC6;NACC1;KLF2;TBX2;NFIL3;SOX12;POU2F1;MAFF;HSF5;NR4A2;SP2;TFCP2;E2F5;SKIL;ATF6B;FOXO4;ZBTB5;ZNF445;ZFP1;SIX4;ATF4;SP4;ZNF691;ZBTB33;RREB1;FOXD2;MKX;BCL6B;ZNF250;ZSCAN25;HEY1;ZFHX4;NFKB2;SP7;ZBTB37;JUNB;FOXN2;ZBTB48;ZNF496;IRF5;NR2F1;HIVEP1;SOX8;NR1H4;PAX3;HOXA4;FOXE1;FOXL2;NFATC3;PRDM1;SPI1;ATF3;JUND;NKX6-1;ZBTB45;POU3F3;HSF4;ZBTB25;PRRX1;MGA;NKX2-2;THAP1
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.23835659275346277,-1.1044421296636444,0.1826625386996904,0.6250296370859864,1.0,98/269,26.50%,VCL;FZD6;TRAF5;YWHAE;FOXO1;ACTG1;PRR5L;EGFR;NFKBIA;RPL5;TNFRSF1B;UBC;FAF2;SPOPL;MID1;MFHAS1;JUN;HERC2;DNAJA1;RALB;GABARAPL2;TRIM37;NKD2;RPS27A;UBB;SMAD5;XRCC5;AXIN2;UBE2J1;ANKRA2;APC;MAP1LC3B;UBXN1;USP7;TXNIP;SLC22A18;ARIH1;PER1;YWHAZ;PRDX6;RPL23;BAG5;HGS;FZD4;JAK1;ISG15;SQSTM1;RRAGA;HDAC6;GABARAP;UBE2L3;FBXW7;CCT2;CD40;UBE2J2;HM13;PRKAR2B;PA2G4;AUP1;PRKACA;BAG1;UBE2A;RTN4;PCBP2;UBE2G1;RPA2;SLF2;UCHL1;ARRB2;RIPK1;TRIB2;TRAF4;GLMN;FHIT;DIO2;FAF1;SKI;DTX3L;ATXN3;BCL10;SMAD6;TMBIM6;RNF40;TSG101;TRIB3;SUMO3;SUMO2;CUL3;MUL1;CUL4A;CXCR4;WFS1;UQCRC1;CASP8;OTUB1;PRKAR2A;FANCL;ASB4
prerank,histone methyltransferase activity (GO:0042054),0.3668095949247759,1.1002324238141195,0.31529850746268656,0.8194253352770176,1.0,10/32,17.39%,KMT5A;DOT1L;PRMT2;N6AMT1;SETD7;SMYD3;SMYD2;MEN1;NTMT1;NSD3
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.33756535615686134,-1.0997193945453436,0.3029661016949153,0.6329552033296303,1.0,10/33,15.98%,DCUN1D3;RNF144A;RNF144B;RNF125;RPS3;ARIH2;ARIH1;DCUN1D5;AUP1;RNF19A
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.34431940941060113,-1.0996293563567807,0.3063457330415755,0.6293258803877801,1.0,5/31,8.45%,SLC12A7;SLC12A2;ABCC9;SLC12A6;KCNK5
prerank,estrogen receptor binding (GO:0030331),-0.3484244993053738,-1.0988215334811926,0.3333333333333333,0.627527390125378,1.0,15/32,22.80%,LEF1;TACC1;WIPI1;ESR1;NRIP1;DDX54;PHB2;DCAF13;NCOA6;RERG;ARID5A;LATS1;CCDC62;SRARP;DCAF1
prerank,hyaluronic acid binding (GO:0005540),-0.46192966706034166,-1.0978050354669728,0.36327345309381237,0.626303671917254,1.0,2/10,3.14%,LAYN;CD44
prerank,transaminase activity (GO:0008483),0.4727560370640091,1.096845453364399,0.3524416135881104,0.8244561237736541,1.0,6/11,27.57%,BCAT2;GOT1;GOT2;BCAT1;PSAT1;ABAT
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.34970677190546706,-1.0928527191812063,0.3216494845360825,0.634459390898852,1.0,9/27,15.98%,DCUN1D3;RNF144A;RNF144B;RNF125;ARIH2;ARIH1;DCUN1D5;AUP1;RNF19A
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.4586826450097339,1.0923223248461669,0.3406813627254509,0.8328085435110029,1.0,4/11,13.61%,PRMT2;FBXO11;PRMT9;PRMT3
prerank,cholesterol transfer activity (GO:0120020),-0.40383569821918475,-1.0898722923574042,0.3516260162601626,0.6382430254572765,1.0,6/16,12.35%,ABCA1;PLTP;NPC2;MTTP;STARD4;GRAMD1A
prerank,bHLH transcription factor binding (GO:0043425),0.40463169102000807,1.08868049137103,0.3471698113207547,0.8386331851237084,1.0,7/19,17.25%,SMAD3;FHL2;MAP3K10;USF1;BHLHE41;SIRT1;KDM1A
prerank,transcription corepressor binding (GO:0001222),0.3649995391854405,1.087316456001267,0.30278884462151395,0.8369274051340037,1.0,8/27,18.39%,RORA;USP11;PHF1;LCOR;CTBP2;PER2;MTF2;HDGF
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.2371339856511133,-1.0867671267647148,0.21987951807228914,0.6420482847865638,1.0,79/248,23.00%,RHOJ;DNM3;RHOBTB1;RHOA;ATP2B1;RAB14;RAP1A;ATL3;MYH9;EEF1A1;RAB6A;GTPBP10;RAB31;RALB;GNA11;GBP4;GCH1;RAP2A;GBP5;MYL6;ARHGDIB;GNB1;EEF2;ABCA3;RASL12;CHD1L;NKIRAS1;ABCD2;BMS1;GFM1;RAB22A;MYO19;DYNC1I1;DNAJC27;GNG5;KRAS;NRAS;RAB3A;GNAI3;GNB2;RAB27A;SMCHD1;RRAGA;RERG;RAB11B;SAR1A;RAB5C;GNA12;RND3;RAB1B;GFM2;RAP1GAP;CFTR;RAP2B;KIF1C;MRAS;GNL1;SRPRA;RUVBL1;GNA14;KIF20B;RAB11A;ARL8B;RHOBTB3;RHOB;ABCG4;RRAGD;AGAP2;GPR88;MTG1;RAC3;RAB27B;RAB35;CDC42;AGAP3;MYO1E;RND2;RAB3B;RHOT2
prerank,cytokine receptor binding (GO:0005126),-0.27780405914095935,-1.0844791834517529,0.28837209302325584,0.6437444350461625,1.0,14/83,11.59%,KITLG;IL6ST;OSMR;LIFR;TGFB2;VEGFC;SOCS2;SPRED2;IL6R;CXCL12;IL1RAP;IL34;JAK1;PIBF1
prerank,semaphorin receptor activity (GO:0017154),-0.4502493217485222,-1.083911071701048,0.38028169014084506,0.6413162090081227,1.0,2/11,0.78%,NRP1;NRP2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.3021229621059225,-1.0836358981661305,0.31880733944954126,0.6382578534903007,1.0,13/53,14.15%,SLC47A1;SLC1A5;SLC7A5;SFXN1;SLC38A5;SLC43A2;SLC7A7;SLC7A1;SLC1A3;SLC43A1;SLC1A1;SLC38A6;SLC36A4
prerank,endopeptidase regulator activity (GO:0061135),0.35152323756508214,1.0833872061020422,0.34572490706319703,0.8430525463022102,1.0,8/40,13.54%,TFPI;ITIH2;RENBP;SERPIND1;HRG;ABCA2;SPINT2;APH1A
prerank,metal ion binding (GO:0046872),-0.22029262862613028,-1.077255476113734,0.1843137254901961,0.6504489308334576,1.0,104/477,18.38%,CDH11;SNRK;LTBP4;SPARC;SPOCK2;RAPGEF2;PLA2G4A;ESYT2;CSGALNACT1;SLIT2;STIM2;MARK1;GSN;MAP3K5;RASGRP3;THBS1;STK38L;STK3;CDH13;MICU3;IQGAP1;CDH1;PLSCR1;EML1;IRAK3;PLSCR4;ASPN;FBN1;TPD52;GSS;MAP3K20;RAP2A;ERN1;S100A13;PDE2A;MCTP2;TPM4;HSPE1;CDC42BPA;SRR;TPT1;ANXA1;NCS1;CALM3;PPP3CA;TGM2;SYT4;PAPOLA;ESYT3;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;HMGCLL1;NOTCH4;ADCY2;HPRT1;GCLC;S100A11;RP2;S100A6;APOE;SNN;DYSF;S100A16;HACL1;CRACR2A;FKBP9;COMP;RET;ITPR3;RPE;POSTN;STK38;ARSA;CALML4;ANXA7;AGRN;CDH2;MICU2;ACVR1C;MT3;S100A10;MCTP1;CEMIP2;AOC3;DSG2;LRP1;TOP2A;PDXK;TDG;LATS1;NUDT16;MAST2;MAPK12;STK26;NUDT12;MT2A;GRIN1;ENPP1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.34879934759057196,1.0771233552510422,0.3602941176470588,0.8570424197973364,1.0,11/38,20.85%,TFPI;SERPINA10;FURIN;SERPIND1;HRG;SPINT2;SERPINA9;SERPINE3;SERPING1;SPOCK1;ANXA2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.35036032821571605,-1.0765248549176172,0.3416666666666667,0.6485106713592554,1.0,10/27,22.56%,POLR3F;POLR3H;POLR1F;POLR3B;PRIMPOL;POLR1A;POLR3A;POLR2I;POLR1H;POLR2F
prerank,pentosyltransferase activity (GO:0016763),0.3531691962836998,1.07590112306474,0.33691756272401435,0.8553529517996152,1.0,16/36,24.44%,LARGE1;LACC1;TNKS2;PARP14;PARP4;UPP2;QTRT2;PARP16;QTRT1;SIRT1;UMPS;ART4;QPRT;PARP10;PNP;TIPARP
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.3501006100989382,-1.075837961472456,0.3584905660377358,0.646559586210288,1.0,10/27,22.56%,POLR3F;TENT2;POLR3H;POLR1F;POLR3B;POLR1A;POLR3A;POLR2I;POLR1H;POLR2F
prerank,enoyl-CoA hydratase activity (GO:0004300),0.4634260095466821,1.0750750536336395,0.3731958762886598,0.8524282195210596,1.0,3/10,10.83%,ECHDC3;ECHS1;ECHDC2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.4424609593543789,-1.0711954394093728,0.37142857142857144,0.6506831754999692,1.0,4/11,15.83%,BAG5;PFN1;GRPEL1;BAG1
prerank,adenyl nucleotide binding (GO:0030554),-0.4424609593543789,-1.0711954394093728,0.37142857142857144,0.6506831754999692,1.0,4/11,15.83%,BAG5;PFN1;GRPEL1;BAG1
prerank,ubiquitin protein ligase activity (GO:0061630),0.25749176417658826,1.0697095080560906,0.30303030303030304,0.8635075527033808,1.0,59/228,21.78%,RNF220;RNF152;RNF43;SH3RF2;PDZRN3;ASB2;DTX1;TRIM62;SIAH2;RNF41;TRIM5;RNF126;KCMF1;TRIM71;SHPRH;RNF14;UBE4B;TRIM35;DTX2;PELI3;DTX3;BRAP;RNF135;TOPORS;RNF10;FBXO6;RNF6;RNF121;HLTF;RNFT1;PRPF19;RLIM;RING1;FBXO17;RNF138;RNF5;RNF7;MDM2;TRIM3;RBBP6;RNF130;ANKIB1;FBXL22;RNF139;TRIM13;RNF13;MYCBP2;RNF26;TRIM63;RNF180;TRIM2;BFAR;NFX1;TRIM41;TRIM9;RNF11;HECW1;UBOX5;TRIM32
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.21637929554006077,-1.0685798608854375,0.1717557251908397,0.6537905679580048,1.0,132/597,20.37%,KLF12;LEF1;FOXP1;MEF2C;ERG;PBX1;ELK3;BNC2;TBX15;RARB;MEOX2;ETS1;PPARD;FLI1;TCF12;KAT7;TBX3;FOXO3;CTCF;RUNX2;NFATC1;PRDM16;STAT3;SIX1;TBX18;RUNX1;JUN;ESR1;TBX1;GLI3;DHX33;NFIX;TFEB;SOX17;BHLHE40;PRRX2;NR3C2;VSX1;NFYA;PSPC1;IRF9;SMAD5;CREB3L1;LHX6;HES1;JDP2;ETV1;XRCC5;AR;SP3;KLF11;TGIF1;TFCP2L1;RFX7;ELF4;ETV5;FOXQ1;NFAT5;MBNL2;PRDM5;HEY2;GATA2;BACH2;HMBOX1;IRF2;KLF4;ELK1;TAL1;NR2C1;HOXA6;AHR;MAFK;ETS2;CPSF4;PER1;SREBF2;NFATC2;SOX7;CEBPD;HHEX;SOX18;TEAD1;RARG;ORC1;KLF2;TBX2;SOX12;SUV39H1;MAFF;HSF5;NR4A2;MTERF3;ZW10;SP2;TFCP2;ATF6B;FOXO4;ZFP1;ARID5A;SIX4;ATF4;ZBTB33;FOXD2;BCL6B;ZNF250;HEY1;NFKB2;ORC2;ZBTB37;JUNB;FOXN2;ZBTB48;CDC45;ORC5;IRF5;NR2F1;HIVEP1;SOX8;PAX3;HOXA4;FOXE1;FOXL2;NFATC3;LMX1B;POLA1;PRDM1;ZNF177;SPI1;ATF3;HMGB1;XPA;JUND
prerank,single-stranded DNA helicase activity (GO:0017116),-0.3789809509481443,-1.0679485544346563,0.384928716904277,0.6515515247329364,1.0,12/19,37.41%,HELQ;WRNIP1;RFC4;MCM5;MCM6;RFC2;DSCC1;HELB;CHTF18;PIF1;DHX9;POLQ
prerank,nuclear export signal receptor activity (GO:0005049),-0.44134744453486957,-1.067013934598746,0.3815261044176707,0.6501534947035721,1.0,7/11,36.48%,XPO5;XPO6;NUP214;RAN;NUP42;XPO7;XPO1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.47454448627687656,1.0666559696864955,0.3699186991869919,0.8678082254863828,1.0,5/10,24.85%,NSD1;SMYD2;NSD3;SETD2;SETD5
prerank,Toll-like receptor binding (GO:0035325),-0.44539296206137086,-1.0665844240606979,0.3884462151394422,0.6476323817366536,1.0,7/11,36.87%,DAB2IP;MYD88;TLR6;CD36;TLR1;S100A9;TLR2
prerank,receptor ligand activity (GO:0048018),0.2535965021599344,1.0662091056227614,0.30139103554868624,0.8633950944276358,1.0,23/245,7.53%,BMP7;FGF1;WNT4;BMP6;IGF1;IL18;FGF4;WNT5B;FGF9;METRNL;WNT7A;TAFA3;IL17D;CHGB;BMP3;NRTN;TNFSF13;BMP8A;NTS;COLEC10;WNT6;NRG1;INHA
prerank,adenyl ribonucleotide binding (GO:0032559),0.25084074195603406,1.065736844306933,0.30867709815078237,0.8593136527352898,1.0,44/291,12.93%,ATP1A2;PRKAG2;HSPA1A;P2RX6;OXSR1;TRPV1;SPHK1;ABCG5;GCK;DMPK;OAS2;PRKAG3;WNK3;BMPR1A;NVL;ABCF3;PLK1;MYO9B;NIM1K;SYN2;PGK1;HNRNPU;PNPLA8;WNK4;PDK2;MYO3A;PRKCI;KSR1;SLC19A1;MSH6;ABCD1;OAS3;TGFBR1;ACSS2;PEX1;MYO18A;MPPED2;ABCA2;PYGL;MTHFS;DARS2;RTEL1;TARS1;SYN3
prerank,protease binding (GO:0002020),-0.26223578135387193,-1.0652179510792907,0.31894484412470026,0.6475100246720156,1.0,21/99,16.57%,VWF;SLC2A13;FAP;F3;FN1;UBC;CARD16;ITGB1;CRADD;CST3;SERPINE1;CCBE1;SPATA2;PSAP;COMP;SERPINB9;ECM1;TYSND1;BRCA2;COL1A1;ADRM1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.42279526272938683,1.0647854253495477,0.37524950099800397,0.856622545169063,1.0,3/14,8.26%,KCND3;KCNJ5;KCNH2
prerank,ephrin receptor binding (GO:0046875),-0.37967054674908385,-1.064536751120822,0.38085106382978723,0.6456162527243957,1.0,6/21,9.26%,ANKS1A;CHN1;LYN;EFNA5;SRC;PTPN1
prerank,zinc ion binding (GO:0008270),-0.23182159780684256,-1.0637451656642487,0.2761904761904762,0.6440757289518781,1.0,64/293,14.81%,LIMS1;MSRB3;SHANK3;MYRIP;ECE1;ZEB1;CBLB;TNFSF10;CTCF;PLSCR1;ENPEP;KLF7;KAT6A;ZDHHC20;GCH1;CRIP1;ARHGEF2;ADH5;RNF125;TNKS;CRIP2;MSRB2;S100A13;HHIP;PDE2A;ZNF3;PAPPA;SEC24D;GRIN2B;HPF1;ARIH2;SOD1;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;PTPN1;ZFPM2;KLF4;SEC23A;ADH1A;ARIH1;RABIF;RPS29;TES;SIRT5;RPS27;PTGR2;BLM;ACE2;SLC30A5;LNPEP;SEC24B;CLIP1;IFIH1;SMPDL3A;CA2;LANCL1;MT3;ADAM33
prerank,PDZ domain binding (GO:0030165),0.30598964378082305,1.0612078586685514,0.35130434782608694,0.8616633549295182,1.0,13/61,11.11%,TGFBR3;ARHGAP29;CXXC4;GRID2;FZD3;FZD8;LLGL2;DLG4;NSF;FZD7;PDZK1;PLEKHA2;SYNJ2
prerank,protein kinase inhibitor activity (GO:0004860),-0.30826721633358795,-1.0590268406541345,0.3384615384615385,0.6524006229947303,1.0,16/42,23.56%,YWHAB;SPRED2;CIT;RACK1;NCK1;SPRY2;CDKN1C;RPTOR;PARVA;GSKIP;SOCS3;TAOK3;IBTK;PRKRIP1;CDKN1B;SOCS1
prerank,NAD+ binding (GO:0070403),-0.42640682993139656,-1.056790873601064,0.38461538461538464,0.6544491726818359,1.0,4/12,23.33%,SIRT5;HADH;GLUD1;SIRT6
prerank,poly-pyrimidine tract binding (GO:0008187),0.38360293835541337,1.05657443571502,0.3838582677165354,0.8702137880697118,1.0,5/23,8.14%,RBM11;PABPC4L;HNRNPU;PATL1;PTBP1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.39822650160385975,1.0565502327784861,0.3934740882917466,0.8647807374245399,1.0,2/18,9.53%,HSD17B2;DHRS11
prerank,neuropeptide receptor activity (GO:0008188),0.3641453438823329,1.0536547029250527,0.3805970149253731,0.8678643350281422,1.0,5/29,13.81%,GPR143;NMUR1;GPR37;GRPR;OPRM1
prerank,transforming growth factor beta receptor binding (GO:0005160),0.39187695759445096,1.0528631158327666,0.3841698841698842,0.8650442023718182,1.0,2/18,0.93%,TGFBR3;SMAD3
prerank,voltage-gated ion channel activity (GO:0005244),0.42194519765757726,1.0499047724352115,0.3799621928166352,0.8690155761505197,1.0,6/14,24.91%,KCNA3;KCND2;VDAC1;VDAC2;VDAC3;HCN1
prerank,ribosomal large subunit binding (GO:0043023),0.4492587710603688,1.0480207244926047,0.3898635477582846,0.8693409405941993,1.0,3/11,7.63%,CPEB2;CPSF6;NEMF
prerank,alpha-tubulin binding (GO:0043014),0.34581346027887916,1.0476344046843278,0.39114391143911437,0.8650987228042497,1.0,12/31,26.99%,EML4;DNAL1;TBCE;CDK5R1;DLEC1;WASHC1;PACRG;SETD2;SPAST;ARL8A;FNTA;TBCEL
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.39626601618164214,-1.0460952639713932,0.39473684210526316,0.6772065130344612,1.0,6/15,16.82%,PIK3R1;SOCS2;PIK3R6;SOCS5;CISH;SOCS3
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.40010307015795665,1.0447931630749694,0.40540540540540543,0.8685477349665068,1.0,3/17,7.89%,DPYD;DHCR24;PTGR1
prerank,double-stranded RNA binding (GO:0003725),-0.2774551800388988,-1.0443321957583904,0.3341584158415842,0.6774679682550568,1.0,11/70,9.80%,MBNL1;LRRFIP1;RFTN1;AGO1;ADARB1;ACTN1;DHX33;TFRC;SIDT2;AGO2;DROSHA
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.2509664747754394,1.041977829095944,0.3511450381679389,0.8721157380043623,1.0,51/232,19.45%,RNF220;RNF152;RNF43;SH3RF2;PDZRN3;ASB2;DTX1;TRIM62;SIAH2;RNF41;TRIM5;RNF126;KCMF1;TRIM71;SHPRH;RNF14;TRIM35;DTX2;PELI3;DTX3;BRAP;RNF135;TOPORS;RNF10;FBXO6;RNF6;RNF121;HLTF;RNFT1;PRPF19;RLIM;RING1;PIAS4;FBXO17;RNF138;RNF5;RNF7;MDM2;TRIM3;RBBP6;RNF130;ANKIB1;FBXL22;RNF139;TRIM13;RNF13;MYCBP2;RNF26;TRIM63;RNF180;TRIM2
prerank,magnesium ion binding (GO:0000287),-0.24793960558372835,-1.0411938884633718,0.33707865168539325,0.6818721040560787,1.0,35/135,21.24%,SNRK;MARK1;MAP3K5;STK38L;STK3;PLSCR1;IRAK3;GSS;MAP3K20;RAP2A;ERN1;PDE2A;CDC42BPA;SRR;PAPOLA;ADCY2;HPRT1;GCLC;RP2;HACL1;STK38;TOP2A;PDXK;TDG;LATS1;NUDT16;MAST2;MAPK12;STK26;NUDT12;DUT;DYRK2;MAP2K7;MAP3K6;MTPAP
prerank,potassium:proton antiporter activity (GO:0015386),-0.43210992868344145,-1.041155189290089,0.3867735470941884,0.6783584738316195,1.0,1/10,0.87%,SLC9A2
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.44948540615857,1.0382165082456476,0.4260355029585799,0.8783045601620633,1.0,2/10,15.49%,CDKN2A;HEXIM2
prerank,titin binding (GO:0031432),0.4254192604618149,1.0357962658476756,0.4279835390946502,0.8798943727051409,1.0,2/13,3.61%,ACTN2;CAPN3
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.4346926109055444,-1.0341118957949067,0.4194831013916501,0.6926678223422772,1.0,3/10,6.77%,FAP;NAALAD2;PRCP
prerank,cytokine receptor activity (GO:0004896),-0.2677686096035374,-1.0336035454706916,0.3769633507853403,0.6903619551668205,1.0,16/83,12.28%,GHR;IL6ST;IL1R1;OSMR;LIFR;F3;CD44;IL17RD;IL6R;IL20RB;IL1RAP;CNTFR;IL4R;FZD4;CD74;IL1RL2
prerank,chemokine binding (GO:0019956),0.34427791014960174,1.0327333370138219,0.40463458110516937,0.8842026378320446,1.0,3/30,6.42%,CCR9;ACKR2;PDPN
prerank,phosphatidylglycerol binding (GO:1901611),-0.3970852340747533,-1.0317728425130996,0.41561181434599154,0.6914999266710191,1.0,2/13,4.91%,PITPNC1;PLTP
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.34881552757257395,1.027128844859401,0.42125237191650855,0.8959722389156503,1.0,6/28,11.12%,PRKAA2;TNK2;MAP2K6;LRRK2;MAPK10;MAPK14
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.3350626334112415,1.0260867339757078,0.43283582089552236,0.8936324196520268,1.0,7/32,15.51%,KDM7A;BBOX1;TET1;PHF8;KDM2A;KDM4A;TET2
prerank,ubiquitin-protein transferase activity (GO:0004842),0.23591621788006895,1.0246097797844227,0.3780313837375178,0.8927623342975619,1.0,85/346,21.78%,RNF220;RNF152;RNF43;UBE2E2;DDB2;SH3RF2;PDZRN3;ASB2;DTX1;TRIM62;SIAH2;HECTD3;RNF41;TRIM5;RNF126;KCMF1;KLHL13;MAEA;DZIP3;TRIM71;SHPRH;RNF14;TRIM35;FBXO11;DTX2;PELI3;DTX3;BRAP;RNF135;TRAF7;TOPORS;RNF20;RNF10;FBXO6;UBE2W;RNF6;RNF121;HLTF;TAF1;RNFT1;PRPF19;FBXO9;OBI1;PML;RLIM;RING1;FBXO17;RNF31;RNF138;UBE2R2;RBCK1;RNF5;RNF7;RNF213;MDM2;KLHL20;TRIM3;UBE2S;RBBP6;RNF130;ANKIB1;FBXL22;FBXO22;RNF139;TRIM13;RNF13;MYCBP2;RNF26;KCTD13;TRIM63;RNF180;TRIM2;FBXL5;BFAR;NFX1;TRIM41;RNF103-CHMP3;RMND5A;KLHL42;RNF146;TRIM9;KLHL21;RNF11;HECW1;TRIM32
prerank,snoRNA binding (GO:0030515),-0.32748306668829075,-1.022700070259639,0.4121475054229935,0.71072627253718,1.0,19/30,34.01%,XRCC5;BMS1;NUDT16;NUFIP1;NOP58;NHP2;NUDT16L1;DKC1;IMP4;NOP56;NUDT1;NOP10;DDX21;DHX37;NUDT7;ISG20;TSR1;HEATR1;NOP14
prerank,acetylcholine receptor activity (GO:0015464),0.3658419105775143,1.0217433692543976,0.4130019120458891,0.8968784542579937,1.0,3/22,11.25%,CHRM2;CHRNB2;CHRM1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.3013601516181552,-1.0202213160328604,0.41983122362869196,0.7132757773329819,1.0,16/40,21.88%,METTL2A;METTL2B;THUMPD2;NNMT;PCMTD2;PRMT7;DNMT3B;PCMTD1;ASMT;SUV39H1;ICMT;GAMT;MEPCE;LCMT1;DNMT1;HNMT
prerank,protein kinase activator activity (GO:0030295),0.3014556984744374,1.0190137856068089,0.42526690391459077,0.9005607455401677,1.0,6/60,4.00%,PRKAG2;RICTOR;FAM20A;GPRC5A;GPRC5C;GPRC5B
prerank,glutathione transferase activity (GO:0004364),0.3591446117627528,1.0148667001426073,0.4372549019607843,0.907888468505184,1.0,7/23,18.67%,PTGES;GSTM2;GSTO1;GSTM1;GSTA3;GSTZ1;MGST2
prerank,phosphatase binding (GO:0019902),-0.24608172839616238,-1.0135316177973572,0.4,0.72642775875508,1.0,35/105,21.50%,MAP3K5;CDC27;PIK3R1;IQGAP1;EGFR;STAT3;CRY1;ITGA1;ANAPC5;MET;RACK1;PXN;MAPK1;SHOC2;CEACAM1;FLT4;EIF2AK3;GTF2F1;NFATC2;TERF2IP;JAK1;VRK3;SYTL2;CSRNP2;PPP6R1;ELL;MAST2;RPA2;CARHSP1;MAPK3;JAK3;TRPC4AP;MAP2K7;JUP;SH3YL1
prerank,DNA binding (GO:0003677),0.21840855331725698,1.0117238640386674,0.4118421052631579,0.9124540260719237,1.0,158/694,20.26%,DENND4A;RORA;HLF;EPAS1;NUPR1;SMAD3;DDB2;APLP2;SPHK1;CXXC5;MSX2;THRB;SCRT1;CHD4;ARID4A;NR6A1;PPARA;NFYB;SLTM;ESRRA;ERCC1;PMS2;SIM1;MEIS1;POLRMT;AIFM1;TET1;RBPJ;PCID2;PQBP1;PAX6;IKZF1;DNMT3A;E2F1;ARID3A;AUNIP;TFPT;HNRNPU;HOXA7;ZKSCAN3;PBX4;NFYC;NR2F2;SUPV3L1;CEBPA;MEIOB;SPRTN;PHF1;CHD3;MSH4;KDM5B;NLRP3;MBD4;MSH6;MAFA;HINFP;MAX;ZNF711;PPARGC1A;TDP2;USF1;NR1H3;PRDM2;ZBTB22;SSBP2;ZDHHC1;ZIC2;CLOCK;BCL2;PSIP1;STAT1;RXRA;BATF;PARP4;CR2;TOPORS;SSBP1;FUBP1;MRE11;CSRNP3;MBD1;WBP11;BCLAF3;E2F4;CSRNP1;TAF1;ZFPL1;ZBTB49;SOX9;PURB;TERT;ARNT;AIFM2;MSH3;FOXC1;RNF138;HDAC4;SAFB2;PRKDC;MEN1;RAD51D;CENPC;POLR3C;PLAGL2;POLE;MCM7;TLR8;ABL1;RPA3;RBM5;TCF7L2;TCF4;POLG;POLR2D;ERF;HIC2;RAD52;ILF2;CAMTA2;HDGFL2;SAFB;TRNP1;GTF3C1;CLSPN;LHX4;MCMDC2;RELA;ARID5B;TSHZ3;MTF2;SOX6;SRRT;GLI2;ZBTB6;HDGF;SMC1B;POU6F1;HMCES;NHEJ1;CGGBP1;SOX2;MLX;MLXIPL;ILF3;DDIT3;TFAP4;GTF3C4;MEF2A;FOXL1;LONP1;SPTY2D1;CALCOCO1;DDX3X;SMAD2;MEIS3;COLEC11;POLR2A;RFX2
prerank,serine-type endopeptidase activity (GO:0004252),0.2806892038908218,1.0083077418172552,0.4517241379310345,0.9178051871132273,1.0,19/80,22.26%,PCSK4;FURIN;F10;PLAT;HTRA2;CORIN;PLG;CTRL;KLK8;CTSH;PRSS36;HGF;KLK1;PRSS53;RHBDF1;DPP4;KLK6;C1RL;PCSK2
prerank,telomeric DNA binding (GO:0042162),-0.3171637667013603,-1.0081948614527951,0.42570281124497994,0.736696422777646,1.0,14/32,26.50%,RPA1;XRCC5;HMBOX1;TERF2IP;BLM;ZBTB48;NCL;PURA;TEN1;UPF2;TINF2;CTC1;HNRNPD;TERF2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.3781874692377477,-1.0055966823276414,0.4361493123772102,0.7394368020300958,1.0,1/15,0.89%,PLA2G4A
prerank,ATPase activator activity (GO:0001671),0.36826962470224606,1.0044129874485523,0.4552238805970149,0.9247724929506866,1.0,4/20,9.18%,ATP1B3;ATP1B2;DNAJB4;DNAJC10
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4033354139706447,-1.004053351063201,0.4479166666666667,0.7394172282136379,1.0,4/12,17.60%,SLC6A6;SLC38A5;SLC36A4;SLC7A8
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.38056683814612025,-1.0025576168686763,0.46041666666666664,0.7394233543521459,1.0,4/15,10.71%,PLA2G4A;SH3PXD2B;PLEKHA5;JPH2
prerank,microtubule plus-end binding (GO:0051010),-0.35028322772094334,-1.0020401151661928,0.47514910536779326,0.737120082490335,1.0,12/20,28.28%,DST;CLIP4;APC;CLIP2;CLIP1;PAFAH1B1;MAPRE2;DCTN1;KNSTRN;STIM1;MAPRE3;FBXW11
prerank,lipoprotein particle receptor binding (GO:0070325),-0.3236416925074411,-1.0003231380655608,0.4535637149028078,0.7378950709766413,1.0,8/27,17.09%,DNAJA1;ANKRA2;APOE;AP2A1;LANCL1;APBB3;LDLRAP1;LRP1
prerank,nuclear receptor coactivator activity (GO:0030374),-0.2781891944410934,-0.9979624277000032,0.4369369369369369,0.7402002153086501,1.0,19/52,23.86%,ACTN4;TACC1;ETS1;DCAF6;ACTN1;SLC30A9;ELK1;FGF2;SS18;TMF1;NCOA6;ENY2;MED14;ZMIZ2;NCOA3;CCDC62;MED13;ZMIZ1;MED24
prerank,beta-tubulin binding (GO:0048487),0.33625028827033565,0.9960919866375239,0.4584103512014787,0.9449327943511228,1.0,17/31,28.75%,GJB6;EML4;IFT74;PDCD5;HTT;SMC3;CCT5;CDK5R1;DLEC1;PACRG;LRPPRC;SPAST;ARL8A;MAP1S;BCAS3;EMD;RACGAP1
prerank,RNA binding (GO:0003723),-0.19135703026167664,-0.9960293419114106,0.5126050420168067,0.7413675758047112,1.0,373/1321,24.25%,SPTBN1;MBNL1;SYNE1;SORBS2;ACTN4;AHNAK;DCN;TMSB4X;LRRFIP1;RFTN1;FNDC3A;FNDC3B;YWHAE;SPATS2L;RBPMS;RPS15;RPL38;MYH9;RPL18A;RPL41;MACF1;RBM3;EEF1A1;RPS12;RPS20;STAT3;ZMAT3;QKI;DARS1;AGO1;FAU;RPL5;RPL32;ADARB1;CAST;ZC3H7A;UBC;RPS10;RPS23;RPL10;DHX32;JUN;DAP3;CTNNA1;RPS24;CS;GTPBP10;EIF3E;RPL7;RPL37A;ACTN1;SERBP1;KCTD12;ALKBH1;FLNA;DHX33;EIF3H;CCDC9B;GNL3;CPNE3;TFRC;SMC1A;DCP1B;CSNK1E;CISD2;RPS17;RPS16;MAP3K20;MRPL20;PABPC1;RBM33;PSPC1;TRNAU1AP;RPL39;FASTKD1;RPS27A;DNAJC21;EXOSC1;FCF1;PRR3;RPL13;RACK1;MAP4;CDC40;EEF2;RPLP0;XRCC5;PPIA;SNRNP200;RPL30;REXO4;YBX3;RPS5;HSPE1;RPL35A;SMNDC1;RBM28;RPS8;NOVA2;TPT1;TRIM56;TRIM25;SYF2;PSMA6;RPF1;MRPL21;PUM2;SNRPD1;RPS7;SIDT2;ALDOA;RPL22;MYBBP1A;FRG1;RPL29;MBNL2;RPS3;KTN1;RPS28;G3BP1;RPL7A;RPS26;SPEN;SRP19;BMS1;GFM1;THUMPD1;SURF6;RPL6;RPL18;RPL36;LSM7;EIF4E;PTPN1;TENT4B;TRMT10A;AGO2;RPS25;DDX54;RPL28;PELP1;DROSHA;RBM42;COL14A1;RPL27;TRMT10B;TCF20;WDR33;GTF2F1;LARP1B;CPSF4;YWHAZ;LRRC59;FBRSL1;RPL24;RSRC2;FASN;TES;RPL23;RPL17;MRPL23;RTF1;SECISBP2L;HSPB1;S100A16;YARS2;MRPS31;IPO5;RPS27;DIDO1;TNS1;SNRPD2;ZCCHC24;NGRN;YLPM1;RPS9;RPL22L1;RRP7A;TDRD7;DCAF13;NCBP2;PDIA4;NCOA5;RBM7;RPL21;TPR;MRPL10;ERH;KIN;PFN1;RPL34;NMD3;R3HDM1;ELAC2;SAP18;FUS;HNRNPAB;ACAA2;RPL10A;PEBP1;UBE2L3;SYNCRIP;KMT2C;ANXA7;RPL35;CMSS1;TASOR;PPP1CC;POLR1G;IFIH1;RBM6;CAVIN1;RPL12;UBAP2L;CCDC124;AQR;MRPL12;RPL19;DDX27;DDX23;RBFOX2;EIF1B;GLRX3;ZC3H4;RPL14;PUM1;NCBP1;SRP14;DHX38;KPNA2;SRSF3;DDX49;DHFR;RPS18;TEP1;ESF1;PA2G4;RPS13;HELZ;RPL37;PPIE;RRP12;UNC50;RPS15A;RTN4;KIF1C;DDX25;DNAJC2;PTCD3;RPP21;FMR1;RPP38;TBRG4;RBM25;FXR1;ADAT1;ALDH18A1;PDAP1;MRPS12;RBM10;N4BP1;NUSAP1;PCBP2;LRP1;EIF4G3;HDAC2;TOP2A;DUS3L;MRPL43;PWP2;MRPL1;NUDT16;HMGN2;AGO4;SRPRA;MANF;MRPL45;XPO5;RIDA;BARD1;ZCCHC3;MCAT;PCBP1;MRPL44;DSP;UBTF;ASS1;NTPCR;ZC3H12A;USP10;CSTF1;NUFIP1;NOP58;DIMT1;NCL;AIMP1;DYNC1H1;CHCHD1;MRTO4;MEPCE;METTL3;DUT;EBNA1BP2;UBAP2;HMGB1;TOE1;RPL3;UCHL5;CKAP4;LSM3;TENT5A;RBMS3;NYNRIN;RRBP1;SERPINH1;EXD1;EIF4H;MTPAP;RTCB;PURA;HNRNPF;TOP1;EIF4A3;RPL15;RRS1;NHP2;LSM2;MRPL2;PPIB;NUDT16L1;DKC1;ARL6IP4;RPS21;MSN;RPL8;NPM3;LUC7L3;SNW1;RBM46;PRKRIP1;GTF2E2;RPS19;ZNFX1;EIF3B;MKI67;CCDC9;CAPRIN1;NANOS3;PPP1R10;RPL13A;PHF6;IMP4;UTP14A;NOP16;PRMT1;PTCD2;ZFR;CDK11B;AARS2;NUCKS1;PPP1R8;ZC3H15;SUMO2;RPL23A;WDR46;TARBP2;MRPS30;PARP12;MATR3;NAA15;AATF;TRA2B;BZW1
prerank,DNA-binding transcription factor binding (GO:0140297),0.24329168142317245,0.9946764171097061,0.46417445482866043,0.9440236082381273,1.0,36/189,13.91%,ZMYND8;SMAD3;MAGEA2;CXXC5;BEX1;FHL2;CHD4;PPARA;NFYB;POU1F1;GTF2I;IFI27;RBPJ;ATN1;KAT5;MIER3;NLRP3;HES6;MAP3K10;USF1;BBS5;DMAP1;BCL2;STAT1;LDB2;LDB1;TTC8;TAF1;ZBTB49;PURB;GABPA;NOC2L;BHLHE41;PIAS4;PSMC5;HDAC4
prerank,fibroblast growth factor binding (GO:0017134),-0.34807237216149245,-0.9942931897902325,0.4530938123752495,0.7421552914094333,1.0,6/21,17.36%,THBS1;GLG1;S100A13;FGFRL1;GPC1;FGFR3
prerank,GABA receptor activity (GO:0016917),0.3608270464491648,0.9941150420714481,0.45660377358490567,0.9404768314734797,1.0,6/21,18.33%,GABRG1;GABBR1;GABBR2;GABRG3;GABRB2;GABRB3
prerank,histone deacetylase activity (GO:0004407),-0.3499237271091401,-0.9940989412385868,0.46041666666666664,0.7389735392041694,1.0,7/19,23.33%,MIER1;HDAC9;HDAC6;HDAC2;MIER2;SIRT7;SIRT6
prerank,galactosyltransferase activity (GO:0008378),0.4226307831765883,0.9936099300142259,0.48303393213572854,0.9367412276484202,1.0,4/11,8.97%,B4GALT2;B4GALT1;B3GALT6;B4GALT3
prerank,methylated histone binding (GO:0035064),0.2874688921529276,0.9913824702970835,0.48623853211009177,0.9381542887378206,1.0,11/62,12.21%,ZMYND8;KDM7A;SGF29;PHF8;PHF1;PHF2;MSH6;MPHOSPH8;TAF1;TDRD3;KDM4A
prerank,DNA polymerase activity (GO:0034061),0.35889435003793135,0.9906829228727015,0.44763860369609854,0.9352078468912614,1.0,8/22,20.29%,POLM;REV1;TERT;POLI;POLE;POLG;POLN;POLE4
prerank,methylation-dependent protein binding (GO:0140034),0.29131247148178985,0.9903576733996035,0.48736462093862815,0.9309636513568923,1.0,10/57,12.21%,ZMYND8;KDM7A;SGF29;PHF8;PHF1;PHF2;MSH6;MPHOSPH8;TDRD3;KDM4A
prerank,DNA polymerase binding (GO:0070182),0.3700173011254989,0.9888158801378081,0.46520874751491054,0.9304303536262507,1.0,6/18,19.69%,FANCD2;FANCI;RTEL1;SMG6;HSP90AA1;LONP1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.3078964682852623,0.9886267280035693,0.4684512428298279,0.9259246473775694,1.0,11/44,14.33%,KMT5A;DOT1L;KMT2A;N6AMT1;NSD1;SETD4;KMT5C;SETD7;SMYD3;SMYD2;MEN1
prerank,active ion transmembrane transporter activity (GO:0022853),0.3198828393559686,0.9883169100899233,0.48154981549815495,0.9219295534861215,1.0,8/37,12.95%,SLC22A6;SLC22A8;ATP13A3;COX7A1;COX7A2L;UQCRH;CYB5A;COX10
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.4205453419121514,-0.9879584360556765,0.47184466019417476,0.7464839024942137,1.0,6/10,41.31%,DUSP6;DUSP1;DUSP7;DUSP5;DUSP16;DUSP2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.4205453419121514,-0.9879584360556765,0.47184466019417476,0.7464839024942137,1.0,6/10,41.31%,DUSP6;DUSP1;DUSP7;DUSP5;DUSP16;DUSP2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.2113799842335173,0.9861329116752442,0.5132408575031526,0.9233501681042667,1.0,94/831,9.89%,AEBP1;ZKSCAN2;MAF;RORA;HLF;EPAS1;CREB5;SMAD3;KCNIP3;OSR1;NR2E1;HMX2;NPAS3;SOX5;MSX2;OVOL2;THRB;ZSCAN29;ZBTB38;SCRT1;MYBL2;NR6A1;CREBRF;ARNT2;ZNF23;PPARA;ZNF431;PBX2;SALL4;ZFP3;NFYB;GLIS3;UBP1;ESRRA;POU1F1;HOXB9;SIM1;TFDP2;ENO1;HOXB3;MEIS1;MAFG;CCAR1;MLXIP;PEG3;RUVBL2;RBPJ;PAX6;IKZF1;MZF1;IKZF2;DNMT3A;E2F1;ZBTB26;ZFHX2;HNRNPU;HOXA7;ZKSCAN3;RFX8;DRGX;PBX4;NFYC;NR2F2;CEBPA;BCL11B;ZSCAN22;HOXB6;TEF;KLF15;ZNF569;KDM6B;ZNF467;HOXA3;E2F8;HES6;MAFA;HINFP;MAX;USF1;NR1H3;HIF3A;PRDM2;ZBTB22;HDX;ZIC2;CLOCK;HOXB4;NSD1;ZFP90;FOXP4;STAT1;RXRA;BATF;SALL3
prerank,manganese ion binding (GO:0030145),0.29588473983752517,0.9857793584705181,0.4570383912248629,0.9195513503284507,1.0,12/48,14.89%,PPM1M;ARG2;LARGE1;B4GALT1;TDP2;GALNT3;MPPED2;ENDOU;GYG1;GALNT2;GALNT1;ABL1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.36573177017196823,-0.9848298731675655,0.4850894632206759,0.7506537762329328,1.0,6/16,22.09%,CD38;RPS3;OARD1;TDG;NEIL3;SMUG1
prerank,endodeoxyribonuclease activity (GO:0004520),0.3560560779128412,0.984101862734473,0.45652173913043476,0.9195007265366907,1.0,4/20,17.39%,ERCC1;MBD4;MRE11;EXOG
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.38184970256056006,-0.9838379491791855,0.5051546391752577,0.7493236055198785,1.0,2/14,1.76%,SLC26A7;SLC26A2
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.29578300516452755,0.9834803962826906,0.45517241379310347,0.9163123302449984,1.0,11/49,13.42%,OPTN;DZIP3;TNIP3;IKBKG;ABRAXAS1;ZFAND6;SPRTN;TNIP2;IKBKE;BAG6;OTUD7A
prerank,GTPase binding (GO:0051020),-0.22279152886051007,-0.9829158416098739,0.5278592375366569,0.7481655955063694,1.0,36/194,12.58%,SPTBN1;CAV1;FGD5;RABGAP1L;PLCE1;FGD6;SH3BP4;IQGAP1;RASIP1;UNC13B;ABCA1;ANKFY1;CDC42EP5;USP6NL;EXOC4;FLNA;STRN3;ARHGEF2;PAK2;EPS8;ARHGDIB;GNB1;RUSC2;YBX3;RAPGEF6;RAPGEF4;EVI5L;SOD1;ATG16L1;PDE6D;WHAMM;CDC42EP2;FNBP1L;GNB2;RANBP9;ARHGAP1
prerank,ion gated channel activity (GO:0022839),-0.33132338684101764,-0.981083640936883,0.4861995753715499,0.7492561442312319,1.0,5/24,15.78%,KCNT2;ANO1;TTYH2;ANO4;ANO2
prerank,sequence-specific DNA binding (GO:0043565),0.21541115090885796,0.9807956316723745,0.514018691588785,0.9190530394809462,1.0,70/590,11.25%,MAF;RORA;HLF;EPAS1;CREB5;SMAD3;OSR1;NR2E1;HMX2;CXXC5;MSX2;OVOL2;THRB;ZSCAN29;ZBTB38;CXXC4;SCRT1;FBXL19;MYBL2;NR6A1;ARNT2;ZNF23;PPARA;UBP1;SLTM;ESRRA;POU1F1;KMT2A;HOXB9;MAFG;POLRMT;TET1;RBPJ;PAX6;E2F1;ZBTB26;HNRNPU;HOXA7;ZKSCAN3;DRGX;PBX4;NR2F2;DPF1;BCL11B;HOXB6;TEF;KLF15;KDM5B;NLRP3;E2F8;KDM2A;HES6;MAFA;MAX;ZNF711;PPARGC1A;USF1;PRDM2;ZBTB22;CLOCK;HOXB4;BCL2;RXRA;BATF;SMG5;CSRNP3;MBD1;E2F4;CSRNP1;TAF1
prerank,transcription cis-regulatory region binding (GO:0000976),-0.20455549782420193,-0.9800783441047828,0.5335463258785943,0.7481620090379498,1.0,59/406,12.08%,LEF1;FOXP1;MEF2C;ACTN4;PBX1;ELK3;TRPS1;BNC2;PLAGL1;ETS1;FLI1;TCF12;FOXO3;CTCF;PRDM16;STAT3;AGO1;SIX1;TBX18;DACH1;RUNX1;ZNF25;JUN;ZBTB46;GLI3;TFEB;SOX17;VSX1;NFYA;PSPC1;CREB3L1;LHX6;XRCC5;ZNF3;TWIST2;AR;SP3;KLF11;ZNF436;ETV5;FOXN3;RPS3;PRDM5;AGO2;IRF2;KLF4;ELK1;TAL1;AHR;RFXAP;MAFK;PER1;SOX7;TWIST1;HHEX;SOX18;ETV6;FOXF2;FOSL2
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.3145761777992618,0.9781033175327973,0.4573502722323049,0.9220759257170759,1.0,12/35,16.78%,TRMT9B;TARS2;NT5C3A;MRPL58;TRPT1;DUS1L;BCDIN3D;QTRT2;QRSL1;QTRT1;MTFMT;DTWD2
prerank,delayed rectifier potassium channel activity (GO:0005251),0.3234912501957243,0.9777840073217979,0.47619047619047616,0.9182600190701319,1.0,7/32,17.16%,KCNA3;KCNC3;KCNH2;KCNC2;KCNS3;KCNA4;KCNQ3
prerank,symporter activity (GO:0015293),0.44134052139966384,0.9759381857074649,0.4894433781190019,0.9187413949195639,1.0,1/10,0.72%,SLC5A5
prerank,phosphatase activator activity (GO:0019211),-0.38181396663100725,-0.9756860491294383,0.4971209213051823,0.7555302445266687,1.0,6/14,20.19%,CALM3;PPP2R5C;GTF2F1;BMP2;B3GAT3;PPP2R5B
prerank,peptidase activator activity (GO:0016504),-0.3310680031401423,-0.974607156226373,0.4720496894409938,0.7547397634719503,1.0,7/22,20.92%,CAV1;CASP8AP2;PCOLCE;ADRM1;PSMD14;PSENEN;PSME1
prerank,tau-protein kinase activity (GO:0050321),0.36213723020437083,0.9713461787021961,0.4903100775193798,0.9269186170611684,1.0,3/20,4.96%,ROCK2;PHKG2;TTBK2
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.3722159793375521,0.9703164635196286,0.49706457925636005,0.9204987864076021,1.0,5/17,16.59%,EPHA8;EPHA6;EPHA4;EPHA10;EPHB1
prerank,ephrin receptor activity (GO:0005003),0.3722159793375521,0.9703164635196286,0.49706457925636005,0.9204987864076021,1.0,5/17,16.59%,EPHA8;EPHA6;EPHA4;EPHA10;EPHB1
prerank,NAD binding (GO:0051287),0.3430804928574177,0.9698284381419569,0.4951830443159923,0.917201468582125,1.0,4/26,10.86%,ADH4;SORD;ALDH1A1;ALDH2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.40489755005564004,-0.9686968072574279,0.541015625,0.7658585695269522,1.0,6/12,21.24%,TENT2;PAPOLA;TENT4B;TENT5C;TENT5A;MTPAP
prerank,transition metal ion binding (GO:0046914),0.21911914327690404,0.9669221493185738,0.5625,0.9207517936706645,1.0,61/397,13.24%,MOXD1;UPB1;ZMYND8;SMAD3;KDM7A;ADH7;ADH4;ADAMTS13;CXXC5;SORD;CXXC4;ENPP5;CHD4;FBXL19;ENPP3;ETHE1;KMT2A;PITRM1;PPM1M;BBOX1;LOXL3;GLRA1;ARG2;TET1;PHF8;LARGE1;LACC1;GALT;B4GALT1;PHF2;CHD3;KDM5B;QPCT;KDM2A;CSRP1;TDP2;CPA2;PRDM2;NSD1;TRAF7;RXRA;GALNT3;CUTC;HRG;MBD1;DOHH;MPPED2;ZFPL1;RABGGTB;PLA2G15;KDM5C;EPRS1;ENDOU;GYG1;KDM4A;RBAK;GALNT2;FDX1;TARS1;PIAS4;ATAD3A
prerank,solute:proton symporter activity (GO:0015295),-0.36151661447585315,-0.9643283463933867,0.5031578947368421,0.7733254633261244,1.0,3/16,12.83%,SLC2A13;SLC39A8;SLC2A9
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.40109613655503795,0.9642633190924375,0.47775628626692457,0.9238756881237449,1.0,6/11,26.56%,UBE4B;PRPF19;UBOX5;UBR5;AMFR;RBX1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.4210900921562704,0.9642248084774856,0.5009560229445507,0.9194042026663596,1.0,3/10,15.66%,RENBP;GFUS;DSE
prerank,metallopeptidase activity (GO:0008237),-0.23340850883743994,-0.9636827546605841,0.5333333333333333,0.7714627810261948,1.0,34/113,23.93%,ADAMTSL3;ECE1;ADAMTSL1;ADAMTS5;ADAMTS17;EIF3H;LAP3;ADAM10;ADAMTS6;PAPPA;ADAMTS1;ADAMTS14;ADAM19;MMP11;METAP1D;ACE2;ADAMTS20;LNPEP;ADAM15;ADAM33;PHEX;ADAMTS2;NUDT16;ADAMTS12;PSMD14;NLN;COPS6;RCE1;MMP2;ADAM21;ERAP1;THOP1;ADAMTS3;MBTPS2
prerank,anion transmembrane transporter activity (GO:0008509),-0.3957607928299406,-0.963031828742943,0.5089108910891089,0.7695565515658226,1.0,3/12,4.77%,ABCG2;SLCO2B1;SLC39A8
prerank,neuropeptide receptor binding (GO:0071855),0.3828759377049204,0.962288251108323,0.5196078431372549,0.9202337005385768,1.0,2/14,7.85%,NTS;SHANK1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.3800735202995107,0.9621043534354006,0.4962825278810409,0.9163585826313186,1.0,4/13,17.56%,AGPAT4;ABHD5;LCLAT1;AGPAT2
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.21792129574027977,-0.961573001465274,0.5614525139664804,0.7697960942845234,1.0,29/181,11.65%,ACTB;ACTN4;TACC1;PPARD;MDFIC;TBX3;NFKBIA;LMO2;NFATC1;STAT3;CRY1;MIER1;JUN;DNAJA1;BHLHE40;HES1;AR;PSMA6;HEY2;ARID1A;SPEN;NRIP1;ZFPM2;KLF4;ELK1;TAL1;MYOCD;HSPB1;MTA1
prerank,cation transmembrane transporter activity (GO:0008324),0.287768988758904,0.9601879838804701,0.5517857142857143,0.917170877479481,1.0,10/48,15.24%,SLC41A1;SLC38A3;SLC6A9;SLC38A1;SFXN2;SLC38A9;SLC66A1;SLC22A2;SLC38A7;MMGT1
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.4024397642419134,-0.9570291707405506,0.5207100591715976,0.7774608510661497,1.0,5/11,26.50%,RPA1;TERF2IP;RPA2;CTC1;TERF2
prerank,nucleotidase activity (GO:0008252),-0.36904540834847277,-0.9550647134325972,0.5133079847908745,0.7789079718262488,1.0,5/15,21.75%,BPNT2;NT5C1A;NT5E;NT5C;ACP3
prerank,myosin II binding (GO:0045159),-0.39792504711474047,-0.9470996369113331,0.522633744855967,0.7947525682610901,1.0,2/10,1.81%,SHROOM4;GSN
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.31111237018219,0.9449233420674801,0.5226039783001808,0.9550440440750483,1.0,5/29,9.98%,SLC13A3;SLC26A1;SLC25A11;SLC19A1;SLC25A12
prerank,voltage-gated anion channel activity (GO:0008308),0.38170118635535843,0.9444834567811631,0.5265225933202358,0.9516787909445961,1.0,7/15,21.40%,CLCN6;CLCN2;CLCN4;CLCN3;VDAC1;VDAC2;VDAC3
prerank,voltage-gated chloride channel activity (GO:0005247),0.42125525703988453,0.9442795861735813,0.5295275590551181,0.9475947365641667,1.0,4/10,13.89%,CLCN6;CLCN2;CLCN4;CLCN3
prerank,protein phosphatase regulator activity (GO:0019888),0.2793476223742763,0.9438323612272094,0.5468164794007491,0.9442315060650565,1.0,6/53,9.30%,PPP2R2B;PPP1R16A;DMPK;PPP4R4;PHACTR4;EIF2AK2
prerank,adrenergic receptor binding (GO:0031690),0.3636476504487771,0.942950638110656,0.5390781563126252,0.9420888435062809,1.0,5/16,10.07%,MAGI2;ADRA2A;ARRDC3;DLG4;C1QBP
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.37231932143035545,-0.9419015437338818,0.5145067698259188,0.8037335122279419,1.0,4/12,8.96%,INSR;PIK3R1;SOCS2;IGF2
prerank,glycine binding (GO:0016594),0.40194449829816814,0.9418282657117337,0.5353535353535354,0.9407442268343709,1.0,3/11,5.48%,GRIN3A;GLRA1;GLDC
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.3207920631822209,-0.9417445368573375,0.5609243697478992,0.8005376921726219,1.0,7/22,16.36%,DNAJA1;ANKRA2;APOE;AP2A1;LANCL1;APBB3;LDLRAP1
prerank,thioesterase binding (GO:0031996),-0.38984017348938327,-0.9410565274115354,0.5333333333333333,0.7986656776438141,1.0,3/11,21.41%,TRAF5;TRAF4;CDC42
prerank,MHC class II protein complex binding (GO:0023026),-0.392188055845726,-0.939817904591508,0.5296610169491526,0.7980550320631038,1.0,2/11,11.77%,YWHAE;CD74
prerank,calcium ion binding (GO:0005509),0.2185553652827541,0.9382215050443911,0.6386066763425254,0.9460637154691889,1.0,44/323,12.28%,SYT11;SYT12;ANXA6;DSC2;DSC3;MAN1C1;ADAMTS13;FBLN1;PON1;CPNE1;PLSCR2;ENPP3;ANXA5;CDH3;CDH15;CDH17;S100A4;CAPN3;SMOC2;ITPR1;SYT9;PLA2G4C;SYT1;CALR3;CDH10;CDH18;SYT13;ADGRV1;CRNN;SYT10;GALNT3;SLC25A12;GJB2;SLC25A23;ITPR2;CANX;RYR2;TRPM2;AMY1B;AMY1A;AMY1C;DMP1;CCDC47;CPNE6
prerank,metalloendopeptidase activity (GO:0004222),-0.24287882684080697,-0.9379099523303133,0.5955882352941176,0.7992171405026782,1.0,22/76,23.93%,ADAMTSL3;ECE1;ADAMTSL1;ADAMTS5;ADAMTS17;ADAM10;ADAMTS6;ADAMTS1;ADAMTS14;ADAM19;MMP11;ADAMTS20;ADAM33;PHEX;ADAMTS2;ADAMTS12;NLN;RCE1;MMP2;THOP1;ADAMTS3;MBTPS2
prerank,ubiquitin-specific protease binding (GO:1990381),0.3458306332437637,0.9374071029940839,0.5566218809980806,0.9437534809651205,1.0,9/19,29.56%,DERL1;LCOR;BAG6;CHMP3;SART3;AMFR;SUMO1;PRKN;SELENOS
prerank,Notch binding (GO:0005112),0.3408734206523322,0.9371758159792885,0.5350194552529183,0.9399954559881886,1.0,3/22,3.30%,SNED1;DTX1;GALNT11
prerank,telomerase RNA binding (GO:0070034),0.3345369264633825,0.9345333553490184,0.5399239543726235,0.9430320993405077,1.0,10/22,24.98%,HNRNPU;SMG5;TERT;SMG6;PINX1;GAR1;SNRPB;DCP2;HNRNPC;WRAP53
prerank,androgen receptor binding (GO:0050681),0.3195125910176976,0.9324202576215543,0.5660749506903353,0.9444119761511973,1.0,6/25,10.92%,DDX5;PRMT2;RNF14;NSD1;PRKCB;RNF6
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3050540972407425,0.93233080204581,0.5357142857142857,0.9402726790061953,1.0,7/33,13.46%,CTR9;CCAR2;HNRNPU;LLPH;CDC73;RPRD2;SMYD2
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.3681091979026476,-0.9321190002597116,0.5720081135902637,0.8098223655589832,1.0,3/12,10.24%,ENTPD1;ENTPD6;ENTPD2
prerank,GTPase inhibitor activity (GO:0005095),0.37888102635449994,0.931981306509066,0.5447154471544715,0.9369196126064079,1.0,3/13,7.16%,CPEB2;TNK2;ARL2
prerank,hormone activity (GO:0005179),0.27476400474480095,0.9311079975245015,0.5726795096322241,0.9351586372141232,1.0,6/54,11.50%,IGF1;METRNL;CHGB;INHA;VIP;GRP
prerank,nucleotide diphosphatase activity (GO:0004551),0.3720614834295531,0.9287411204374195,0.5173076923076924,0.9374335977796787,1.0,4/14,13.71%,ENPP5;NUDT4;CILP2;NUDT11
prerank,endopeptidase inhibitor activity (GO:0004866),0.2616868366995675,0.928232157492451,0.5870307167235495,0.9344723727543448,1.0,7/82,3.24%,TFPI;ITIH2;TIMP3;COL4A3;RENBP;SERPINA10;FURIN
prerank,serine-type peptidase activity (GO:0008236),0.24941093029507627,0.9262182360303087,0.6079077429983526,0.9357738386935172,1.0,19/96,19.35%,PCSK4;FURIN;PREP;F10;PLAT;HTRA2;CORIN;PLG;CTRL;KLK8;CTSH;ENDOU;PRSS36;HGF;KLK1;ST14;PRSS53;RHBDF1;DPP4
prerank,protein kinase C binding (GO:0005080),-0.26807215757579916,-0.925692069458621,0.5840909090909091,0.8219676411422678,1.0,16/43,21.63%,PDLIM5;CAVIN2;ADCY4;RACK1;HDAC7;HDAC9;GRK5;HSPB1;SQSTM1;TRPV4;IRS1;TOP2A;HINT1;DSP;NELL2;CAVIN3
prerank,lipase activator activity (GO:0060229),0.4072592382112522,0.9246556302358361,0.558282208588957,0.9356711792214708,1.0,2/10,6.52%,ARHGAP6;PDPK1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.3722311499563021,-0.923751447418489,0.5675146771037182,0.8228698174090986,1.0,6/12,15.50%,PIK3C2A;PIK3R6;PIK3CA;PIK3CD;PIK3C3;IPMK
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.20849003851239825,0.9224555249805608,0.6915760869565217,0.9371399197727793,1.0,57/431,13.02%,ATP1A2;PRKAG2;ANXA6;HSPA1A;P2RX6;OXSR1;TRPV1;SPHK1;ABCG5;GCK;RRAGC;DMPK;OAS2;WNK3;RHOBTB2;RAB42;BMPR1A;RAB21;ATL1;GBP3;NVL;ABCF3;PLK1;MYO9B;NIM1K;SYN2;PGK1;HNRNPU;PNPLA8;WNK4;PDK2;ARL2;LRRK2;PRKCI;KSR1;ARL5B;MSH6;RIT1;TUBG1;RHOQ;ABCD1;OAS3;TGFBR1;DRG1;RHOU;PEX1;MYO18A;ABCA2;PYGL;MTHFS;DARS2;RTEL1;TARS1;RAB13;SYN3;GBP6;DRG2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.3620779768060496,0.9217427811694983,0.5647969052224371,0.9348003966491225,1.0,6/14,26.51%,SLC7A11;SLC25A12;SLC38A7;SLC25A13;SLC25A18;SLC17A8
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.27005228048483304,0.9210485105134723,0.6048109965635738,0.9324250532213525,1.0,14/60,16.57%,LRRK1;PPM1M;PPEF2;CTDSPL;PPM1G;LRRK2;PPM1D;PPP1CB;CDC14B;PPP6C;PPP2CB;PPP3R1;UBLCP1;PPM1B
prerank,ankyrin binding (GO:0030506),0.33829346879934885,0.9202912573146892,0.5566801619433198,0.9301225841239266,1.0,2/19,2.51%,CACNA1D;FLNC
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.39618305785048846,0.9196106322437559,0.5683760683760684,0.9277713543102059,1.0,3/10,14.73%,OTUD4;STAMBP;DESI2
prerank,ubiquitin binding (GO:0043130),-0.24228755132798313,-0.9190304015352059,0.6287015945330297,0.8305228337467135,1.0,27/73,26.70%,FAF2;NBR1;UBXN1;VPS36;DDI2;MVB12B;USPL1;HSPB1;SQSTM1;RAD23B;UBXN2A;FBXW7;AUP1;ADRM1;N4BP1;TOP2A;UCHL1;NEDD4;GGA3;FAF1;NUP62;TSG101;OTUB2;TOM1L1;CXCR4;OTUB1;RNF168
prerank,ribosomal small subunit binding (GO:0043024),0.3459485576544715,0.9181260527859005,0.5548780487804879,0.927526106147119,1.0,1/17,0.46%,CPEB2
prerank,cAMP response element binding (GO:0035497),0.40090496729313996,0.9174442388439019,0.5766129032258065,0.9251168907328431,1.0,1/10,0.61%,CREB5
prerank,solute:sodium symporter activity (GO:0015370),0.31692959238453655,0.9169358960240883,0.5746268656716418,0.9223159068896662,1.0,3/27,3.35%,SLC5A3;SLC5A10;SLC4A9
prerank,flavin adenine dinucleotide binding (GO:0050660),0.272521509151712,0.9158254855669344,0.5746527777777778,0.9210681049452255,1.0,15/53,17.25%,DDO;DPYD;AIFM1;QSOX1;MICAL3;KMO;NDOR1;GCDH;AIFM2;MTHFR;SQLE;LDHD;CYB5R1;ILVBL;KDM1A
prerank,microtubule minus-end binding (GO:0051011),0.3688821455881311,0.9156837489443372,0.5797979797979798,0.9175072390121009,1.0,3/13,9.09%,TUBGCP5;CEP290;TUBGCP4
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.33930183460617586,-0.9128360422973948,0.5932203389830508,0.8413939636953561,1.0,3/15,11.97%,SLC1A5;SLC1A3;SLC1A1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.366775849385692,0.9096660474792112,0.5938104448742747,0.9286493508316389,1.0,4/14,22.03%,CAPN3;CAPN15;CAPN10;CAPN11
prerank,proton transmembrane transporter activity (GO:0015078),0.29324166118433737,0.9088849430477087,0.5869565217391305,0.9267842122040346,1.0,9/39,13.89%,COX7A1;COX7A2L;ATP6V1B2;CLCN4;UQCRH;CYB5A;MFSD3;COX10;CLCN3
prerank,inward rectifier potassium channel activity (GO:0005242),0.3140308202281683,0.9082422120908282,0.5797665369649806,0.9244477191800872,1.0,5/24,10.01%,KCNJ13;KCNJ5;KCNJ10;KCNH2;KCNJ16
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.3730277832102328,-0.9077956701989955,0.5818181818181818,0.8496130369329037,1.0,11/12,52.89%,ELOVL4;GPR88;GPR52;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.36281277176312565,0.9075322810247531,0.5404858299595142,0.9223299608843168,1.0,5/13,29.37%,DICER1;DNASE1L2;SLX4;DNASE1L1;ENDOV
prerank,metalloaminopeptidase activity (GO:0070006),-0.3388416667019152,-0.9061608198298028,0.5955284552845529,0.8496138346643621,1.0,5/16,26.80%,ENPEP;LNPEP;RNPEPL1;ERAP1;XPNPEP1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.3118588844760829,0.9060823349153239,0.5793357933579336,0.9220838195957624,1.0,6/27,11.10%,SLC41A1;SLC23A1;ITPR1;TUSC3;MAGT1;ITPR2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.3649961878119458,0.9053611286317346,0.5841784989858012,0.9201992489920203,1.0,4/14,8.88%,ACO1;CIAO3;NDUFS1;EXO5
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.3606907055175417,-0.9046328303132483,0.56,0.8495973346409427,1.0,5/12,29.74%,CNOT6L;PAN3;TOE1;CNOT1;NOCT
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.39589905226525535,0.9044929500081476,0.5597609561752988,0.9183385718836795,1.0,3/10,16.85%,CRMP1;DPYSL2;OPLAH
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.32920059274104996,0.9040996950496244,0.5799180327868853,0.9154943777103762,1.0,7/21,20.29%,POLM;REV1;POLI;POLE;POLG;POLN;POLE4
prerank,hexose transmembrane transporter activity (GO:0015149),-0.36812456338768806,-0.9025484903162472,0.5855670103092784,0.8507474958418904,1.0,2/12,6.47%,SLC2A1;SLC2A3
prerank,nuclear receptor binding (GO:0016922),0.23773563978642173,0.902208187224056,0.6499133448873483,0.916234776201809,1.0,27/111,17.38%,PPARGC1B;DDX5;SMAD3;BRD8;HMGN3;SMARCD3;PRMT2;RNF14;MED1;TAF10;PPARGC1A;NSD1;STAT1;RXRA;MED25;LCOR;PRKCB;RNF6;TAF1;WBP2;NCOR2;TCF7L2;SIRT1;TADA3;STAT5B;KDM1A;PRPF6
prerank,calcium-activated potassium channel activity (GO:0015269),-0.36602664451176214,-0.9005637039138348,0.592079207920792,0.8515922286362246,1.0,7/11,36.21%,KCNMB2;KCNU1;KCNN3;KCNN1;KCNMB4;KCNMA1;KCNMB1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.3539369772680555,0.8997354948815167,0.5901960784313726,0.918663442466129,1.0,2/15,9.99%,KMT2A;SETD4
prerank,heme binding (GO:0020037),0.2613069008263639,0.8970324992363163,0.656140350877193,0.9216199075431815,1.0,15/65,16.33%,CYP26B1;CYP11B1;SDHD;FLVCR1;CYCS;CYP27A1;EIF2AK1;SDHC;HCCS;SLC48A1;HRG;CYB5A;CYP51A1;PGRMC1;PTGES2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.32903885073481687,-0.8968532362905751,0.592741935483871,0.8562160415415553,1.0,5/16,15.91%,SLC26A7;SLC26A2;SLC1A1;SLC26A6;CFTR
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.35296930513342817,-0.8957182774749982,0.5886075949367089,0.8551478879483448,1.0,4/14,11.87%,SPOCK2;NGF;RECK;LXN
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.3441480771408534,0.895043480143073,0.5891472868217055,0.9188166145684393,1.0,6/16,14.91%,ATP6V0A2;ATP6V0B;ATP6V1B2;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.3441480771408534,0.895043480143073,0.5891472868217055,0.9188166145684393,1.0,6/16,14.91%,ATP6V0A2;ATP6V0B;ATP6V1B2;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,iron ion binding (GO:0005506),0.27217100517234666,0.8945440053631976,0.6193078324225865,0.9164413866122909,1.0,9/48,13.22%,KDM7A;ETHE1;TET1;PHF8;HAAO;PHF2;DOHH;FDX1;CDO1
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.2718477320612154,-0.8911312757804807,0.6463963963963963,0.8619536335247324,1.0,3/35,3.40%,FOXP1;H3-3A;AGO1
prerank,SUMO transferase activity (GO:0019789),0.3435478691354287,0.8894450744572776,0.6,0.9248825641272815,1.0,4/16,16.22%,TOPORS;PIAS4;HDAC4;MDM2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.3584109355058556,-0.8884421819803506,0.5980392156862745,0.8643568774810942,1.0,7/11,54.49%,SLC25A47;SLC25A45;SLC22A4;SLC22A3;SLC22A1;SLC25A48;SLC25A29
prerank,calcium activated cation channel activity (GO:0005227),-0.3231957602457327,-0.8870459128111395,0.6066252587991718,0.8637889894853137,1.0,8/17,36.21%,ANO1;KCNMB2;ANO6;ANO10;KCNN1;KCNMB4;KCNMA1;KCNMB1
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3369458656977877,-0.8849763743362106,0.6222222222222222,0.8647476472789646,1.0,4/15,15.43%,SCARB1;ZFYVE16;SNX10;EPB41
prerank,small GTPase binding (GO:0031267),0.2198685511441368,0.881967985319693,0.735202492211838,0.9389387295172695,1.0,44/169,19.36%,AFDN;RNF152;MICALL1;UNC13D;MTSS2;RNF41;PICALM;RAB3GAP1;OPTN;SGSM3;MYO9B;NOX1;GGA2;PIH1D2;TNPO3;LRRK2;RIMS1;WASF1;NDRG1;BICD1;DOCK7;KIF3A;RABGGTB;SPHK2;GOLGA5;CYFIP1;SGSM2;DENND10;FGD4;FGD2;GOLGA4;GGA1;WAS;ARHGEF16;CCDC186;RANGAP1;CDKL5;KIF3B;BRK1;OCRL;HPS4;MYCBP2;KCTD13;MYO5A
prerank,solute:anion antiporter activity (GO:0140323),-0.3370183510076918,-0.8811221177207809,0.626746506986028,0.8694835132657373,1.0,2/14,1.76%,SLC26A7;SLC26A2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.27590584087254966,-0.8799449466826357,0.6513761467889908,0.8651608572320681,1.0,9/34,19.88%,NDUFA10;NDUFA8;NDUFS6;NDUFA5;NDUFA7;NDUFA4;NDUFA1;NDUFS8;NDUFS7
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.27590584087254966,-0.8799449466826357,0.6513761467889908,0.8651608572320681,1.0,9/34,19.88%,NDUFA10;NDUFA8;NDUFS6;NDUFA5;NDUFA7;NDUFA4;NDUFA1;NDUFS8;NDUFS7
prerank,tau protein binding (GO:0048156),0.27706850800832944,0.879830828910883,0.6446601941747573,0.9403045403760988,1.0,4/40,4.96%,ROCK2;MAP2;PICALM;TTBK2
prerank,microtubule binding (GO:0008017),-0.19623527664082396,-0.8792779473459802,0.8333333333333334,0.8629721977285952,1.0,55/222,19.35%,MTUS1;DNM3;DST;STARD9;MACF1;EML1;MID1;MID2;FAM161A;GABARAPL2;SGIP1;ARHGEF2;MAP4;CLIP4;MAP7D3;APC;MAP1LC3B;RPS3;CDK5;NEFM;FGF13;MAP9;WHAMM;DYNC1I1;MAP4K4;MACO1;CLIP2;KIF23;RMDN1;HDAC6;TRPV4;GAS2L1;REEP3;CLIP1;VAPB;KATNB1;MAP1B;PAFAH1B1;KIF1C;FMR1;NUSAP1;PEX14;TOGARAM1;KIF13A;CEP295;CRIPT;MAST2;GAPDH;REEP1;KIF20B;RAB11A;CCDC69;RP1;MAPRE2;PRC1
prerank,phospholipase activator activity (GO:0016004),0.383853461110252,0.8789057926451245,0.6028513238289206,0.9387428412318233,1.0,2/10,6.52%,ARHGAP6;PDPK1
prerank,phospholipase A2 activity (GO:0004623),0.3125760505546106,0.8781054362219232,0.6175373134328358,0.9369829689156911,1.0,6/26,16.47%,PLAAT5;PLA2G4C;PNPLA8;PLA2G15;ABHD3;PLAAT3
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.3710807405386607,0.8760828998048571,0.6081871345029239,0.937963567877763,1.0,4/12,18.33%,GABRG1;GABRG3;GABRB2;GABRB3
prerank,adenylate cyclase binding (GO:0008179),0.3796632293876336,0.8739193963797528,0.6171079429735234,0.9393620021743132,1.0,1/10,0.47%,ADCY5
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.3699528890691213,0.8731023633500876,0.6313645621181263,0.9374046087629683,1.0,6/11,23.31%,CASP3;CFLAR;CASP12;PYCARD;CASP9;CASP6
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.3550147457064682,-0.8728966317354147,0.6297029702970297,0.872760444541383,1.0,4/11,19.75%,AKR1B1;AKR1A1;RDH11;DHRS13
prerank,protein phosphatase 2A binding (GO:0051721),-0.29829557665139245,-0.8697487590754782,0.6618556701030928,0.8758433696859694,1.0,4/23,5.35%,DAB2IP;FOXO1;MFHAS1;STRN3
prerank,RNA polymerase II complex binding (GO:0000993),0.2861061106748723,0.8690337131170379,0.64,0.9428093429881947,1.0,7/32,13.46%,CTR9;CCAR2;HNRNPU;CDC73;SCAF1;RPRD2;SMYD2
prerank,5'-3' exonuclease activity (GO:0008409),0.3438119457082321,0.8681396182213563,0.6220472440944882,0.9411978867052656,1.0,4/14,22.32%,CPSF3;MRE11;EXOG;DCP2
prerank,SH2 domain binding (GO:0042169),-0.2785637154323003,-0.8669698898908559,0.6804979253112033,0.8781538769582526,1.0,9/31,17.59%,AFAP1L2;RACK1;SH3PXD2B;SRC;SQSTM1;SH2B2;TRPV4;IRS1;LAT2
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.3582910143922835,-0.86599139559471,0.6280487804878049,0.8766447040812957,1.0,3/12,15.08%,PIK3R1;SH2B2;IRS1
prerank,ionotropic glutamate receptor binding (GO:0035255),0.3785586521245295,0.8612697923519451,0.6252465483234714,0.9531312918821853,1.0,4/10,9.33%,SHANK1;SHISA7;DLG4;NSF
prerank,sequence-specific mRNA binding (GO:1990825),-0.3643499792120409,-0.8608052422340388,0.640495867768595,0.8837725238339409,1.0,4/10,25.60%,DHFR;FMR1;RBM24;TYMS
prerank,ribosome binding (GO:0043022),-0.24610785641313404,-0.8606563692113487,0.703125,0.8805903189437773,1.0,13/46,16.72%,NAA16;SERBP1;RACK1;EEF2;MTIF3;SRP19;TMCO1;GTPBP6;SEC61A1;NOMO1;FMR1;NAA10;NCLN
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.313051374865596,-0.8565811713838676,0.6973415132924335,0.8854023901497824,1.0,8/18,23.56%,PIK3R1;SOCS2;PIK3R6;SOCS5;CISH;SOCS3;AGAP2;SOCS1
prerank,glucose transmembrane transporter activity (GO:0005355),0.3240699244745384,0.856009547321985,0.6693227091633466,0.9612354463947567,1.0,2/17,2.73%,SLC5A3;SLC5A10
prerank,pyrophosphatase activity (GO:0016462),0.2622832738805013,0.8551846700524737,0.708994708994709,0.9591862135091953,1.0,10/50,13.71%,BNIPL;FITM2;ENPP3;PRUNE1;PRUNE2;NUDT4;CILP2;TRPM2;PPA1;NUDT11
prerank,sodium channel regulator activity (GO:0017080),-0.2597162412277398,-0.8532775994592852,0.7190265486725663,0.8884234521443882,1.0,6/37,13.48%,NEDD4L;FXYD5;CAMK2D;FXYD6;FGF13;SCN4B
prerank,MAP kinase phosphatase activity (GO:0033549),0.35671680914336035,0.8520166264757304,0.6435643564356436,0.9624273618372156,1.0,1/12,1.67%,DUSP29
prerank,GABA-A receptor activity (GO:0004890),0.32396937714751206,0.8517216219057527,0.6647173489278753,0.9594103243789289,1.0,4/18,18.33%,GABRG1;GABRG3;GABRB2;GABRB3
prerank,thyroid hormone receptor binding (GO:0046966),0.2891254132597006,0.8514667624888531,0.6704545454545454,0.9562891957199114,1.0,5/28,9.69%,BRD8;HMGN3;PRMT2;MED1;NSD1
prerank,hexosaminidase activity (GO:0015929),0.3540790085741435,0.8501694582164481,0.6303030303030303,0.9555552802180834,1.0,4/12,13.67%,NAGA;HEXD;SPAM1;HYAL1
prerank,palmitoyltransferase activity (GO:0016409),0.291191853657656,0.8496860477094087,0.6685714285714286,0.9530321790193678,1.0,9/28,17.81%,ZDHHC12;ZDHHC24;ZDHHC1;ZDHHC16;ZDHHC6;ZDHHC3;ZDHHC21;GLUL;ZDHHC23
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.23622165577267307,-0.8496737869258114,0.7511848341232228,0.8920680369777353,1.0,22/57,29.46%,NDUFA10;NDUFA8;NDUFS6;NDUFA5;NDUFA7;NDUFA4;UQCR11;COX8A;UQCRFS1;COX4I1;NDUFA1;COX15;NDUFS8;NDUFS7;UQCR10;CYBRD1;NDUFA4L2;UQCRC1;COX4I2;NDUFB8;CYB561D2;NDUFA9
prerank,chemoattractant activity (GO:0042056),-0.27521809285363935,-0.8469256067418077,0.6866267465069861,0.8941580703495255,1.0,5/26,13.96%,VEGFC;BMP4;FGF2;FGF7;VEGFA
prerank,FMN binding (GO:0010181),-0.35817969689362866,-0.8465830050262395,0.6626506024096386,0.8913635147429018,1.0,5/11,31.88%,NOS3;POR;PNPO;NOS2;NOS1
prerank,O-acyltransferase activity (GO:0008374),0.2801993389144124,0.8455049033069957,0.6564748201438849,0.9583116617210352,1.0,6/30,12.95%,SOAT2;PLA2G4C;SOAT1;MOGAT1;PLA2G15;DGAT2
prerank,phospholipase inhibitor activity (GO:0004859),0.375010929616996,0.8448869274453832,0.670061099796334,0.9560473992575711,1.0,1/10,2.89%,ANXA5
prerank,NADPH binding (GO:0070402),-0.32637149544196875,-0.8432761073745578,0.6652631578947369,0.8944171883255922,1.0,5/13,21.42%,QDPR;DHFR;CBR3;GRHPR;KCNAB1
prerank,NADP binding (GO:0050661),-0.2578293231741577,-0.8427446174468806,0.7448132780082988,0.8920573755253879,1.0,8/32,21.42%,NOS3;ME1;CAT;QDPR;DHFR;CBR3;GRHPR;KCNAB1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.29587908626540554,0.8416575021709566,0.667296786389414,0.959039605911805,1.0,8/24,17.81%,ZDHHC12;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC3;ZDHHC21;GLUL;ZDHHC23
prerank,ATPase regulator activity (GO:0060590),-0.2521542176536901,-0.8408868962001832,0.7368421052631579,0.8920401593771682,1.0,11/38,18.55%,DNAJC1;FNIP2;DNAJA1;DNAJA2;BAG5;PFN1;GRPEL1;KATNB1;BAG1;PLN;TOR1AIP2
prerank,poly(U) RNA binding (GO:0008266),0.31197880652937265,0.8408543466907319,0.6549707602339181,0.9570378739396191,1.0,3/20,6.18%,RBM11;PABPC4L;PATL1
prerank,mRNA binding (GO:0003729),0.20021032241627473,0.8369165695020435,0.8784773060029283,0.9616747507108127,1.0,60/249,22.23%,CPEB2;CELF2;DDX5;SRRM2;NOVA1;SRSF5;ANGEL2;CPSF6;ACO1;ELAVL4;HNRNPA2B1;PABPC4L;RBM47;HNRNPU;PTBP2;NCBP3;CPEB4;UNK;HNRNPL;PTBP1;UTP23;ELAVL1;C1QBP;SRRM4;FUBP1;RNF20;SLBP;YTHDC1;NUP98;BOLL;UPF3B;PURB;FXR2;CSDC2;PCBP4;GRSF1;ETF1;RBM5;SNIP1;RNPS1;CCT5;PTBP3;RBFOX1;RBPMS2;ELAVL2;SRSF6;PUM3;SF3B1;LARP4B;CELF6;DDX3X;EIF2A;EIF3A;CPEB3;LARP1;YTHDF3;CELF1;LUC7L;SRRM3;ZC3H12B
prerank,kinase inhibitor activity (GO:0019210),-0.25938464876719197,-0.8368643822853801,0.7190775681341719,0.8964101873369175,1.0,11/33,23.56%,LRP6;YWHAB;NCK1;CDKN1C;PARVA;GSKIP;SOCS3;TAOK3;PRKRIP1;CDKN1B;SOCS1
prerank,wide pore channel activity (GO:0022829),0.29511653077460454,0.8350690952801485,0.6811320754716981,0.9619080643417185,1.0,3/23,13.21%,GJB6;GJB2;GJA3
prerank,potassium ion antiporter activity (GO:0022821),0.3344565377123557,0.831685939970043,0.6673306772908366,0.9650803836052048,1.0,3/15,15.85%,SLC24A3;SLC9A9;SLC9A3
prerank,gap junction channel activity (GO:0005243),0.30055236999404394,0.8306274147429337,0.7023346303501945,0.9636617650590109,1.0,3/22,13.21%,GJB6;GJB2;GJA3
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.33502288319800483,-0.8302580782303001,0.6850715746421268,0.9050519116783141,1.0,3/12,8.78%,CISD2;XDH;AOX1
prerank,damaged DNA binding (GO:0003684),0.255601503507174,0.8295889118562916,0.7307692307692307,0.9624758525910792,1.0,4/44,5.86%,DDB2;ERCC1;XRCC1;AUNIP
prerank,cation:chloride symporter activity (GO:0015377),0.36093712381156096,0.8288075007765113,0.6803921568627451,0.9605195924026436,1.0,3/10,11.60%,SLC6A1;SLC12A5;SLC12A1
prerank,ferrous iron binding (GO:0008198),-0.2896676958741008,-0.8277828594587973,0.7010752688172043,0.9060868666716066,1.0,9/21,29.49%,FTO;ALKBH1;FTL;ALKBH2;EGLN3;FXN;FECH;FTH1;ACP5
prerank,WW domain binding (GO:0050699),0.2883595641334774,0.8273812594293085,0.6727605118829981,0.9598521032528466,1.0,7/26,16.81%,NDFIP1;TNK2;CDC25C;WBP11;PMEPA1;NDFIP2;SCNN1A
prerank,miRNA binding (GO:0035198),-0.2647501745814022,-0.8266627318205433,0.7330415754923414,0.904724697632269,1.0,9/30,19.05%,AGO1;ZC3H7A;PUM2;AGO2;PUM1;FMR1;RBM10;AGO4;ZC3H12A
prerank,methyltransferase activity (GO:0008168),0.25460869987181983,0.8257559766265964,0.7022058823529411,0.9596825316758588,1.0,15/46,21.33%,METTL27;ARMT1;N6AMT1;NSUN3;BCDIN3D;COMT;TRMT11;NSUN2;PRMT3;NTMT1;COMTD1;RRP8;COQ3;AS3MT;PRMT5
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.305708686115501,-0.8251778058733185,0.7089397089397089,0.9039611439995823,1.0,5/17,18.47%,DTYMK;NME6;CLP1;NME2;AK4
prerank,poly(A) binding (GO:0008143),0.29842536439988787,0.8248696783725743,0.7029126213592233,0.9580967621008795,1.0,4/21,8.49%,ELAVL4;PABPC4L;HNRNPU;TIA1
prerank,ribonuclease activity (GO:0004540),0.24208950444653216,0.8243926264610525,0.7678244972577697,0.9555714095551757,1.0,10/56,15.04%,RNASEH2A;YBEY;CPSF3;EXOSC8;EXOSC2;ENDOU;AGO3;DICER1;SND1;SMG6
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.32787792880174954,-0.8239528341529248,0.6794354838709677,0.9028683077703438,1.0,3/12,14.77%,SPPL3;DDI2;HM13
prerank,RNA cap binding (GO:0000339),0.3191413727051536,0.8237413886387794,0.6947565543071161,0.9534360980187415,1.0,5/16,13.87%,CYFIP2;NCBP3;CYFIP1;EIF4E2;SNUPN
prerank,pseudouridine synthase activity (GO:0009982),-0.3179948311683256,-0.8235670727646269,0.6955645161290323,0.9002400701393591,1.0,5/13,31.05%,PUS3;PUS7L;DKC1;PUSL1;RPUSD3
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.33123328054298073,0.8223871548970356,0.6938369781312127,0.9527217667617125,1.0,2/13,4.20%,GABRG1;GLRA1
prerank,poly-purine tract binding (GO:0070717),0.28331536992591877,0.8210435506980065,0.7255639097744361,0.9519079645727072,1.0,5/27,8.49%,ELAVL4;PABPC4L;HNRNPU;PATL1;TIA1
prerank,mannosyltransferase activity (GO:0000030),-0.28107412269872134,-0.8203284516827958,0.7257731958762886,0.9025810081960041,1.0,2/21,4.65%,TMTC2;TMTC1
prerank,motor activity (GO:0003774),-0.22109787500960226,-0.8196723990720248,0.8378995433789954,0.9003572022232716,1.0,19/60,25.64%,MYH9;STARD9;DYNC1I2;MYL6;DYNLRB1;DNAH2;DYNC1I1;KIF23;KIF24;KIF1C;KIF13A;DNAH3;KIF20B;GPR88;MYO1E;KIFC1;KIF4A;KIF22;KIF14
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.2949172251684781,0.8180988512966971,0.7003891050583657,0.9543082794741024,1.0,8/22,18.10%,ATP6V0A2;ATP6V0B;ATP6V1B2;ATP6V1E1;ATP6V0E2;ATP6V1C1;ATP6V0D2;ATP2A1
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.3158270936551344,-0.8173399614431777,0.7219917012448133,0.9011389919989838,1.0,4/14,18.47%,DTYMK;NME6;NME2;AK4
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.34133898582785577,-0.8168799127898622,0.6837944664031621,0.8985742822421954,1.0,3/11,17.49%,ALKBH1;RPS3;NEIL3
prerank,growth factor activity (GO:0008083),0.22778339088861285,0.8144270753976375,0.8115183246073299,0.9577954406837855,1.0,12/74,15.88%,FGF1;FGF4;FGF9;NRTN;NRG1;INHA;ENDOU;BDNF;HBEGF;CSPG5;IL6;HGF
prerank,Hsp70 protein binding (GO:0030544),0.2662367202949841,0.8118751508334248,0.7454212454212454,0.9590066579713699,1.0,7/31,16.14%,DNAJC18;DNAJB14;PPEF2;DNAJC10;GPR37;TSC1;DNAJB2
prerank,actinin binding (GO:0042805),0.2942033043244499,0.8111704598713289,0.711864406779661,0.9569659768545202,1.0,6/21,18.13%,CACNA1D;CSRP3;CSRP1;RARA;RELA;NFKB1
prerank,chloride channel inhibitor activity (GO:0019869),0.3421105663359034,0.8064773948663344,0.6837944664031621,0.9620132186460983,1.0,2/10,7.03%,WNK3;WNK4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.22451801079652212,-0.8061474341221243,0.7956204379562044,0.9134530717728245,1.0,17/54,20.16%,ACER2;DARS1;NTAN1;MIER1;GLS;TGM2;HDAC9;AGA;SIRT5;HDAC6;HDAC2;HINT1;ASAH2;MIER2;PIGL;ACER3;SIRT7
prerank,anion:anion antiporter activity (GO:0015301),0.30892060434630275,0.8039146543650172,0.7254098360655737,0.9633131811798068,1.0,6/17,16.11%,SLC26A1;SLC25A5;SLC25A11;SLC19A1;SLC4A3;SLC26A11
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.3353701045613361,-0.803690456513993,0.7423664122137404,0.9143827453233971,1.0,5/10,35.38%,NAA16;NAA10;NAA15;NAA50;NAA60
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.2917228420307362,0.8009961169656992,0.7371428571428571,0.9652773808973195,1.0,5/22,13.42%,OPTN;IKBKG;SPRTN;IKBKE;OTUD7A
prerank,aspartic-type peptidase activity (GO:0070001),-0.3402557413330858,-0.7995638650682259,0.7096114519427403,0.9179263327920462,1.0,2/10,8.46%,DDI2;CTSD
prerank,phospholipase activity (GO:0004620),0.23113334126712662,0.7988861179008957,0.8035087719298246,0.9657811686976445,1.0,15/67,16.47%,ASPG;PLAAT5;PLA2G4C;DDHD2;SMPD3;PNPLA8;SEC23IP;SMPD2;PLA2G15;ABHD3;GDE1;PDIA3;PLBD2;PLCB3;PLAAT3
prerank,cytochrome-c oxidase activity (GO:0004129),0.31891499924825684,0.7988201470364041,0.7383720930232558,0.9625906514721763,1.0,4/15,12.95%,COX7A1;COX7A2L;CYB5A;COX10
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.32262244219282565,-0.7970724862665703,0.7320388349514563,0.9188405107802496,1.0,7/11,43.04%,NAA16;NAA10;NAA15;NAA50;NAA60;NAA40;NAA11
prerank,leucine zipper domain binding (GO:0043522),0.3465698238177322,0.7936889990399864,0.7,0.9680134340211874,1.0,1/10,2.35%,PAWR
prerank,translation elongation factor activity (GO:0003746),0.3185858992030992,0.7932518023879934,0.7114228456913828,0.9654441052256161,1.0,2/14,5.39%,GTPBP1;TUFM
prerank,voltage-gated sodium channel activity (GO:0005248),-0.26820061798114825,-0.7931823574592143,0.7806451612903226,0.9218655123936401,1.0,6/22,23.54%,CACNA1G;SCN4B;CACNA1I;SCN3A;CACNA1H;SCN7A
prerank,single-stranded DNA binding (GO:0003697),0.21419752483851362,0.7916516984873635,0.865874363327674,0.9649477958072,1.0,20/93,17.08%,ERCC1;PMS2;HNRNPU;MEIOB;SPRTN;TDP2;SSBP2;SSBP1;FUBP1;WBP11;PURB;MSH3;RNF138;RAD51D;POLR3C;MCM7;RPA3;POLR2D;RAD52;MCMDC2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.26880946904658465,-0.7912026303907629,0.7635983263598326,0.9214536410933012,1.0,7/24,19.82%,EEF2K;CAMK2D;MAPKAPK2;PTK2B;MKNK2;PHKA2;CAMK1G
prerank,NF-kappaB binding (GO:0051059),0.2777014001445275,0.7888270219275849,0.7490272373540856,0.9662835773528531,1.0,5/24,17.09%,CDKN2A;CPNE1;COMMD7;COMMD6;RELA
prerank,peptide hormone receptor binding (GO:0051428),0.33774211895459316,0.7866280613227782,0.7404426559356136,0.9667538353683005,1.0,3/11,19.34%,VIP;PSMC5;GNRH1
prerank,mRNA methyltransferase activity (GO:0008174),0.32232404050674945,0.7858977144701953,0.7267326732673267,0.9647692674251115,1.0,5/12,23.25%,RNMT;NSUN2;TRMT61B;TRMT10C;METTL8
prerank,MHC class I protein binding (GO:0042288),0.31602214355992336,0.7836147297505797,0.7495107632093934,0.9653172929483359,1.0,1/13,2.23%,DERL1
prerank,single-stranded RNA binding (GO:0003727),0.2420039261082782,0.7828366373450804,0.7958477508650519,0.9633639500007452,1.0,16/43,26.19%,RBM11;HNRNPU;PTBP1;ZFR2;SRA1;AGO3;TLR8;POLR2D;ILF3;LONP1;DDX3X;DHX58;SNRPC;JMJD6;U2AF2;TLR7
prerank,tubulin binding (GO:0015631),0.18385966498011685,0.7814731370905034,0.9688385269121813,0.9623505947493349,1.0,34/295,11.06%,GJB6;FMN1;MTUS2;MAP2;EML4;KIF5C;TTLL6;CLIP3;IFT74;IRAG2;PLK1;EML2;PRUNE1;CLASP1;DNAL1;KIF3C;PDCD5;KIF16B;ABRAXAS1;AGBL4;LRRK2;KIF13B;TBCE;TUBGCP5;GOLGA2;HTT;SKA2;TUBGCP4;DRG1;NDRG1;APC2;SBDS;RITA1;KIF3A
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.33130146106226815,0.7793280913777233,0.73558648111332,0.9623951784959064,1.0,4/12,12.19%,CYFIP2;NCBP3;CYFIP1;EIF4E2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.3231929860274533,-0.7788561921072715,0.733615221987315,0.9376698176258502,1.0,1/11,0.90%,DAB2IP
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.3395510562008429,0.7787078581632871,0.7393939393939394,0.9601390274727151,1.0,5/10,23.31%,CASP3;CFLAR;CASP12;CASP9;CASP6
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.3087160258342009,-0.7773828072744643,0.7698412698412699,0.9366128642750586,1.0,3/13,6.76%,SLC38A5;SLC7A7;SLC7A1
prerank,chloride channel regulator activity (GO:0017081),0.3061905193353154,0.7773586289260278,0.7717171717171717,0.9592176961911351,1.0,2/14,7.03%,WNK3;WNK4
prerank,ligand-gated anion channel activity (GO:0099095),0.2991388456172426,0.7771412406372998,0.7572254335260116,0.956414706151155,1.0,5/17,18.33%,GABRG1;GLRA1;GABRG3;GABRB2;GABRB3
prerank,transferrin receptor binding (GO:1990459),0.33553213642849994,0.7767404382194532,0.752851711026616,0.9539103929293418,1.0,2/10,6.54%,CHUK;IKBKG
prerank,protein phosphatase activator activity (GO:0072542),0.3174114521055078,0.7759727696856981,0.7611940298507462,0.951830279150926,1.0,2/13,7.62%,IGFBP3;PHACTR4
prerank,RNA polymerase core enzyme binding (GO:0043175),0.252959983980336,0.7735704966198076,0.8025830258302583,0.9524395942371905,1.0,9/33,20.72%,CTR9;CCAR2;HNRNPU;CDC73;RPRD2;SMYD2;RRN3;SPTY2D1;SUPT4H1
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.30911764118263646,-0.7712831390199933,0.7509578544061303,0.942755234423402,1.0,7/12,35.06%,GNS;ARSA;SGSH;ARSJ;ARSI;IDS;SULF2
prerank,lysophospholipase activity (GO:0004622),-0.26764240868539074,-0.7710753266837128,0.7935871743486974,0.9396943065646778,1.0,4/20,13.92%,PLA2G4A;MGLL;ABHD4;PLA2G6
prerank,peptidoglycan binding (GO:0042834),0.33165559430084124,0.7709761925085635,0.7561436672967864,0.9534820400426346,1.0,4/10,20.78%,PGLYRP3;NLRP3;HK1;RNASE7
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.23890623157870702,-0.7707058296016913,0.8240534521158129,0.9368704631286333,1.0,6/34,8.96%,STK3;IQGAP1;CAB39;CALM3;SPRY2;IGF2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.29554388453423325,-0.7705957909502437,0.7652859960552268,0.9337729139233371,1.0,5/14,18.84%,MTMR11;MTMR7;MTMR12;MTMR1;PTEN
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.33268669705107035,0.7688031621616225,0.7514792899408284,0.9536241323953888,1.0,1/10,0.64%,DSC2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.33226056204807913,0.7682444410805462,0.7451737451737451,0.9513150255823052,1.0,3/10,19.14%,NOX1;CYBA;NCF1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.32412754205372823,0.7680497390145907,0.7427385892116183,0.9485910569389668,1.0,10/10,67.61%,APEX1;MGME1;TATDN1;DCLRE1A;POLD1;EXD2;EXO1;DCLRE1B;DCLRE1C;FEN1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.3221133270566397,0.7667079685477304,0.7484662576687117,0.9475474938312639,1.0,4/12,17.09%,RUVBL2;STAT1;TAF1;RELA
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.26833500808473176,-0.7613894643873571,0.819838056680162,0.9433528246721593,1.0,5/20,16.33%,EIF3H;USP7;EIF3F;USP47;USP50
prerank,I-SMAD binding (GO:0070411),-0.29806254579755886,-0.7612633433488101,0.7864476386036962,0.940225837792614,1.0,3/13,5.66%,SMURF1;SMAD1;SMAD5
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.21055284564437707,0.7600646727324152,0.9066213921901528,0.9541206333593047,1.0,16/75,19.98%,ADH7;ADH4;SORD;ME2;PTGR1;DHRS11;BDH1;GFUS;SDR42E1;LDHD;LDHB;PRXL2B;HSD17B11;HMGCR;RDH12;HSD17B4
prerank,alpha-actinin binding (GO:0051393),-0.251310831744239,-0.7600313433569613,0.8279569892473119,0.938572889556484,1.0,4/24,11.60%,PDLIM5;PALLD;SYNPO2;LDB3
prerank,UDP-galactosyltransferase activity (GO:0035250),0.31986496457338864,0.7590764098850029,0.75,0.9525403586080974,1.0,2/10,8.17%,B4GALT1;B3GALT6
prerank,lipid phosphatase activity (GO:0042577),-0.2907606025316183,-0.7586636532262957,0.8053949903660886,0.9372561399857576,1.0,5/14,23.99%,PLPP1;PLPP3;SGPP1;PLPP2;PLPP6
prerank,cysteine-type endopeptidase activity (GO:0004197),0.21156887549512643,0.7582221964428052,0.8947368421052632,0.9507860656590617,1.0,24/78,23.82%,CAPN3;USP11;USP12;CASP3;USP18;USP26;CFLAR;USP40;CTSH;USP20;PDIA3;USP42;USP9X;CASP12;USP48;CAPN15;USP16;PYCARD;CAPN10;CASP9;CAPN11;CASP6;LGMN;USP38
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.22305391241580075,-0.7564720702519468,0.8687089715536105,0.9371867451450535,1.0,7/38,16.36%,SHANK3;PIK3R1;NCK1;SPATA2;SH2B2;IRS1;LDLRAP1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.28982278306890485,0.7551549472323301,0.7811320754716982,0.9520592346244081,1.0,4/15,17.56%,AGPAT4;ABHD5;LCLAT1;AGPAT2
prerank,phospholipase binding (GO:0043274),0.30786170341893404,0.7494888839392428,0.7762376237623763,0.9569883802336795,1.0,2/13,6.52%,ARHGAP6;PDPK1
prerank,endoribonuclease activity (GO:0004521),0.24630695806399158,0.7492779616585616,0.8505747126436781,0.9542385504308306,1.0,8/32,17.39%,YBEY;CPSF3;ENDOU;AGO3;DICER1;SND1;SMG6;EXOG
prerank,deoxyribonuclease activity (GO:0004536),0.29184707353367884,0.7474750853056082,0.797244094488189,0.9536468416513312,1.0,8/14,31.02%,MBD4;MRE11;DNASE1L2;MAP1S;APEX1;DNASE1L1;ZRANB3;NME1
prerank,endopeptidase activity (GO:0004175),0.17669426970526916,0.7444573566491314,0.9837037037037037,0.9546218568697923,1.0,40/257,16.60%,ADAMTS13;PCSK4;ADAMTS15;ADAMTS16;CPNE1;FURIN;PITRM1;PREP;ADAMTS10;AFG3L2;USP11;F10;PLAT;USP12;CASP3;USP18;SPRTN;HTRA2;USP26;NAPSA;CORIN;PLG;CTRL;KLK8;USP40;CTSH;PRSS36;USP20;NRDC;ADAMTSL5;ADAMTS18;ADAMTS9;PDIA3;PSMA1;USP42;HGF;ADAMTS7;KLK1;USP9X;BACE2
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.2972005461912378,-0.7443918205072824,0.8043052837573386,0.9494580118690612,1.0,4/14,16.45%,TSEN2;ELAC2;RPP21;RPP38
prerank,deubiquitinase activity (GO:0101005),-0.1908262838361506,-0.7440261472384899,0.9430051813471503,0.9466885778446611,1.0,25/88,25.89%,USP53;USP24;EIF3H;USP46;OTUD7B;MINDY1;USP7;USP35;EIF3F;MINDY2;USP47;USP50;JOSD1;PSMD14;UCHL1;ZC3H12A;USP10;UCHL5;CYLD;ATXN3;USP15;OTUB2;UFD1;USP1;OTUB1
prerank,general transcription initiation factor binding (GO:0140296),-0.24754115005104782,-0.7400589339655993,0.8505263157894737,0.9481475492556495,1.0,4/25,11.85%,ESR1;AR;AHR;HHEX
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.3123594869097638,-0.7390679121418723,0.7965451055662188,0.9460502950691315,1.0,4/10,11.91%,PIK3C2A;PIK3CA;PIK3CD;PIK3C3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.3123997344849611,0.737632511229308,0.7793522267206477,0.9605040414489694,1.0,1/11,4.52%,ARG2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.2373758582542659,0.7368861063379828,0.8483754512635379,0.9585373272369474,1.0,11/37,18.82%,HARS2;TARS2;RARS2;EPRS1;QARS1;DARS2;TARS1;IARS2;FARSA;YARS1;IARS1
prerank,regulatory RNA binding (GO:0061980),-0.22630626465331544,-0.7353716758389828,0.9101382488479263,0.9474565822333971,1.0,12/38,24.18%,AGO1;ZC3H7A;PUM2;AGO2;PUM1;FMR1;RBM10;AGO4;ZC3H12A;PIWIL2;TARBP2;MATR3
prerank,DNA secondary structure binding (GO:0000217),-0.23558032599635056,-0.731870824584626,0.8867924528301887,0.948550074068373,1.0,5/31,13.01%,MEF2C;RAD51B;XPC;BLM;LIN54
prerank,endonuclease activity (GO:0004519),0.21897091400174937,0.7307247664194815,0.8857142857142857,0.9635100088362964,1.0,9/49,15.04%,YBEY;CPSF3;MBD4;MRE11;ENDOU;AGO3;DICER1;SND1;SMG6
prerank,exonuclease activity (GO:0004527),0.2210188396605214,0.7273507561766571,0.8840304182509505,0.9649247707775888,1.0,8/46,17.39%,ENPP3;CPSF3;EXOSC8;MRE11;EXOSC2;AEN;POLG;EXOG
prerank,P-type ion transporter activity (GO:0015662),-0.2912458227881043,-0.7257847468099881,0.848,0.9523600870254811,1.0,2/12,8.36%,ATP2B1;ATP2A3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.2751488603115527,-0.7243412625771932,0.8683651804670913,0.9507253112786141,1.0,6/14,21.40%,QDPR;ALDH1L2;DHFR;NOXRED1;BLVRB;PYCR3
prerank,5'-nucleotidase activity (GO:0008253),-0.2877475668552768,-0.7210150959356002,0.8119001919385797,0.9513055807278818,1.0,4/13,21.75%,NT5C1A;NT5E;NT5C;ACP3
prerank,nucleotidyltransferase activity (GO:0016779),0.2639995829494741,0.7204076027475363,0.8313953488372093,0.9700921039143388,1.0,5/19,14.63%,TENT4A;REV1;TUT4;TERT;CRPPA
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.2249155370784427,-0.7195032132267329,0.9095022624434389,0.9497804342497119,1.0,11/34,21.95%,UBE2D3;UBE2J1;UFC1;UBE2F;UBE2Q1;UBE2L3;UBE2J2;UBE2A;UBE2G1;UBE2Z;UBE2QL1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.3059569466533277,-0.7194806610489881,0.8114754098360656,0.9466453531127772,1.0,5/10,30.91%,ANKRD13A;ANKRD13B;ANKRD13D;FAAP20;LAPTM5
prerank,carboxy-lyase activity (GO:0016831),0.2540724770017981,0.7097333308679875,0.863013698630137,0.9792879441894435,1.0,7/23,23.70%,GGCX;AZIN2;GAD1;UMPS;FAHD1;PISD;BCKDHA
prerank,kinesin binding (GO:0019894),-0.2300775174815285,-0.7095876455569865,0.8698347107438017,0.9539624276764843,1.0,5/27,19.35%,ACTB;AP1AR;ATCAY;ARHGEF10;PRC1
prerank,tropomyosin binding (GO:0005523),0.27570410967879777,0.6965141877308492,0.8455445544554455,0.9906813225463017,1.0,2/16,9.13%,NEBL;TMOD2
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.21632875143356214,-0.6924261593905531,0.9173913043478261,0.967422921510126,1.0,8/29,24.87%,ACER2;PARG;GAA;ACER3;ENGASE;HPSE;PGGHG;GANAB
prerank,endopeptidase activator activity (GO:0061133),-0.2937098361098718,-0.6902915576491996,0.8682170542635659,0.9661030882584253,1.0,4/10,20.92%,ADRM1;PSMD14;PSENEN;PSME1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.254419728063104,-0.6893860799860134,0.896414342629482,0.963785120240211,1.0,5/16,18.84%,MTMR11;MTMR7;MTMR12;MTMR1;PTEN
prerank,thiol-dependent deubiquitinase (GO:0004843),0.1887136459209227,0.6824666920986283,0.9636963696369637,1.0,1.0,19/83,19.68%,USP11;USP12;OTUD4;USP18;USP26;USP19;USP40;STAMBP;USP20;USP39;OTUD7A;DESI2;UCHL3;USP42;USP9X;USP31;USP48;USP21;USP16
prerank,pyridoxal phosphate binding (GO:0030170),-0.23524602031430797,-0.6817302324454293,0.9067245119305857,0.9678466879442132,1.0,9/20,28.24%,SRR;PYGB;THNSL2;PDXK;PNPO;SHMT2;CBS;SHMT1;AGXT
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.2634142842775085,-0.6808686637479295,0.8510158013544018,0.9654617116422639,1.0,7/13,36.05%,KCNQ1;PRKAR2B;PKIA;PRKAR1B;PRKAR2A;CSK;EZR
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.2880547360492124,0.6789033381689484,0.8360323886639676,1.0,1.0,11/11,71.21%,CNGB1;HCN1;CNGA1;KCNA10;HCN2;CNGA3;CNGA4;CNGA2;AQP1;CNGB3;HCN4
prerank,exopeptidase activity (GO:0008238),-0.1917621073016891,-0.672338376047492,0.9654377880184332,0.969729943039702,1.0,9/50,13.19%,FAP;ENPEP;LAP3;NAALAD2;PRCP;CPE;METAP1D;ACE2;LNPEP
prerank,tRNA binding (GO:0000049),0.20910679133478233,0.6698190393518684,0.9350877192982456,1.0,1.0,12/43,22.89%,TRMT9B;PSTK;NEMF;DARS2;TERT;NSUN2;NSUN6;TRMT10C;ELP5;EIF2A;DALRD3;ELP1
prerank,adenylyltransferase activity (GO:0070566),0.24138619316003226,0.6661076837212461,0.9016064257028112,1.0,1.0,5/21,14.89%,OAS2;TENT4A;OAS3;PAPOLB;ABL1
prerank,four-way junction DNA binding (GO:0000400),0.2577144996160229,0.665302321936146,0.8835758835758836,1.0,1.0,6/17,21.74%,MSH6;MEN1;RAD51D;ABL1;XRCC2;RAD51C
prerank,phosphatidate phosphatase activity (GO:0008195),0.2646557579045087,0.6630293255139031,0.8840864440078585,1.0,1.0,2/13,8.96%,LPIN1;PLPPR3
prerank,CXCR chemokine receptor binding (GO:0045236),-0.26955386947988613,-0.6588845775838958,0.8917835671342685,0.9772324468811528,1.0,7/11,48.43%,CXCL12;PF4;PPBP;CXCL5;CXCL1;CXCL13;CXCL2
prerank,omega peptidase activity (GO:0008242),0.18032318601274133,0.6582385785534904,0.9806763285024155,1.0,1.0,20/89,19.68%,USP11;USP12;OTUD4;USP18;USP26;USP19;USP40;STAMBP;USP20;USP39;OTUD7A;DESI2;UCHL3;USP42;GGT5;USP9X;USP31;USP48;USP21;USP16
prerank,MHC protein binding (GO:0042287),-0.22682742374022236,-0.654781919936137,0.9188034188034188,0.9771307175654047,1.0,3/20,11.77%,TAP2;ATP5F1B;CD74
prerank,calcium channel inhibitor activity (GO:0019855),-0.27732090286326416,-0.6526896879950714,0.891170431211499,0.9754485450300384,1.0,2/11,9.10%,SLC30A1;MCUB
prerank,RNA stem-loop binding (GO:0035613),0.2727259821845708,0.652665214658143,0.896421845574388,1.0,1.0,5/12,24.77%,EPRS1;DDX3X;CPEB3;MYH10;CSDE1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.21947995358934216,-0.6460134365115338,0.9511201629327902,0.97715809926384,1.0,12/24,39.05%,DTYMK;NME6;NME2;PPIP5K1;AK4;PMVK;ITPKB;ITPKC;PPIP5K2;ITPKA;IP6K3;NME4
prerank,CCR chemokine receptor binding (GO:0048020),-0.20795559984573606,-0.6459446414390875,0.9561586638830898,0.9740720409767116,1.0,18/28,48.33%,CCL13;CCL25;CCR2;NARS1;CCRL2;CCL5;CCL4;CCL8;CCL19;CCL14;MSMP;CCL7;DEFB130A;CCL1;CCL3;CCL11;DEFB1;CXCL13
prerank,3'-5' exonuclease activity (GO:0008408),-0.18711290435844485,-0.6450049399541188,0.9746300211416491,0.9716066939026574,1.0,16/45,31.65%,CNOT6L;REV3L;REXO4;TRIR;ERI2;TOE1;EXD1;EXOSC5;EXOSC4;EXOSC3;XRN2;ERI1;NOCT;DIS3L2;ISG20;APLF
prerank,cysteine-type peptidase activity (GO:0008234),0.18434214980482858,0.6446933096696235,0.976027397260274,1.0,1.0,17/73,19.68%,CAPN3;USP11;USP12;CASP3;USP18;USP26;ATG4D;USP40;CTSH;USP20;PDIA3;ATG4C;USP42;USP9X;USP48;USP21;USP16
prerank,phosphatidylinositol kinase activity (GO:0052742),0.2594639429035941,0.642017133127384,0.8923679060665362,1.0,1.0,4/15,15.05%,PIK3R3;PIK3CB;PI4KA;ATM
prerank,aminopeptidase activity (GO:0004177),-0.21218586872335368,-0.641655694927088,0.9358974358974359,0.9707568833941447,1.0,9/26,26.80%,ENPEP;LAP3;METAP1D;LNPEP;RNPEPL1;ERAP1;KDM8;JMJD7;XPNPEP1
prerank,MAP-kinase scaffold activity (GO:0005078),-0.26279779418445515,-0.636339134184445,0.9201596806387226,0.9710649837620315,1.0,1/11,2.65%,IQGAP1
prerank,phosphate ion binding (GO:0042301),-0.26814920120153835,-0.6346831781600079,0.9188118811881189,0.9690379469438647,1.0,4/10,31.19%,PDE2A;ADSS1;ADSS2;CHST14
prerank,CoA hydrolase activity (GO:0016289),0.2403203199204933,0.6295694014243592,0.9194214876033058,1.0,1.0,7/16,28.53%,ABCD1;ACOT1;ACOT6;ACOT13;ACOT9;ACOT11;HIBCH
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.21731421038028903,0.6268360231650516,0.9415322580645161,1.0,1.0,4/28,13.37%,RNASEH2A;POP4;AGO3;DICER1
prerank,disordered domain specific binding (GO:0097718),0.2264391598409605,0.6252843763251266,0.9324324324324325,1.0,1.0,1/23,0.70%,HSPA1A
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.26667145829457267,0.6245855874846126,0.9207547169811321,1.0,1.0,6/11,28.57%,NUDT4;NUDT11;DCPS;DCP2;NUDT3;NUDT5
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.2363824100239783,-0.6242496690432515,0.9426877470355731,0.9723009464124098,1.0,4/16,20.19%,SLC44A2;SLC44A1;SLC7A8;SLC5A7
prerank,snRNA binding (GO:0017069),0.1970751076349414,0.6224784639812572,0.9752212389380531,1.0,1.0,13/42,22.70%,CCNT2;HNRNPU;LSM4;LSM11;LSM8;HEXIM2;SNU13;DDX39B;SNRPB2;LARP7;SART3;SF3B3;EFTUD2
prerank,O-methyltransferase activity (GO:0008171),0.27126823622372465,0.620556995362401,0.9030927835051547,1.0,1.0,3/10,19.87%,BCDIN3D;COMT;COQ3
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.22260887956751635,0.6190978315833955,0.9598393574297188,1.0,1.0,3/22,14.05%,DUSP29;MTMR2;DUSP19
prerank,exoribonuclease activity (GO:0004532),-0.24876708232047579,-0.6162923104154255,0.9262135922330097,0.9736502598220321,1.0,5/12,27.07%,EXOSC1;ZC3H12A;EXOSC5;EXOSC4;EXOSC3
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.19823075578405733,0.6156125564120023,0.9716446124763705,1.0,1.0,9/33,23.37%,ANGEL2;EXOSC2;ANGEL1;USB1;DIS3L;CNOT8;PNLDC1;DCP2;PAN2
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.26068315959951827,-0.6145511464877934,0.9213709677419355,0.9714556179687378,1.0,5/10,39.41%,BRCA2;MSL3;NAA50;NAA60;NAA40
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.18740979426965948,0.5999108340723205,0.9805996472663139,1.0,1.0,3/42,7.99%,CDKN2A;CCNT2;CCNYL1
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.1832236589989305,-0.5952421200094409,0.9770354906054279,0.977702959299271,1.0,13/34,31.36%,CNOT6L;PAN3;ERI2;TOE1;EXOSC5;EXOSC4;EXOSC3;XRN2;ERI1;CNOT1;NOCT;DIS3L2;ISG20
prerank,RNA methyltransferase activity (GO:0008173),0.2226788489344271,0.5951515999268827,0.9318181818181818,1.0,1.0,2/19,8.81%,TRMT9B;BCDIN3D
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.2164694796951074,0.5945993381280168,0.9575645756457565,1.0,1.0,6/21,16.45%,WASF1;RYR2;WASF3;AKAP8;AKAP8L;AKAP6
prerank,neuropeptide hormone activity (GO:0005184),0.2118090452261306,0.5930398273770936,0.9598540145985401,1.0,1.0,22/22,78.85%,VIP;GRP;PENK;PPY;HCRT;QRFP;CORT;OXT;GHRH;NPPA;ADCYAP1;UCN;CALCB;GAL;SPX;CRH;NMB;PNOC;NPFF;NPY;AGRP;CCK
prerank,water transmembrane transporter activity (GO:0005372),-0.24506914904416768,-0.5903536834545375,0.9350912778904665,0.9767164567263618,1.0,1/11,5.58%,AQP11
prerank,microtubule motor activity (GO:0003777),0.18119014574215567,0.5897266019322965,0.9872029250457038,1.0,1.0,5/51,7.43%,DNAH1;KIF5C;KIF3C;KIF16B;KIF13B
prerank,nuclear localization sequence binding (GO:0008139),0.21957658969370042,0.5890922119792943,0.9440298507462687,0.9991523057387451,1.0,4/18,16.76%,POM121;BRAP;TNPO2;IPO4
prerank,mannose binding (GO:0005537),-0.23937008453136854,-0.589027569751827,0.9491869918699187,0.9742200223966638,1.0,1/12,4.25%,LMAN2L
prerank,TBP-class protein binding (GO:0017025),-0.2092167381618496,-0.5880504028956404,0.9753914988814317,0.9715973080620794,1.0,4/21,17.97%,ESR1;AHR;HHEX;RUVBL1
prerank,U6 snRNA binding (GO:0017070),0.23255142452728547,0.586377351096797,0.9368635437881874,0.9975784069340988,1.0,6/14,25.78%,LSM4;LSM8;DDX39B;LARP7;SART3;PRPF8
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.2512794773803856,-0.5821746629144199,0.9339805825242719,0.9709243455141344,1.0,4/10,25.19%,CDA;GDA;ADA;DCTD
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.20696773024102166,0.5810364005141312,0.9565217391304348,0.9971436107595567,1.0,9/25,26.33%,TNKS2;PARP14;PARP4;PARP16;SIRT1;ART4;PARP10;TIPARP;SIRT3
prerank,vitamin D receptor binding (GO:0042809),0.23172420416394268,0.5791284031188881,0.934020618556701,0.9951901084427264,1.0,2/14,9.80%,MED1;RXRA
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.19226967428355496,0.5785240664456315,0.9837251356238698,0.9926386462917283,1.0,5/31,16.90%,UBE2E2;UBE2W;TAF1;UBE2R2;UBE2S
prerank,acyl-CoA hydrolase activity (GO:0047617),0.21806773117557743,0.5748929324277375,0.9705882352941176,0.9914595609826852,1.0,5/17,21.24%,ABCD1;ACOT1;ACOT6;ACOT13;ACOT9
prerank,ribonuclease P RNA binding (GO:0033204),0.24799602228996315,0.5585884153739401,0.9276595744680851,0.9950269167958747,1.0,1/10,5.44%,POP4
prerank,gamma-tubulin binding (GO:0043015),0.20583461241371645,0.5572494886201702,0.9767441860465116,0.99266472603484,1.0,11/21,31.62%,TUBGCP5;TUBGCP4;NDRG1;RAD51D;DDX3X;ARHGEF7;BRSK1;RACGAP1;TUBGCP3;PAK1;BLOC1S2
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.2277253909538292,0.5402182819976405,0.9707724425887265,0.9953137920185308,1.0,1/11,8.95%,CHRNB2
prerank,nuclear import signal receptor activity (GO:0061608),-0.20083535265994923,-0.5321260806227099,0.9789915966386554,0.9836804305988015,1.0,3/15,15.34%,IPO5;HIKESHI;KPNA2
prerank,ribonuclease P activity (GO:0004526),0.22939317234119871,0.5272111530602902,0.9507494646680942,0.9961793730490981,1.0,1/11,5.44%,POP4
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.18460462603891167,0.5126101259410414,0.9821428571428571,0.9969367218964313,1.0,20/21,59.99%,CHRNB2;GRM5;GRM1;CHRFAM7A;CHRNA7;CHRNA2;CHRNA6;DRD4;ANXA9;GRIA1;DRD1;CHRNA1;DRD5;CHRNA4;CHRNB3;CHRNB4;CHRNE;CHRNA3;CHRNG;CHRNA5
prerank,3'-5' DNA helicase activity (GO:0043138),0.19106779438931434,0.5070458767322314,0.9848156182212582,0.9953852763609702,1.0,1/16,3.43%,RECQL4
prerank,carbohydrate kinase activity (GO:0019200),0.1944636243801396,0.4556918371815303,0.9902534113060428,1.0,1.0,11/11,80.57%,HK1;KHK;HK2;POMK;NAGK;GALK1;GNE;HK3;FGGY;XYLB;GALK2
prerank,nuclease activity (GO:0004518),0.12497127129413638,0.424751204153407,1.0,1.0,1.0,12/52,27.49%,RNASEH2A;MRE11;AEN;SND1;EXOG;RNASE7;DNASE1L2;N4BP2;MAP1S;APEX1;RNASEL;DNASE1L1
prerank,sodium channel activity (GO:0005272),0.12990846863577626,0.4017116097531295,1.0,0.9988235135753611,1.0,9/37,24.91%,GRIK5;GRIK2;SHROOM2;SCN8A;SCNN1A;SCN9A;ASIC4;ASIC2;HCN1
